{'idx': 1309, 'sentence': 'Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .', 'label': {'cruciform DNA': 'DNA', 'HMG boxes': 'protein', 'cross-over DNA': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[]\n[]', 'response3': '[{"HMG boxes": "protein"}, {"DNA": "DNA"}, {"DNA": "DNA"}]', 'prediction': {'HMG boxes': 'protein', 'DNA': 'DNA'}}
{'idx': 228, 'sentence': 'We have carried out experiments to define the nature of the higher affinity CVZ binding site .', 'label': {'higher affinity CVZ binding site': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 51, 'sentence': 'Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.', 'label': {'T-cell determinants': 'protein'}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[{"T-cell": "cell_type"}]', 'prediction': {'T-cell': 'cell_type'}}
{'idx': 1518, 'sentence': 'Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .', 'label': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type', 'Anti-immunoglobulin M': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"nuclear calcium/calmodulin-dependent protein kinase II": "protein"}, {"human B lymphocytes": "cell_type"}]', 'prediction': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type'}}
{'idx': 563, 'sentence': 'The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .', 'label': {'PDGF(B)': 'protein', 'PDGF(B) mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"PDGF(B) mRNA": "RNA"}]', 'prediction': {'PDGF(B) mRNA': 'RNA'}}
{'idx': 501, 'sentence': 'Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .', 'label': {'CCRF-CEM': 'cell_line', 'TCF-1 alpha': 'protein', 'nonlymphoid (HeLa) cell lines': 'cell_line', 'mature B cells': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[\n{"TCF-1 alpha": "protein"},\n{"57- to 53-kD proteins": "protein"},\n{"Jurkat": "cell_line"},\n{"CCRF-CEM": "cell_line"},\n{"JY": "cell_line"},\n{"Namalwa": "cell_line"},\n{"HeLa": "cell_line"}\n]', 'prediction': {'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}}
{'idx': 457, 'sentence': 'TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .', 'label': {'T lymphocytes': 'cell_type', 'TAR': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 285, 'sentence': 'ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .', 'label': {'ER': 'protein', 'lymphocyte DNA': 'DNA', 'lymphocytes': 'cell_type', 'lymphocyte cytosolic protein': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1508, 'sentence': 'Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .', 'label': {'BOB.1/OBF.1': 'protein', 'B cell-specific coactivator': 'protein', 'murine homolog': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"BOB.1/OBF.1": "protein"}]', 'prediction': {'BOB.1/OBF.1': 'protein'}}
{'idx': 209, 'sentence': 'Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.', 'label': {'lymphoblastoid cell line': 'cell_line', 'IM-9': 'cell_line', 'type-II EBS': 'protein', 'Type-II estrogen -binding sites': 'protein', 'human lymphoblastoid cell line': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types in the target sentence are present in this example."},\n{"Example 2": 2},\n{"Reason 2": "The entity type \'cell_line\' is mentioned in this example, which is somewhat relevant to the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1385, 'sentence': "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.", 'label': {'LTR': 'DNA', 'HIV-1 LTR': 'DNA', 'C/EBP sites': 'DNA', 'C/EBP site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1516, 'sentence': 'Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .', 'label': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'protein', 'COOH-terminal domain': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"BOB.1/OBF.1": "protein"}, {"GAL4 DNA binding domain": "DNA"}]', 'prediction': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'DNA'}}
{'idx': 1827, 'sentence': 'A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .', 'label': {'human interleukin 2 gene promoter': 'DNA', 'EGR-1': 'protein', 'Sp1': 'protein', 'regulatory element': 'DNA', 'binding site': 'DNA', 'zinc finger proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"zinc finger proteins Sp1": "protein"}, {"EGR-1": "protein"}]', 'prediction': {'zinc finger proteins Sp1': 'protein', 'EGR-1': 'protein'}}
{'idx': 1116, 'sentence': 'The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .', 'label': {'thymocytes': 'cell_type', 'p53': 'protein', 'mitogen-activated mature T lymphocytes': 'cell_line', 'tumour suppressor p53': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"p53": "protein"}, {"apoptosis": "cell_type"}, {"thymocytes": "cell_type"}, {"T lymphocytes": "cell_type"}]', 'prediction': {'p53': 'protein', 'apoptosis': 'cell_type', 'thymocytes': 'cell_type', 'T lymphocytes': 'cell_type'}}
{'idx': 178, 'sentence': 'T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .', 'label': {'T lymphocytes': 'cell_type', 'lavage cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"T lymphocytes": "cell_type"}, {"1,25(OH)2D3": "protein"}, {"T lymphocytes": "cell_type"}, {"1,25(OH)2D3": "protein"}, {"lavage cells": "cell_line"}]', 'prediction': {'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'lavage cells': 'cell_line'}}
{'idx': 1209, 'sentence': 'A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 864, 'sentence': 'Differences in transcriptional enhancers of HIV-1 and HIV-2 .', 'label': {'transcriptional enhancers': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[]\n[]', 'response3': '[{"HIV-1": "RNA"}, {"HIV-2": "RNA"}]', 'prediction': {'HIV-1': 'RNA', 'HIV-2': 'RNA'}}
{'idx': 65, 'sentence': 'Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .', 'label': {'promoter': 'DNA', 'PRDII element': 'DNA'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 61, 'sentence': 'From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.', 'label': {'82': 'protein', '43-47 kD': 'protein', 'major protein': 'protein', 'T-cells': 'cell_type', 'minor proteins': 'protein', '67': 'protein', 'HeLa cells': 'cell_line', '52 kD': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 191, 'sentence': 'A block to RNA elongation is largely responsible for decreased c-myc transcription .', 'label': {'c-myc': 'DNA'}, 'response1': "['RNA']", 'response2': '[]', 'response3': '[{"RNA": "RNA"}, {"c-myc": "protein"}]', 'prediction': {'RNA': 'RNA', 'c-myc': 'protein'}}
{'idx': 447, 'sentence': 'Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.', 'label': {'enhancer': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 476, 'sentence': 'A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .', 'label': {'protooncogenes': 'DNA', 'immediate early response genes': 'DNA', 'growth factor': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"protooncogenes": "protein"}, {"cytoskeletal": "protein"}, {"extracellular matrix genes": "protein"}, {"immediate early response genes": "protein"}, {"growth factor": "protein"}, {"cell proliferation": "cell_type"}]', 'prediction': {'protooncogenes': 'protein', 'cytoskeletal': 'protein', 'extracellular matrix genes': 'protein', 'immediate early response genes': 'protein', 'growth factor': 'protein', 'cell proliferation': 'cell_type'}}
{'idx': 1034, 'sentence': 'p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .', 'label': {'Stat1': 'protein', 'phosphorylation site': 'protein', 'Src homology 2 (SH2) domain': 'protein', 'p94': 'protein', 'p95': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"p94": "protein"}, {"p95": "protein"}, {"Stat1": "protein"}, {"Src homology 2 (SH2)": "protein"}]', 'prediction': {'p94': 'protein', 'p95': 'protein', 'Stat1': 'protein', 'Src homology 2 (SH2)': 'protein'}}
{'idx': 1232, 'sentence': 'IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).', 'label': {'IBR': 'protein', 'transcription factors': 'protein', 'erected wing gene product': 'protein', 'human NRF-1/alpha-Pal factor': 'protein', 'EWG': 'protein', 'P3A2': 'protein', '503-amino-acid-long acidic protein': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"IBR": "protein"}, {"NRF-1/alpha-Pal": "protein"}, {"P3A2": "protein"}, {"EWG": "protein"}]', 'prediction': {'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'EWG': 'protein'}}
{'idx': 54, 'sentence': 'Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .', 'label': {'LTR': 'DNA', 'human T-cell types': 'cell_type', 'T-cell types': 'cell_type', 'element': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1149, 'sentence': 'The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .', 'label': {'Sp1': 'protein', 'DCs': 'cell_type', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 4},\n    {"Example 3": 3}\n]', 'response3': '[\n    {"NF-kappa B": "protein"},\n    {"Sp1": "protein"},\n    {"T cells": "cell_type"},\n    {"DCs": "cell_type"},\n    {"humans": "cell_type"},\n    {"mice": "cell_type"}\n]', 'prediction': {'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type', 'humans': 'cell_type', 'mice': 'cell_type'}}
{'idx': 407, 'sentence': 'Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"VDR": "protein"}, {"VDR": "protein"}]', 'prediction': {'VDR': 'protein'}}
{'idx': 1466, 'sentence': 'As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .', 'label': {'endothelial cells': 'cell_type', 'NFAT': 'protein', 'activated endothelial cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"NFAT": "protein"}, {"CsA": "protein"}, {"endothelial cells": "cell_type"}, {"endothelial cells": "cell_type"}]', 'prediction': {'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}}
{'idx': 1330, 'sentence': 'Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .', 'label': {'I kappa B alpha': 'protein', 'I kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1436, 'sentence': 'Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .', 'label': {'hTR beta 1 mRNA': 'RNA', 'hTR beta 1': 'protein'}, 'response1': "['RNA']", 'response2': '[]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 859, 'sentence': 'We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .', 'label': {'inducible': 'protein', 'Jurkat cells': 'cell_line', 'C1': 'protein', 'HIV enhancer': 'DNA', 'C2': 'protein', 'constitutive, C2 , protein': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[]', 'response3': '[{"HIV enhancer": "protein"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'HIV enhancer': 'protein', 'Jurkat cells': 'cell_line'}}
{'idx': 451, 'sentence': 'However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .', 'label': {'NF-muE3': 'protein', 'B cells': 'cell_type', 'lymphoid cells': 'cell_type', 'transfected reporter gene': 'DNA', 'Ig heavy chain enhancer': 'DNA', 'non- lymphoid cells': 'cell_type', 'non-B cells': 'cell_type', 'endogenous Ig heavy chain enhancer': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 919, 'sentence': 'The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .', 'label': {'56-kDa protein': 'protein', 'p56': 'protein', 'EC1 antibody': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"EC1 antibody": "protein"}, {"p56": "protein"}]', 'prediction': {'EC1 antibody': 'protein', 'p56': 'protein'}}
{'idx': 1206, 'sentence': 'In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.', 'label': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"androgen receptors": "protein"}, {"mononuclear leukocytes": "cell_type"}, {"follicular": "cell_type"}, {"luteal": "cell_type"}, {"menstrual cycle": "cell_type"}, {"flutamide": "protein"}]', 'prediction': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type', 'follicular': 'cell_type', 'luteal': 'cell_type', 'menstrual cycle': 'cell_type', 'flutamide': 'protein'}}
{'idx': 569, 'sentence': 'In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .', 'label': {'PDGF(B)': 'protein', 'EGR2': 'DNA', 'c-jun': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"c-jun": "protein"}, {"EGR2": "protein"}, {"PDGF(B)": "protein"}]', 'prediction': {'c-jun': 'protein', 'EGR2': 'protein', 'PDGF(B)': 'protein'}}
{'idx': 1657, 'sentence': 'HMG-I binds to GATA motifs : implications for an HPFH syndrome .', 'label': {'HMG-I': 'protein', 'GATA motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any entities that match the entity types in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any entities that match the entity types in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any entities that match the entity types in the target sentence."}\n]', 'response3': '[{"HMG-I": "protein"}, {"GATA motifs": "DNA"}, {"HPFH syndrome": "cell_type"}]', 'prediction': {'HMG-I': 'protein', 'GATA motifs': 'DNA', 'HPFH syndrome': 'cell_type'}}
{'idx': 1780, 'sentence': 'Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .', 'label': {'Id3': 'protein', 'Mo': 'cell_line', 'Id2': 'protein', '4/5 T-cell lines': 'cell_line', 'S-LB1': 'cell_line', 'MT-2': 'cell_line', 'ATL-1k': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types present in the target sentence are mentioned in this example."},\n{"Example 2": 2},\n{"Reason 2": "The entity type \'cell_line\' is mentioned in this example, which is present in the target sentence. However, the example does not mention the entity type \'RNA\' which is also present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types present in the target sentence are mentioned in this example."}\n]', 'response3': '[\n{"Id2": "RNA"},\n{"Id3": "None"},\n{"T-cell lines": "cell_line"},\n{"human T-cell leukemia virus type I (HTLV-I)": "cell_type"},\n{"ATL-1k": "cell_line"},\n{"MT-2": "cell_line"},\n{"S-LB1": "cell_line"},\n{"type II (Mo)": "None"}\n]', 'prediction': {'Id2': 'RNA', 'Id3': 'None', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'None'}}
{'idx': 13, 'sentence': 'We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.', 'label': {'platelet-activating factor': 'protein', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"platelet-activating factor": "protein"}, {"B cells": "cell_type"}, {"arachidonic acid": "protein"}, {"5-hydroxyeicosatetraenoic acid": "protein"}]', 'prediction': {'platelet-activating factor': 'protein', 'B cells': 'cell_type', 'arachidonic acid': 'protein', '5-hydroxyeicosatetraenoic acid': 'protein'}}
{'idx': 1554, 'sentence': 'The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .', 'label': {'GP': 'protein', 'normal platelets': 'cell_type', 'cis-acting elements': 'DNA', 'GP Ib alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[\n    {"GP Ib alpha": "protein"}\n]', 'prediction': {'GP Ib alpha': 'protein'}}
{'idx': 1650, 'sentence': 'This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .', 'label': {'PU.1': 'protein', 'myeloid PU.1 binding site': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence, but does not contain \'protein\'."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"PU.1": "protein"}, {"myeloid": "cell_type"}]', 'prediction': {'PU.1': 'protein', 'myeloid': 'cell_type'}}
{'idx': 326, 'sentence': 'We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .', 'label': {'EB1': 'protein', 'R-responsive element': 'DNA', 'HeLa cells': 'cell_line', 'domain B': 'DNA', 'EB1 -responsive B-cell-specific element': 'DNA'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1429, 'sentence': 'Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .', 'label': {'TR': 'protein'}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[{"TR": "protein"}]', 'prediction': {'TR': 'protein'}}
{'idx': 865, 'sentence': 'Response to T cell activation signals .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 696, 'sentence': 'First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .', 'label': {'TRE -DNA fragment': 'DNA', 'nuclear proteins': 'protein', 'TRE': 'DNA'}, 'response1': "['protein', 'DNA', 'cell_line']", 'response2': '[]', 'response3': '[{"TRE -DNA fragment": "DNA"}, {"cell lines": "cell_line"}, {"nuclear proteins": "protein"}]', 'prediction': {'TRE -DNA fragment': 'DNA', 'cell lines': 'cell_line', 'nuclear proteins': 'protein'}}
{'idx': 318, 'sentence': 'Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.', 'label': {'estrogen receptor': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"estrogen receptor": "protein"}]', 'prediction': {'estrogen receptor': 'protein'}}
{'idx': 440, 'sentence': 'All three proteins show the same sequence specificity and binding affinity .', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"proteins": "protein"}]', 'prediction': {'proteins': 'protein'}}
{'idx': 1563, 'sentence': 'Pathogenesis of atherosclerosis .', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 689, 'sentence': 'High-risk patients can be recognized morphologically.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence mentions tumors and clinical course, but does not contain any named entities related to the entity types in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence mentions genes and isoforms, but does not contain any named entities related to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 189, 'sentence': 'Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .', 'label': {'human T lymphoblastic tumor cell line': 'cell_line', 'c-myc': 'DNA'}, 'response1': "['protein', 'cell_line']", 'response2': '[]', 'response3': '[{"c-myc": "protein"}, {"T lymphoblastic tumor cell line": "cell_line"}]', 'prediction': {'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}}
{'idx': 778, 'sentence': 'Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .', 'label': {'OTF-1': 'protein', 'pre-B cells': 'cell_line', 'immunoglobulin gene': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"OTF-1": "protein"}, {"pre-B cells": "cell_type"}, {"HeLa cells": "cell_line"}, {"immunoglobulin gene": "DNA"}]', 'prediction': {'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'DNA'}}
{'idx': 198, 'sentence': "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.", 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 735, 'sentence': 'This prompted us to analyze the octamer-binding proteins in the latter cells.', 'label': {'octamer-binding proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"octamer-binding proteins": "protein"}]', 'prediction': {'octamer-binding proteins': 'protein'}}
{'idx': 1735, 'sentence': 'We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .', 'label': {'VDR': 'protein', 'IL-2 promoter/reporter constructs': 'DNA', 'Jurkat cells': 'cell_line', 'VDR overexpression vector': 'DNA', 'IL-2': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"IL-2": "protein"}, {"Jurkat cells": "cell_line"}, {"IL-2 promoter/reporter constructs": "DNA"}, {"VDR": "protein"}, {"DNA": "DNA"}]', 'prediction': {'IL-2': 'protein', 'Jurkat cells': 'cell_line', 'IL-2 promoter/reporter constructs': 'DNA', 'VDR': 'protein', 'DNA': 'DNA'}}
{'idx': 704, 'sentence': 'Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .', 'label': {'ubiquitous and developmentally regulated proteins': 'protein', 'ubiquitous': 'protein', 'developmentally regulated proteins': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"immunoglobulin heavy": "protein"}, {"kappa light chain": "protein"}]', 'prediction': {'immunoglobulin heavy': 'protein', 'kappa light chain': 'protein'}}
{'idx': 1236, 'sentence': 'Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .', 'label': {'direct-repeat palindrome': 'DNA', 'IBR/F': 'protein', 'IBR/F binding sites': 'DNA', 'optimal site': 'DNA', 'alternating RCGCRYGCGY consensus': 'protein'}, 'response1': "['DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any specific entities mentioned in the target sentence."}\n]', 'response3': '[{"RCGCRYGCGY": "DNA"}, {"TGCGCATGCGCA": "DNA"}]', 'prediction': {'RCGCRYGCGY': 'DNA', 'TGCGCATGCGCA': 'DNA'}}
{'idx': 541, 'sentence': 'To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1652, 'sentence': 'Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.', 'label': {'PU.1': 'protein', 'PU-SF complex': 'protein', 'myeloid promoters': 'DNA', 'PU.1 site': 'DNA', 'PU-SF': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"PU-SF complex": "protein"}, {"PU.1": "protein"}, {"PU.1": "protein"}]', 'prediction': {'PU-SF complex': 'protein', 'PU.1': 'protein'}}
{'idx': 88, 'sentence': 'TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .', 'label': {'TNF alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1494, 'sentence': 'Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .', 'label': {'latent NF-kappa B': 'protein', 'cytokine': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 940, 'sentence': 'Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .', 'label': {'PBMC': 'cell_type', 'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1098, 'sentence': 'Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .', 'label': {'microtubules': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 255, 'sentence': 'c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.', 'label': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[]', 'response3': '[{"c-myc RNA": "RNA"}, {"RWLeu-4 cells": "cell_line"}]', 'prediction': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line'}}
{'idx': 775, 'sentence': 'Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.', 'label': {'OTF-1': 'protein', 'OTF-2': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"OTF-2": "protein"},\n    {"OTF-1": "protein"},\n    {"cell types": "cell_type"}\n]', 'prediction': {'OTF-2': 'protein', 'OTF-1': 'protein', 'cell types': 'cell_type'}}
{'idx': 161, 'sentence': 'Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1130, 'sentence': 'B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .', 'label': {'B-lymphoblastoid cell lines': 'cell_line'}, 'response1': "['cell_line', 'virus']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any entities related to the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence mentions tumors and clinical course, which are not relevant to the entities in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence talks about genes and isoforms, which are not related to the entities in the target sentence."}\n]', 'response3': '[\n{"B-lymphoblastoid cell lines": "cell_line"},\n{"Epstein-Barr virus": "virus"}\n]', 'prediction': {'B-lymphoblastoid cell lines': 'cell_line', 'Epstein-Barr virus': 'virus'}}
{'idx': 600, 'sentence': 'Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .', 'label': {'immunoglobulin heavy-chain gene': 'DNA', 'lymphoid-specific enhancer element': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"lymphoid-specific enhancer element": "DNA"}, {"immunoglobulin heavy-chain gene": "protein"}]', 'prediction': {'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'protein'}}
{'idx': 1698, 'sentence': 'Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .', 'label': {'natural killer cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1287, 'sentence': 'Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .', 'label': {'Platelet thromboxane receptors': 'protein', 'Platelet': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1266, 'sentence': 'Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .', 'label': {'EBV -positive B cell lines': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[]\n[]', 'response3': '[{"EBV": "cell_line"}]', 'prediction': {'EBV': 'cell_line'}}
{'idx': 1813, 'sentence': 'Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .', 'label': {'BLR2 mRNA': 'RNA', 'BLR2': 'protein'}, 'response1': "['RNA', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[{"BLR2 mRNA": "RNA"}, {"mitogen- and anti-CD3- treated peripheral blood lymphocytes": "cell_type"}]', 'prediction': {'BLR2 mRNA': 'RNA', 'mitogen- and anti-CD3- treated peripheral blood lymphocytes': 'cell_type'}}
{'idx': 1764, 'sentence': 'The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .', 'label': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'transcription factor': 'protein', 'mitogen-stimulated cells': 'cell_type'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the examples contain entity types present in the target sentence, so they are not helpful for extracting named entities from the target sentence."}\n]', 'response3': '[\n    {"DNA": "DNA"},\n    {"AP-1": "protein"},\n    {"NF-kappa B": "protein"}\n]', 'prediction': {'DNA': 'DNA', 'AP-1': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 740, 'sentence': 'On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.', 'label': {'ubiquitous Oct-1': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein', 'lymphoid-specific Oct-2A': 'protein', 'N-Oct-factors': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"N-Oct-factors": "protein"}, {"Oct-1": "protein"}, {"Oct-2A": "protein"}]', 'prediction': {'N-Oct-factors': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein'}}
{'idx': 1182, 'sentence': 'Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .', 'label': {'IL-2': 'protein', 'T cells': 'cell_type', 'COOH-terminal region': 'protein', 'human T cells': 'cell_type', 'Ser386-Val525': 'protein', 'JAK3': 'protein', 'STAT transcription factor': 'protein', 'STAT5': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"STAT5": "protein"},\n{"IL-2": "protein"},\n{"IL-2R beta": "protein"},\n{"IL-2R gamma": "protein"},\n{"JAK3": "protein"}\n]', 'prediction': {'STAT5': 'protein', 'IL-2': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein'}}
{'idx': 393, 'sentence': 'We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.', 'label': {'HNP-1': 'protein', 'pag': 'DNA', 'NP-1': 'protein', 'defensins': 'protein', 'NP-5': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"defensins NP-1": "protein"}, {"NP-5": "protein"}, {"HNP-1": "protein"}, {"pag": "protein"}]', 'prediction': {'defensins NP-1': 'protein', 'NP-5': 'protein', 'HNP-1': 'protein', 'pag': 'protein'}}
{'idx': 1442, 'sentence': 'T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .', 'label': {'interleukin 3': 'protein', 'transcriptional start site': 'DNA', 'IL-3': 'protein'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[{"interleukin 3": "protein"}, {"IL-3": "protein"}, {"DNA": "DNA"}]', 'prediction': {'interleukin 3': 'protein', 'IL-3': 'protein', 'DNA': 'DNA'}}
{'idx': 142, 'sentence': 'This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .', 'label': {'U937 cells': 'cell_line', 'NF-kappa B': 'protein', 'viral RNA': 'RNA', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"HIV type 1": "RNA"}, {"HIV-1": "RNA"}, {"U937": "cell_line"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'RNA', 'HIV-1': 'RNA', 'U937': 'cell_line'}}
{'idx': 93, 'sentence': 'The Thy-1 gene promoter resembles a "housekeeping" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5\'-end termini of the mRNA .', 'label': {'canonical TATA box': 'DNA', '"housekeeping" promoter': 'DNA', 'methylation-free island': 'DNA', "5'-end termini": 'RNA', 'Thy-1 gene promoter': 'DNA', 'mRNA': 'RNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"Thy-1 gene promoter": "DNA"}]', 'prediction': {'Thy-1 gene promoter': 'DNA'}}
{'idx': 1354, 'sentence': 'In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .', 'label': {'TCF-1': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"nuclear TCF-1": "protein"}]', 'prediction': {'nuclear TCF-1': 'protein'}}
{'idx': 466, 'sentence': '(ABSTRACT TRUNCATED AT 250 WORDS)', 'label': {}, 'response1': 'None.', 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1583, 'sentence': 'Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.', 'label': {'ribonucleoproteins': 'protein', 'Ro(SSA)': 'protein', 'autoantibodies': 'protein', 'HLA class II antigens': 'protein', 'La(SSB)': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for extracting named entities."}\n]', 'response3': '[{"HLA class II antigens": "protein"},\n{"ribonucleoproteins Ro(SSA)": "protein"},\n{"La(SSB)": "protein"}]', 'prediction': {'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}}
{'idx': 592, 'sentence': 'The DNA isolated contained an open reading frame encoding 108 amino acid residues .', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'protein\', which is present in the target sentence, but it does not contain \'DNA\' which is also present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"DNA": "DNA"}]', 'prediction': {'DNA': 'DNA'}}
{'idx': 163, 'sentence': 'This phenomenon can be mimicked by administering MP in divided doses.', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1751, 'sentence': 'This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.', 'label': {'NFAT': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1774, 'sentence': 'Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .', 'label': {'PBMC': 'cell_type', 'PBMC receptors': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 206, 'sentence': 'It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"ER": "protein"}, {"ER": "protein"}]', 'prediction': {'ER': 'protein'}}
{'idx': 928, 'sentence': 'A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).', 'label': {'ets-1': 'protein', 'long terminal repeat': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'mouse ets-1 cDNA clone': 'DNA', 'LTR': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[]', 'response3': '[{"mouse ets-1 cDNA clone": "DNA"}, {"mouse thymus cDNA expression library": "DNA"}, {"double-stranded oligonucleotide probe": "DNA"}, {"Moloney murine sarcoma virus (MSV) long terminal repeat (LTR)": "DNA"}]', 'prediction': {'mouse ets-1 cDNA clone': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'Moloney murine sarcoma virus (MSV) long terminal repeat (LTR)': 'DNA'}}
{'idx': 1301, 'sentence': 'It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any entities relevant to the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any entities relevant to the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any entities relevant to the target sentence."}\n]', 'response3': '[{"NK activity": "cell_type"}, {"tumor ER concentration": "protein"}, {"ER": "protein"}]', 'prediction': {'NK activity': 'cell_type', 'tumor ER concentration': 'protein', 'ER': 'protein'}}
{'idx': 1708, 'sentence': 'The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .', 'label': {'nuclear factor (NF)-kappa B': 'protein', 'T cell lines': 'cell_line', 'Ca(2+) -dependent phosphatase': 'protein', 'PKC': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"calcineurin": "protein"}, {"FK506": "protein"}, {"CsA": "protein"}, {"PKC": "protein"}, {"NF-kappa B": "protein"}, {"T cell lines": "cell_line"}]', 'prediction': {'calcineurin': 'protein', 'FK506': 'protein', 'CsA': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 747, 'sentence': 'Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).', 'label': {'unspliced mRNA': 'RNA'}, 'response1': "['protein', 'RNA']", 'response2': '[]', 'response3': '[{"Protein kinase inhibitor H-7": "protein"}, {"unspliced mRNA": "RNA"}, {"human T-cell leukemia virus type I (HTLV-I)": "cell_type"}]', 'prediction': {'Protein kinase inhibitor H-7': 'protein', 'unspliced mRNA': 'RNA', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type'}}
{'idx': 333, 'sentence': 'These protoenhancers alone are weakly or not responsive to R .', 'label': {'protoenhancers': 'DNA', 'R': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 758, 'sentence': 'Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.', 'label': {'CEM-C7': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[]', 'response3': '[{"CEM-C7 cells": "cell_line"}]', 'prediction': {'CEM-C7 cells': 'cell_line'}}
{'idx': 727, 'sentence': 'The importance of the internal ATGs to Rex function is not known.', 'label': {'Rex': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 429, 'sentence': 'As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.', 'label': {'TSAP': 'protein', 'mammalian protein': 'protein', 'sea urchin binding sites': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"BSAP": "protein"}, {"TSAP": "protein"}]', 'prediction': {'BSAP': 'protein', 'TSAP': 'protein'}}
{'idx': 1372, 'sentence': 'The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).', 'label': {'14q32.1': 'DNA', 'TCR alpha/beta loci': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 'TCL1 oncogene': 'DNA', 'human chromosome': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inv14(q11;q32.1)': 'DNA'}, 'response1': "['DNA', 'cell_type']", 'response2': '[]', 'response3': '[{"TCL1 oncogene": "protein"}, {"human chromosome 14q32.1": "DNA"}, {"chromosome translocations": "DNA"}, {"t(14;14)(q11;q32.1)": "DNA"}, {"t(7;14)(q35;q32.1)": "DNA"}, {"inversions": "DNA"}, {"inv14(q11;q32.1)": "DNA"}, {"TCR alpha/beta loci": "DNA"}, {"T-cell leukemias": "cell_type"}, {"T-prolymphocytic ( T-PLL )": "cell_type"}]', 'prediction': {'TCL1 oncogene': 'protein', 'human chromosome 14q32.1': 'DNA', 'chromosome translocations': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inversions': 'DNA', 'inv14(q11;q32.1)': 'DNA', 'TCR alpha/beta loci': 'DNA', 'T-cell leukemias': 'cell_type', 'T-prolymphocytic ( T-PLL )': 'cell_type'}}
{'idx': 546, 'sentence': 'Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .', 'label': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"T lymphocytes": "cell_type"}, {"immunophilin": "protein"}, {"FK506": "protein"}, {"rapamycin": "protein"}]', 'prediction': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}}
{'idx': 1437, 'sentence': 'In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.', 'label': {'hTR beta 1': 'protein', 'hTR beta 1 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 1399, 'sentence': 'To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .', 'label': {'hematopoietic cell lineage': 'cell_line', 'human estrogen receptor': 'protein', 'NF-M': 'protein', 'hormone binding domain': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence mentions tumors, which could potentially be related to \'cell_line\', but the context is not specific enough to definitively identify a named entity."},\n{"Example 3": 1},\n{"Reason 3": "The sentence talks about genes and isoforms, which could be related to \'protein\' or \'DNA\', but again, the context is not specific enough to definitively identify a named entity."}\n]', 'response3': '[\n{"NF-M": "protein"},\n{"hormone binding domain": "protein"},\n{"human estrogen receptor": "protein"}\n]', 'prediction': {'NF-M': 'protein', 'hormone binding domain': 'protein', 'human estrogen receptor': 'protein'}}
{'idx': 1327, 'sentence': 'Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .', 'label': {'human IL-4': 'protein', 'human IL-4 promoter': 'DNA', 'NF-IL6': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"NF-IL6": "protein"}, {"IL-4": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}}
{'idx': 146, 'sentence': 'Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the "octamer" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .', 'label': {'"octamer" motif': 'DNA', 'HLA-DR alpha (DRA) promoter': 'DNA', 'class II promoters': 'DNA', 'immunoglobulin variable region promoters': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence. However, it does not contain the entity type \'protein\' which is also present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"HLA-DR alpha (DRA)": "protein"},\n{"octamer": "protein"},\n{"immunoglobulin variable region": "protein"},\n{"B cell-specific": "cell_type"}\n]', 'prediction': {'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}}
{'idx': 1247, 'sentence': 'The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .', 'label': {'Janus family tyrosine kinase': 'protein', 'Jak3': 'protein', 'gamma c': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"Jak3": "protein"}, {"gamma c": "protein"}, {"Jak3": "protein"}, {"XSCID": "cell_type"}]', 'prediction': {'Jak3': 'protein', 'gamma c': 'protein', 'XSCID': 'cell_type'}}
{'idx': 1300, 'sentence': 'As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 2},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 3},\n    {"Reason 2": "The sentence contains the entity type \'cell_line\', which is present in the target sentence."},\n    {"Example 3": 2},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 350, 'sentence': 'Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .', 'label': {'control cell line': 'cell_line', 'cell line': 'cell_line', 'Ro-VDR': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types in the target sentence are present in this example."},\n{"Example 2": 1},\n{"Reason 2": "None of the entity types in the target sentence are present in this example."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1093, 'sentence': 'The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).', 'label': {'VDR': 'protein', 'vitamin D receptor': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"1,25-dihydroxyvitamin D3": "protein"}, {"VDR": "protein"}]', 'prediction': {'1,25-dihydroxyvitamin D3': 'protein', 'VDR': 'protein'}}
{'idx': 1493, 'sentence': 'Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .', 'label': {'myeloid cells': 'cell_type', 'NF-kappa B': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"NF-kappa B": "DNA"}\n]', 'prediction': {'NF-kappa B': 'DNA'}}
{'idx': 334, 'sentence': "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .", 'label': {'protoenhancers': 'DNA', 'overlapping palindromes': 'DNA'}, 'response1': "['DNA']", 'response2': '[]\n[]', 'response3': '[{"5\'-TTGTCCcgtGGACAAaTGTCC-3\'": "DNA"}]', 'prediction': {"5'-TTGTCCcgtGGACAAaTGTCC-3'": 'DNA'}}
{'idx': 946, 'sentence': 'Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 777, 'sentence': 'We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.', 'label': {'OTF-2': 'protein', 'immunoglobulin gene': 'DNA', 'steady-state immunoglobulin heavy-chain mRNA': 'RNA', 'human pre-B-cell lines': 'cell_line', 'immunoglobulin heavy-chain': 'protein'}, 'response1': "['cell_line', 'RNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 552, 'sentence': 'Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .', 'label': {'IL-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1310, 'sentence': 'The abundant chromosomal protein HMG-1 belongs to this subgroup.', 'label': {'HMG-1': 'protein', 'chromosomal protein': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"HMG-1": "protein"}]', 'prediction': {'HMG-1': 'protein'}}
{'idx': 1409, 'sentence': 'We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .', 'label': {'IL-2': 'protein', 'T cell lines': 'cell_line', 'PRL': 'protein', 'Stat proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1140, 'sentence': 'The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .', 'label': {'transcription factors': 'protein', 'conserved cis-acting sequence': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"GGAAAA": "DNA"}]', 'prediction': {'GGAAAA': 'DNA'}}
{'idx': 449, 'sentence': 'We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .', 'label': {'ubiquitous transcription factor': 'protein', 'E3 enhancer motif': 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1402, 'sentence': 'At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .', 'label': {'eosinophil': 'cell_type', 'myeloid lineages': 'cell_type', 'differentiation markers': 'protein', 'progenitor-specific surface markers': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 664, 'sentence': 'Interferon-gamma and the sexual dimorphism of autoimmunity .', 'label': {'Interferon-gamma': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1726, 'sentence': 'It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .', 'label': {'NF-kappa B': 'protein', 'cytotoxic cytokine': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 1},\n    {"Example 3": 1},\n    {"Reasons": "The provided examples do not contain any of the entity types present in the target sentence, so they are not helpful in aiding the extraction of named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1573, 'sentence': 'Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .', 'label': {'estrogen': 'protein', 'eosinophil cationic protein': 'protein', 'positive cells': 'cell_type', 'progesterone receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"estrogen": "protein"}, {"progesterone": "protein"}, {"eosinophil cationic protein": "protein"}, {"eosinophils": "cell_type"}]', 'prediction': {'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1589, 'sentence': 'Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .', 'label': {'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type', 'NF-AT': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 114, 'sentence': 'These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .', 'label': {'NF-KB': 'protein', 'monocytic cell lineage': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_line\', which is present in the target sentence. However, the context and relevance of the entity in this sentence may not directly aid in extracting named entities from the target_sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 469, 'sentence': 'Cardiac and adrenergic diseases were excluded.', 'label': {}, 'response1': 'None.', 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1683, 'sentence': 'These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .', 'label': {'c-jun': 'DNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1648, 'sentence': 'Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.', 'label': {'PU.1 site': 'DNA', 'GM-CSF receptor alpha': 'protein', 'GM-CSF receptor alpha promoter': 'DNA', 'myelomonocytic cells': 'cell_type', 'C/EBP': 'protein', 'PU.1': 'protein', 'GM-CSF': 'protein', 'C/EBP site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 646, 'sentence': 'Surgically confirmed nodal involvement was observed in 42%.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any specific entities mentioned in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence talks about tumors and clinical course, but does not mention any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence discusses genes and isoforms, but does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 821, 'sentence': '(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .', 'label': {'LMP1': 'protein', 'EBNA-2': 'protein', 'EBV type 1 EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"EBV type 2 EBNA-2": "protein"}, {"LMP1": "protein"}, {"EBV type 1 EBNA-2": "protein"}]', 'prediction': {'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}}
{'idx': 548, 'sentence': 'On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 135, 'sentence': 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).', 'label': {'U9-IIIB': 'cell_line', 'monocytic U937 cells': 'cell_line', 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA': 'RNA', 'chronically HIV infected U937 cell line': 'cell_line', 'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'cell_type', 'cell_line']", 'response2': '[]', 'response3': '[{"Tumor necrosis factor alpha": "protein"}, {"TNF-alpha": "protein"}, {"mRNA": "RNA"}, {"polymerase chain reaction": "DNA"}, {"monocytic U937 cells": "cell_type"}, {"HIV infected U937 cell line": "cell_line"}, {"U9-IIIB": "cell_line"}]', 'prediction': {'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein', 'mRNA': 'RNA', 'polymerase chain reaction': 'DNA', 'monocytic U937 cells': 'cell_type', 'HIV infected U937 cell line': 'cell_line', 'U9-IIIB': 'cell_line'}}
{'idx': 432, 'sentence': 'Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .', 'label': {'transfected B cells': 'cell_line', 'TSAP': 'protein', 'mutant TSAP -binding site': 'DNA', 'upstream promoter element': 'DNA', 'BSAP': 'protein', 'B-cell-specific transcription factor': 'protein', 'wild-type': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[\n{"BSAP": "protein"},\n{"B-cell": "cell_type"},\n{"TSAP": "protein"},\n{"sea urchin": "cell_line"},\n{"B cells": "cell_type"}\n]', 'prediction': {'BSAP': 'protein', 'B-cell': 'cell_type', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B cells': 'cell_type'}}
{'idx': 1161, 'sentence': 'Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .', 'label': {'I kappa B alpha': 'protein', 'NF kappa B': 'protein', 'NF kappa B -I kappa B complex': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"NF kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"NF kappa B -I kappa B complex": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'NF kappa B -I kappa B complex': 'protein'}}
{'idx': 1794, 'sentence': 'Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .', 'label': {'STAT': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence. However, the relevance of the example is limited as it does not contain other entity types like \'protein\'."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1470, 'sentence': 'Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .', 'label': {'neutrophil': 'cell_type', 'tumor necrosis factor (TNF)-alpha': 'protein', 'leukocyte adhesion molecule': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types in the target sentence are present in this example."},\n{"Example 2": 2},\n{"Reason 2": "The entity type \'cell_type\' is present in this example, which is somewhat relevant to the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[\n{"TNF-alpha": "protein"},\n{"CsA": "protein"}\n]', 'prediction': {'TNF-alpha': 'protein', 'CsA': 'protein'}}
{'idx': 644, 'sentence': 'Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?', 'label': {'tumor cells': 'cell_type', 'hematopoietic growth factor': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 2": 2},\n    {"Reason 2": "The sentence contains \'tumors\' which could potentially be related to \'cell_type\' in the target sentence, but the relevance is not strong enough to provide significant aid in extracting named entities."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 435, 'sentence': 'Antibodies are produced exclusively in B lymphocytes .', 'label': {'Antibodies': 'protein', 'lymphocytes': 'cell_type', 'B lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"Antibodies": "protein"}, {"B lymphocytes": "cell_type"}]', 'prediction': {'Antibodies': 'protein', 'B lymphocytes': 'cell_type'}}
{'idx': 1342, 'sentence': 'While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.', 'label': {'amino acid domain': 'protein', 'BH1': 'protein', 'BH3': 'protein', 'Bak': 'protein', 'BH2': 'protein', 'Bax': 'protein', 'Bik': 'protein', 'Bcl-2 family': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"Bik": "protein"}, {"BH1": "protein"}, {"BH2": "protein"}, {"Bcl-2": "protein"}, {"BH3": "protein"}, {"Bax": "protein"}, {"Bak": "protein"}]', 'prediction': {'Bik': 'protein', 'BH1': 'protein', 'BH2': 'protein', 'Bcl-2': 'protein', 'BH3': 'protein', 'Bax': 'protein', 'Bak': 'protein'}}
{'idx': 1022, 'sentence': 'NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .', 'label': {'NK cell NFAT': 'protein', 'AP-1': 'protein', 'nonstimulated cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"NK cell NFAT": "cell_type"}, {"cytosol": "cell_type"}, {"nucleus": "cell_type"}, {"AP-1": "protein"}]', 'prediction': {'NK cell NFAT': 'cell_type', 'cytosol': 'cell_type', 'nucleus': 'cell_type', 'AP-1': 'protein'}}
{'idx': 810, 'sentence': 'Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .', 'label': {'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'protein'}, 'response1': "['cell_type', 'protein', 'protein', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"CML cells": "cell_type"}, {"IFN-alpha": "protein"}, {"CML cytoplasmic proteins": "protein"}, {"nuclear protein-DNA complexes": "protein"}]', 'prediction': {'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'protein'}}
{'idx': 1811, 'sentence': "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .", 'label': {'BLR1': 'protein', 'BLR2': 'protein', 'seven transmembrane receptor': 'protein', 'activated lymphocytes': 'cell_type', 'chemokine receptors': 'protein', "Burkitt's lymphoma receptor 1": 'protein'}, 'response1': "['RNA', 'protein']", 'response2': '[]', 'response3': '[{"Burkitt\'s lymphoma receptor 1": "protein"}, {"BLR1": "protein"}, {"RT-PCR": "DNA"}, {"cDNA": "DNA"}, {"BLR2": "protein"}]', 'prediction': {"Burkitt's lymphoma receptor 1": 'protein', 'BLR1': 'protein', 'RT-PCR': 'DNA', 'cDNA': 'DNA', 'BLR2': 'protein'}}
{'idx': 1316, 'sentence': 'Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.', 'label': {'Helix III': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Helix III": "protein"}, {"helices I": "protein"}, {"helices II": "protein"}]', 'prediction': {'Helix III': 'protein', 'helices I': 'protein', 'helices II': 'protein'}}
{'idx': 939, 'sentence': 'However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.', 'label': {'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"estrogen": "protein"}, {"tamoxifen": "protein"}]', 'prediction': {'estrogen': 'protein', 'tamoxifen': 'protein'}}
{'idx': 292, 'sentence': 'We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.', 'label': {'globin gene': 'DNA', 'mouse embryonic stem (ES) cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"mouse embryonic stem (ES) cells": "cell_type"}]', 'prediction': {'mouse embryonic stem (ES) cells': 'cell_type'}}
{'idx': 542, 'sentence': 'Amino acid sequences of all proteins are essays written in the same language.', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"proteins": "protein"}]', 'prediction': {'proteins': 'protein'}}
{'idx': 505, 'sentence': 'The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .', 'label': {'Jurkat': 'cell_line', 'TCF-1 alpha': 'protein', 'TCR': 'protein', 'T-cell-specific transcription factor': 'protein', 'TCF-1 alpha binding site': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCR alpha": "protein"}, {"Jurkat": "cell_line"}, {"HeLa": "cell_line"}, {"TCF-1 alpha": "protein"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line'}}
{'idx': 1525, 'sentence': 'Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .', 'label': {'antibody': 'protein', 'CaM kinase II': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"CaM kinase II": "protein"}]', 'prediction': {'CaM kinase II': 'protein'}}
{'idx': 1103, 'sentence': 'Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.', 'label': {'platelets': 'cell_type', 'Rap1 protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 538, 'sentence': 'Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .', 'label': {'PHA': 'protein', 'phytohaemagglutinin': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 2},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, making it less helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1529, 'sentence': 'Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .', 'label': {'Oct-2a': 'protein', 'lymphoid-specific transcription factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1197, 'sentence': 'In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.', 'label': {'ubiquitin': 'protein', 'p105 precursor': 'protein', 'E2-F1': 'protein', '-proteasome': 'protein', 'ubiquitin -carrier protein': 'protein', 'p53': 'protein', 'ubiquitin -protein ligase': 'protein', '320-kDa species': 'protein', 'p105': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"ubiquitin -proteasome system": "protein"}, {"p105 precursor": "protein"}, {"ubiquitin": "protein"}, {"E2-F1": "protein"}, {"p53": "protein"}, {"ubiquitin -carrier protein": "protein"}, {"ubiquitin -protein ligase": "protein"}]', 'prediction': {'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}}
{'idx': 877, 'sentence': 'Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .', 'label': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[{"B lymphocytes": "cell_type"}, {"thymic epithelial cells": "cell_type"}]', 'prediction': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}}
{'idx': 1838, 'sentence': 'First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.', 'label': {'LEF-1 -binding site': 'DNA', 'HIV-1 enhancer': 'DNA', 'LEF-1': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_line', 'multimerized copies': 'DNA', 'LEF-1 /GAL4': 'protein'}, 'response1': "['protein', 'cell_line', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"LEF-1": "protein"}, {"HIV-1": "DNA"}, {"Jurkat T cells": "cell_line"}, {"GAL4": "protein"}, {"HIV-1": "DNA"}]', 'prediction': {'LEF-1': 'protein', 'HIV-1': 'DNA', 'Jurkat T cells': 'cell_line', 'GAL4': 'protein'}}
{'idx': 1195, 'sentence': 'Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .', 'label': {'60-kDa precursor': 'protein', 'ubiquitin': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"Palombella": "protein"},\n{"Rando": "protein"},\n{"Goldberg": "protein"},\n{"Maniatis": "protein"},\n{"ubiquitin": "protein"}\n]', 'prediction': {'Palombella': 'protein', 'Rando': 'protein', 'Goldberg': 'protein', 'Maniatis': 'protein', 'ubiquitin': 'protein'}}
{'idx': 817, 'sentence': '(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .', 'label': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 741, 'sentence': 'In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .', 'label': {'Oct-2A expression vector': 'DNA', 'Oct-2A': 'protein', 'N-Oct-3 factor': 'protein', 'melanoma cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"melanoma cells": "cell_type"}, {"N-Oct-3 factor": "protein"}, {"lymphocyte-specific promoter": "DNA"}, {"Oct-2A expression vector": "DNA"}]', 'prediction': {'melanoma cells': 'cell_type', 'N-Oct-3 factor': 'protein', 'lymphocyte-specific promoter': 'DNA', 'Oct-2A expression vector': 'DNA'}}
{'idx': 283, 'sentence': '[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]', 'label': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1043, 'sentence': 'METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1010, 'sentence': 'Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .', 'label': {'murine NFATp': 'protein', 'NFATp protein': 'protein', 'NFATp': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NFATp": "protein"}, {"NFATp": "protein"}, {"thymus": "cell_type"}, {"spleen": "cell_type"}]', 'prediction': {'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}}
{'idx': 186, 'sentence': 'We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .', 'label': {'erythrocytic lineage': 'cell_type', 'NF-E2': 'protein', 'trans-acting factor': 'protein', 'megakaryocytes': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"NF-E2": "protein"}, {"erythrocytic lineage": "cell_type"}, {"megakaryocytes": "cell_type"}]', 'prediction': {'NF-E2': 'protein', 'erythrocytic lineage': 'cell_type', 'megakaryocytes': 'cell_type'}}
{'idx': 1547, 'sentence': 'Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .', 'label': {'multisubunit adhesion receptor': 'protein', 'Ib-IX-V': 'protein', 'Platelet glycoprotein': 'protein', 'GP': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Platelet glycoprotein": "protein"}]', 'prediction': {'Platelet glycoprotein': 'protein'}}
{'idx': 96, 'sentence': 'We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .', 'label': {'Sp1': 'protein', 'dominant promoter elements': 'DNA', 'minimal Thy-1 promoter': 'DNA', 'transcription factor': 'protein', 'multiple binding sites': 'DNA', 'CCAAT box': 'DNA', 'transcription start site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"Thy-1 promoter": "DNA"}, {"transcription factor Sp1": "protein"}, {"CCAAT box": "DNA"}]', 'prediction': {'Thy-1 promoter': 'DNA', 'transcription factor Sp1': 'protein', 'CCAAT box': 'DNA'}}
{'idx': 1763, 'sentence': 'Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .', 'label': {'IL-2': 'protein', 'IL-2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"IL-2 mRNA": "RNA"},\n{"IL-2": "protein"}\n]', 'prediction': {'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}}
{'idx': 224, 'sentence': 'Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).', 'label': {'CEM C7 cells': 'cell_line', 'human acute lymphoblastic T-cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types in the target sentence are present in this example."},\n{"Example 2": 1},\n{"Reason 2": "None of the entity types in the target sentence are present in this example."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[\n{"CEM C7 cells": "cell_line"}\n]', 'prediction': {'CEM C7 cells': 'cell_line'}}
{'idx': 313, 'sentence': 'Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .', 'label': {'malignant soft tissue tumors': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"steroid hormones": "protein"}, {"estrogen binding assay": "protein"}]', 'prediction': {'steroid hormones': 'protein', 'estrogen binding assay': 'protein'}}
{'idx': 1285, 'sentence': "Characterization of 5' end of human thromboxane receptor gene .", 'label': {"5' end of human thromboxane receptor gene": 'DNA', 'human thromboxane receptor gene': 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 327, 'sentence': 'However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .', 'label': {'R-responsive enhancer region': 'DNA', 'EB1 -binding site': 'DNA', 'EB1': 'protein', 'ZRE-B': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"EB1": "protein"}, {"ZRE-B": "DNA"}, {"R-responsive enhancer region": "DNA"}]', 'prediction': {'EB1': 'protein', 'ZRE-B': 'DNA', 'R-responsive enhancer region': 'DNA'}}
{'idx': 1622, 'sentence': 'Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.', 'label': {'gamma interferon': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"proteins": "protein"}]', 'prediction': {'proteins': 'protein'}}
{'idx': 1393, 'sentence': 'This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .', 'label': {'second enhancer': 'DNA', 'T-cell activation response element': 'DNA', 'enhancer': 'DNA'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[{"T-cell": "cell_type"}, {"HIV-1": "cell_line"}, {"HIV-2": "cell_line"}, {"T-cell": "cell_type"}]', 'prediction': {'T-cell': 'cell_type', 'HIV-1': 'cell_line', 'HIV-2': 'cell_line'}}
{'idx': 1221, 'sentence': 'To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .', 'label': {'mouse osteocalcin gene': 'DNA', 'promoter': 'DNA', 'osteoblast-specific cis-acting elements': 'DNA', 'trans-acting factors': 'protein', 'osteoblast-specific gene': 'DNA'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 130, 'sentence': 'At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .', 'label': {'TREp': 'DNA', 'TR': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 788, 'sentence': 'The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).', 'label': {'mineralocorticoid receptors': 'protein'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 781, 'sentence': 'Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1220, 'sentence': 'A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .', 'label': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin promoter': 'DNA', 'osteoblast-specific cis-acting element': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"PEBP2 alpha/AML-1-related factor": "protein"}, {"osteocalcin promoter": "DNA"}, {"osteoblast-specific cis-acting element": "cell_type"}]', 'prediction': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin promoter': 'DNA', 'osteoblast-specific cis-acting element': 'cell_type'}}
{'idx': 958, 'sentence': 'Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .', 'label': {'B-cell-specific genes': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"Markus Neurath": "protein"}, {"Eckhard Stuber": "protein"}, {"Warren Strober": "protein"}, {"BSAP": "protein"}, {"B-cell-specific genes": "protein"}]', 'prediction': {'Markus Neurath': 'protein', 'Eckhard Stuber': 'protein', 'Warren Strober': 'protein', 'BSAP': 'protein', 'B-cell-specific genes': 'protein'}}
{'idx': 1083, 'sentence': 'These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .', 'label': {'cytokine': 'protein', 'NF kappa B': 'protein', 'PBMC': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the entity types present in the target sentence are mentioned in this example."},\n    {"Example 2": 1},\n    {"Reason 2": "None of the entity types present in the target sentence are mentioned in this example."},\n    {"Example 3": 1},\n    {"Reason 3": "None of the entity types present in the target sentence are mentioned in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 514, 'sentence': 'Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .', 'label': {'globin gene': 'DNA', 'enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1133, 'sentence': 'Both LCLs were found by EM to produce RVLP and EBV particles .', 'label': {'LCLs': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1762, 'sentence': 'Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.', 'label': {'IL-2': 'protein', 'early gene': 'DNA', 'NF-kappa B': 'protein', 'Oct1': 'protein', 'transcription factors': 'protein', 'NF-AT': 'protein', 'AP-1': 'protein', 'IL-2 gene': 'DNA'}, 'response1': "['protein', 'DNA', 'RNA']", 'response2': '[]\n[]', 'response3': '[{"IL-2 gene": "DNA"}, {"cysteamine": "protein"}, {"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"NF-AT": "protein"}, {"Oct1": "protein"}, {"IL-2 mRNA": "RNA"}]', 'prediction': {'IL-2 gene': 'DNA', 'cysteamine': 'protein', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein', 'IL-2 mRNA': 'RNA'}}
{'idx': 23, 'sentence': 'Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .', 'label': {'mutant E6 motif': 'DNA'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"E6 motif": "protein"}]', 'prediction': {'E6 motif': 'protein'}}
{'idx': 1476, 'sentence': 'Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .', 'label': {'AP-1 protein': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein', 'cytoplasmic inhibitor': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"AP-1 protein c-Jun": "protein"}, {"I kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1 protein c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 234, 'sentence': 'A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .', 'label': {'cultured': 'cell_line', 'primary cells': 'cell_type', 'adenovirus E2 promoter': 'DNA', 'beta-galactosidase gene': 'DNA', 'beta-galactosidase': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"beta-galactosidase gene": "DNA"}, {"adenovirus E2 promoter": "DNA"}]', 'prediction': {'beta-galactosidase gene': 'DNA', 'adenovirus E2 promoter': 'DNA'}}
{'idx': 1396, 'sentence': 'NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .', 'label': {'hematopoietic progenitor cell line': 'cell_line', 'NF-M': 'protein', 'chicken C/EBP beta': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The example does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 2},\n    {"Reason 2": "The example contains the entity type \'cell_line\', which is present in the target sentence, but does not contain the entity type \'protein\'."},\n    {"Example 3": 1},\n    {"Reason 3": "The example does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"NF-M": "protein"},\n    {"C/EBP beta": "protein"},\n    {"hematopoietic progenitor cell line": "cell_line"}\n]', 'prediction': {'NF-M': 'protein', 'C/EBP beta': 'protein', 'hematopoietic progenitor cell line': 'cell_line'}}
{'idx': 1812, 'sentence': 'The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .', 'label': {'G-protein coupled chemokine receptors': 'protein', 'chemokine receptors': 'protein', 'G-protein': 'protein', 'receptor EBI1': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"protein": "protein"}, {"G-protein coupled chemokine receptors": "protein"}, {"receptor EBI1": "protein"}]', 'prediction': {'protein': 'protein', 'G-protein coupled chemokine receptors': 'protein', 'receptor EBI1': 'protein'}}
{'idx': 1099, 'sentence': 'Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .', 'label': {'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'monocyte': 'cell_type', 'microtubule': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the entity types in the target sentence are present in this example."},\n    {"Example 2": 1},\n    {"Reason 2": "None of the entity types in the target sentence are present in this example."},\n    {"Example 3": 1},\n    {"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1537, 'sentence': 'Furthermore, we identified a repression domain at the N-terminus of Oct-2a .', 'label': {'Oct-2a': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1574, 'sentence': 'CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .', 'label': {'receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1312, 'sentence': 'A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.', 'label': {'HMG-1': 'protein', 'C-terminal HMG box': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"HMG-1": "protein"}]', 'prediction': {'HMG-1': 'protein'}}
{'idx': 601, 'sentence': 'To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .', 'label': {'murine IgH enhancer': 'DNA', 'putative additional lymphoid-specific transcription factor': 'protein', 'octamer (OCTA)-nucleotide motif': 'DNA', 'NF-microB': 'protein', 'enhancer elements': 'DNA', 'immunoglobulin heavy-chain (IgH) gene': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"octamer": "DNA"}, {"IgH": "protein"}, {"NF-microB": "protein"}]', 'prediction': {'octamer': 'DNA', 'IgH': 'protein', 'NF-microB': 'protein'}}
{'idx': 890, 'sentence': 'Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 323, 'sentence': 'The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .', 'label': {'Epstein-Barr virus ( EBV ) ORI1yt enhancer': 'DNA'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[]', 'response3': '[{"Epstein-Barr virus": "DNA"}, {"ORI1yt enhancer": "DNA"}, {"B-cell": "cell_type"}, {"EBV": "protein"}, {"R": "protein"}, {"Z": "protein"}]', 'prediction': {'Epstein-Barr virus': 'DNA', 'ORI1yt enhancer': 'DNA', 'B-cell': 'cell_type', 'EBV': 'protein', 'R': 'protein', 'Z': 'protein'}}
{'idx': 929, 'sentence': 'The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .', 'label': {'ORF': 'DNA', '272 carboxy-terminal amino acids': 'protein', 'ets-1': 'protein', 'human ets-1 protein': 'protein', '813-bp open reading frame': 'DNA', 'cDNA sequence': 'DNA', 'amino acid sequence': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"cDNA sequence": "DNA"}, {"ORF": "protein"}, {"amino acid sequence": "protein"}, {"human ets-1 protein": "protein"}]', 'prediction': {'cDNA sequence': 'DNA', 'ORF': 'protein', 'amino acid sequence': 'protein', 'human ets-1 protein': 'protein'}}
{'idx': 6, 'sentence': 'Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .', 'label': {'Platelet-activating factor': 'protein', 'oncogene': 'DNA', 'human B cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"Platelet-activating factor": "protein"}, {"phospholipid turnover": "cell_type"}, {"calcium flux": "cell_type"}, {"arachidonic acid liberation": "cell_type"}, {"eicosanoid generation": "cell_type"}, {"oncogene expression": "cell_type"}, {"human B cell line": "cell_line"}]', 'prediction': {'Platelet-activating factor': 'protein', 'phospholipid turnover': 'cell_type', 'calcium flux': 'cell_type', 'arachidonic acid liberation': 'cell_type', 'eicosanoid generation': 'cell_type', 'oncogene expression': 'cell_type', 'human B cell line': 'cell_line'}}
{'idx': 1478, 'sentence': 'Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.', 'label': {'activated T cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1793, 'sentence': 'The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"salicylates": "protein"}, {"atherosclerosis": "cell_type"}, {"rheumatoid arthritis": "cell_type"}, {"monocyte": "cell_type"}]', 'prediction': {'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}}
{'idx': 1473, 'sentence': 'Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .', 'label': {'NF-kappa B': 'protein', 'T cells': 'cell_type', 'AP-1': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}}
{'idx': 539, 'sentence': 'PMA enhanced slightly the stimulatory effect of PHA .', 'label': {'PHA': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1025, 'sentence': 'NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .', 'label': {'NFATc': 'protein', 'NK cells': 'cell_type', 'NFATc mRNA': 'RNA'}, 'response1': "['RNA', 'cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"NFATc": "protein"}, {"NFATc mRNA": "RNA"}, {"NK cells": "cell_type"}, {"CD16 ligands": "protein"}]', 'prediction': {'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}}
{'idx': 1560, 'sentence': 'Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .', 'label': {'human T helper (Th) clones': 'cell_line', 'CD30+ cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 3},\n{"Reason 1": "Mentions \'signaling pathway\' which could be related to \'cell_type\' or \'protein\' entities."},\n{"Example 2": 4},\n{"Reason 2": "Mentions \'tumors\', \'ovary\', \'clinical course\' which could be related to \'cell_type\' entities."},\n{"Example 3": 3},\n{"Reason 3": "Mentions \'genes\', \'family members\', \'isoforms\' which could be related to \'DNA\' or \'protein\' entities."}\n]', 'response3': '[\n{"Th": "cell_type"},\n{"CD30": "protein"},\n{"NF-kappa B": "protein"}\n]', 'prediction': {'Th': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 365, 'sentence': 'Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.', 'label': {'c-jun': 'DNA', 'HL-60 cells': 'cell_line', 'untreated HL-60 cells': 'cell_line'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1039, 'sentence': 'Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .', 'label': {'Peripheral blood mononuclear cells': 'cell_type', 'pbmc': 'cell_type', 'bone marrow cells': 'cell_type'}, 'response1': "['RNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"Peripheral blood mononuclear cells": "cell_type"}, {"bone marrow cells": "cell_type"}, {"c-fos": "protein"}, {"c-myc": "protein"}, {"p53": "protein"}, {"bcr/abl mRNA": "RNA"}]', 'prediction': {'Peripheral blood mononuclear cells': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl mRNA': 'RNA'}}
{'idx': 217, 'sentence': 'Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .', 'label': {'GCR': 'protein', 'glucocorticoid receptors': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1782, 'sentence': 'In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .', 'label': {'Id3': 'protein', 'resting PBL': 'cell_type', 'Id3 mRNA': 'RNA', 'PBL': 'cell_type', 'Id2': 'protein', 'Id2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1280, 'sentence': "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.", 'label': {'NF-kappa B': 'protein', 'TATA element': 'DNA', 'transcription factors': 'protein', 'CD69': 'protein', 'AP-1': 'protein', '30 base pairs upstream': 'DNA', 'CD69 gene': 'DNA', "5'-flanking region": 'DNA', 'transcription initiation site': 'DNA', 'Egr-1': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"CD69 gene": "DNA"}, {"TATA element": "DNA"}, {"NF-kappa B": "protein"}, {"Egr-1": "protein"}, {"AP-1": "protein"}]', 'prediction': {'CD69 gene': 'DNA', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}}
{'idx': 611, 'sentence': 'Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"DNA viruses": "DNA"}, {"HIV-1": "RNA"}]', 'prediction': {'DNA viruses': 'DNA', 'HIV-1': 'RNA'}}
{'idx': 1723, 'sentence': 'In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .', 'label': {'tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA': 'RNA', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['cell_line', 'protein', 'RNA']", 'response2': '[]\n[]', 'response3': '[{"monocyte/macrophage cell line": "cell_line"}, {"NF-kappa B": "protein"}, {"tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA": "RNA"}]', 'prediction': {'monocyte/macrophage cell line': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA': 'RNA'}}
{'idx': 1308, 'sentence': 'Two groups of HMG box proteins are distinguished.', 'label': {'HMG box proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 765, 'sentence': 'Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1561, 'sentence': 'In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .', 'label': {'CD30': 'protein', 'NF-kappa B complexes': 'protein', 'p65 RelA': 'protein', 'p50 NF-kappa B1': 'protein', 'NF-kappa B': 'protein', 'transcription factors': 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B complexes": "protein"}, {"p50 NF-kappa B1": "protein"}, {"p65 RelA": "protein"}, {"transcription factors": "protein"}]', 'prediction': {'NF-kappa B complexes': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein', 'transcription factors': 'protein'}}
{'idx': 330, 'sentence': 'ZRE-B is therefore not part of the R- inducible enhancer .', 'label': {'ZRE-B': 'DNA', 'R- inducible enhancer': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1104, 'sentence': 'Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1594, 'sentence': 'Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .', 'label': {'Jurkat cells': 'cell_line', 'NF-kappa B -activating cytokine': 'protein', 'Human IL4 promoter': 'DNA', 'tumor necrosis factor alpha': 'protein', 'RelA -overexpressing cells': 'cell_line', 'NF-kappa B': 'protein', 'RelA': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1086, 'sentence': 'Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .', 'label': {'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'human I kappa B alpha protein': 'protein', 'mouse 70Z/3 cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"I kappa B alpha protein": "protein"}, {"mouse 70Z/3 cells": "cell_line"}, {"murine protein": "protein"}, {"I kappa B alpha": "protein"}, {"NF-kappa B activity": "cell_type"}, {"phorbol myristate acetate": "cell_type"}, {"lipopolysaccharide": "cell_type"}]', 'prediction': {'I kappa B alpha protein': 'protein', 'mouse 70Z/3 cells': 'cell_line', 'murine protein': 'protein', 'I kappa B alpha': 'protein', 'NF-kappa B activity': 'cell_type', 'phorbol myristate acetate': 'cell_type', 'lipopolysaccharide': 'cell_type'}}
{'idx': 1, 'sentence': 'When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.', 'label': {'homeodomain': 'DNA', 'HB24': 'DNA', 'Drosophila homeodomain': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1226, 'sentence': 'Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .', 'label': {'transcription factors': 'protein', 'T-cell nuclear extract-DNA complexes': 'protein', 'OSF2': 'protein', 'osteoblast nuclear extract-DNA complexes': 'protein', 'PEBP2 alpha factors': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"OSF2": "protein"}, {"PEBP2 alpha factors": "protein"}]', 'prediction': {'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}}
{'idx': 663, 'sentence': 'The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .', 'label': {}, 'response1': "['cell_line', 'gene']", 'response2': '[\n{"Example 1": 2},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 3},\n{"Reason 2": "The sentence contains the entity type \'gene\', which is present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1000, 'sentence': 'Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.', 'label': {'HSF2': 'protein', 'HSF3': 'protein', 'HSFs': 'protein', 'HSF1': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 39, 'sentence': 'Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .', 'label': {'KBF1': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"KBF1": "protein"},\n{"NF-kappa B": "protein"},\n{"hybrids": "cell_type"}\n]', 'prediction': {'KBF1': 'protein', 'NF-kappa B': 'protein', 'hybrids': 'cell_type'}}
{'idx': 229, 'sentence': "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .", 'label': {'B-cell line': 'cell_line', 'IM-9': 'cell_line', 'GR': 'protein', "CVZ 's binding sites": 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"CVZ": "protein"}, {"IM-9": "cell_line"}, {"RU 38486": "protein"}, {"GR": "protein"}, {"CVZ": "protein"}, {"CVZ": "protein"}]', 'prediction': {'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'GR': 'protein'}}
{'idx': 743, 'sentence': 'Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .', 'label': {'erythroid cell transcription factor': 'protein', 'non-erythroid cells': 'cell_type', 'EF1': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any specific entities mentioned in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence mentions tumors and clinical course, which are not relevant to the entities in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence talks about genes and isoforms, which are not related to the entities in the target sentence."}\n]', 'response3': '[{"erythroid cell": "cell_type"}, {"EF1": "protein"}]', 'prediction': {'erythroid cell': 'cell_type', 'EF1': 'protein'}}
{'idx': 1799, 'sentence': 'These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .', 'label': {'GAS': 'DNA', 'IFN-gamma-activated sequence': 'DNA', 'STAT proteins': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"STAT proteins": "protein"}, {"IFN-gamma-activated sequence": "DNA"}]', 'prediction': {'STAT proteins': 'protein', 'IFN-gamma-activated sequence': 'DNA'}}
{'idx': 1703, 'sentence': "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .", 'label': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'IFN -activated NK cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"E1A": "protein"}, {"IFN": "protein"}, {"adenovirus-transformed cells": "cell_line"}, {"IFN-activated NK cells": "cell_type"}]', 'prediction': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'IFN-activated NK cells': 'cell_type'}}
{'idx': 629, 'sentence': 'Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .', 'label': {'progesterone receptor': 'protein', 'CD8+ cells': 'cell_line', 'lymphocytes': 'cell_line', 'progesterone receptor -bearing cells': 'cell_line', 'CD4+ cells': 'cell_line'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[{"CD8+ cells": "cell_type"}, {"progesterone receptor-bearing cells": "protein"}, {"CD4+ cells": "cell_type"}, {"positively staining lymphocytes": "cell_type"}]', 'prediction': {'CD8+ cells': 'cell_type', 'progesterone receptor-bearing cells': 'protein', 'CD4+ cells': 'cell_type', 'positively staining lymphocytes': 'cell_type'}}
{'idx': 490, 'sentence': 'Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .', 'label': {'lymphokine genes': 'DNA', 'interleukin-2': 'protein'}, 'response1': "['protein', 'RNA']", 'response2': '[]', 'response3': '[{"Cyclosporin A": "protein"}, {"CsA": "protein"}, {"lymphokine genes": "protein"}, {"interleukin-2": "protein"}]', 'prediction': {'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'protein', 'interleukin-2': 'protein'}}
{'idx': 118, 'sentence': "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .", 'label': {'SCL': 'protein', "SCL 5' regulatory region": 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 493, 'sentence': 'Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .', 'label': {'NFAT-1 complex': 'protein', 'mitogen-inducible DNA-binding complexes': 'protein', 'kappa B complex': 'protein', 'interleukin-2': 'protein', 'interleukin-2 enhancer': 'DNA', 'HIV enhancer': 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[{"DNA-binding complexes": "DNA"}, {"kappa B complex": "DNA"}, {"HIV enhancer": "DNA"}, {"NFAT-1 complex": "DNA"}, {"interleukin-2 enhancer": "DNA"}]', 'prediction': {'DNA-binding complexes': 'DNA', 'kappa B complex': 'DNA', 'HIV enhancer': 'DNA', 'NFAT-1 complex': 'DNA', 'interleukin-2 enhancer': 'DNA'}}
{'idx': 1798, 'sentence': 'In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .', 'label': {'purified human peripheral blood T cells': 'cell_type', 'anti-CD3 Abs': 'protein', 'nuclear STAT proteins': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"STAT proteins": "protein"}, {"T cells": "cell_type"}, {"anti-CD3 Abs": "protein"}]', 'prediction': {'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}}
{'idx': 175, 'sentence': 'To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.', 'label': {'blood mononuclear cells': 'cell_type', 'uncultured cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 3},\n{"Reason 1": "Mentions cell types and diseases related to the target sentence, but does not provide specific examples of named entities."},\n{"Example 2": 2},\n{"Reason 2": "Mentions tumors and clinical course, which are not directly related to the entities in the target sentence."},\n{"Example 3": 2},\n{"Reason 3": "Mentions genes and isoforms, which are not directly related to the entities in the target sentence."}\n]', 'response3': '[\n{"bronchoalveolar lavage": "cell_line"},\n{"blood mononuclear cells": "cell_type"},\n{"sarcoidosis": "cell_type"},\n{"tuberculosis": "cell_type"}\n]', 'prediction': {'bronchoalveolar lavage': 'cell_line', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}}
{'idx': 1498, 'sentence': 'Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.', 'label': {'lymphoblasts': 'cell_type'}, 'response1': "['DNA', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"DNA binding region": "DNA"}, {"steroid hormone receptor": "protein"}]', 'prediction': {'DNA binding region': 'DNA', 'steroid hormone receptor': 'protein'}}
{'idx': 995, 'sentence': 'The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[{"B-cell": "cell_type"}, {"mouse": "cell_line"}]', 'prediction': {'B-cell': 'cell_type', 'mouse': 'cell_line'}}
{'idx': 1671, 'sentence': 'Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .', 'label': {'IL-6 neutralizing antibodies': 'protein', 'IL-6': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 141, 'sentence': 'TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .', 'label': {'monocytic cells': 'cell_type', 'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV LTR": "DNA"}, {"T cells": "cell_type"}, {"monocytic cells": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}}
{'idx': 1557, 'sentence': "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .", 'label': {"Hodgkin's disease -derived, T cell-like, CD30 + cells": 'cell_line', 'nuclear factor (NF)-kappa B': 'protein', 'M44': 'protein', 'L540 cells': 'cell_line', 'M67': 'protein', 'mAb': 'protein', 'agonistic anti- CD30 monoclonal antibodies': 'protein', 'CD30': 'protein'}, 'response1': "['cell_line', 'protein', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "This sentence contains the entity type \'cell_line\', which is present in the target sentence. However, it does not contain the other entity types."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1090, 'sentence': 'Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.', 'label': {'N terminus': 'protein', 'I kappa B alpha': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1568, 'sentence': 'The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .', 'label': {'enzymes': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 257, 'sentence': 'Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .', 'label': {}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"VD3": "protein"}, {"chronic myelogenous leukemia": "cell_type"}]', 'prediction': {'VD3': 'protein', 'chronic myelogenous leukemia': 'cell_type'}}
{'idx': 262, 'sentence': 'This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .', 'label': {'complementary DNA': 'DNA', 'c-jun proto-oncogene product': 'protein', 'palindromic target sequence': 'DNA', 'c-jun': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"complementary DNA": "DNA"}, {"protein": "protein"}, {"c-jun proto-oncogene product": "protein"}, {"target sequence": "DNA"}, {"palindromic target sequence": "DNA"}, {"c-jun": "protein"}]', 'prediction': {'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun proto-oncogene product': 'protein', 'target sequence': 'DNA', 'palindromic target sequence': 'DNA', 'c-jun': 'protein'}}
{'idx': 1351, 'sentence': 'Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"25 kD": "protein"}, {"55 kD": "protein"}, {"alternative splicing": "RNA"}]', 'prediction': {'25 kD': 'protein', '55 kD': 'protein', 'alternative splicing': 'RNA'}}
{'idx': 973, 'sentence': 'To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .', 'label': {'MZF-1': 'DNA', 'DNA binding domain': 'protein', 'yeast transactivator GAL4': 'protein', 'GAL4': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"MZF-1": "protein"}, {"DNA": "DNA"}, {"GAL4": "protein"}]', 'prediction': {'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}}
{'idx': 1125, 'sentence': 'This indicates that the CR of GR may be of functional significance.', 'label': {'GR': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 338, 'sentence': 'Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .', 'label': {'T3R': 'protein', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence, but it does not provide specific named entities for extraction."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1080, 'sentence': 'However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1786, 'sentence': 'Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .', 'label': {'coagulation protease': 'protein', 'tissue factor (TF) receptor': 'protein', 'plasma Factor VII/VIIa': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Factor VII/VIIa": "protein"}, {"tissue factor (TF)": "protein"}]', 'prediction': {'Factor VII/VIIa': 'protein', 'tissue factor (TF)': 'protein'}}
{'idx': 1242, 'sentence': 'LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .', 'label': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"NF kappa B": "protein"}, {"p50/p65 heterodimers": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}}
{'idx': 866, 'sentence': 'T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"T cell": "cell_type"}, {"HIV": "protein"}]', 'prediction': {'T cell': 'cell_type', 'HIV': 'protein'}}
{'idx': 433, 'sentence': 'Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .', 'label': {'regulatory regions': 'DNA', 'BSAP': 'protein', 'high-affinity binding site': 'DNA', 'B-lymphoid-specific genes': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"BSAP": "protein"}, {"immunoglobulin": "protein"}, {"class II major histocompatibility (MHC) genes": "protein"}, {"B-lymphoid-specific genes": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'protein', 'B-lymphoid-specific genes': 'cell_type'}}
{'idx': 1546, 'sentence': 'Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .', 'label': {'platelet glycoprotein Ib alpha gene': 'DNA', 'GATA': 'DNA', 'Ets binding motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"GATA": "protein"},\n    {"Ets": "protein"},\n    {"platelet glycoprotein Ib alpha gene": "protein"}\n]', 'prediction': {'GATA': 'protein', 'Ets': 'protein', 'platelet glycoprotein Ib alpha gene': 'protein'}}
{'idx': 1412, 'sentence': 'We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 411, 'sentence': 'There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1460, 'sentence': 'In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.', 'label': {'multiple myeloma cell lines': 'cell_line', 'PU.1': 'protein', 'Pu box': 'DNA', 'differentiated, plasma cell-like B cells': 'cell_type'}, 'response1': "['cell_line', 'DNA', 'protein', 'RNA']", 'response2': '[]\n[]', 'response3': '[{"PU.1 DNA binding activity": "DNA"}, {"mRNA expression": "RNA"}, {"Pu box -dependent transactivation": "protein"}]', 'prediction': {'PU.1 DNA binding activity': 'DNA', 'mRNA expression': 'RNA', 'Pu box -dependent transactivation': 'protein'}}
{'idx': 638, 'sentence': 'Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .', 'label': {'CD3': 'protein', 'TCR': 'protein', 'VLA-5 fibronectin receptor': 'protein', 'fibronectin': 'protein', 'CD4 cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 2},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence mentions tumors and clinical course, which are related to medical terms but do not match the entity types in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence talks about genes and isoforms, which are related to molecular biology but do not match the entity types in the target sentence."}\n]', 'response3': '[\n{"VLA-5": "protein"},\n{"CD4 cells": "cell_type"},\n{"CD3 - TCR": "cell_type"},\n{"fibronectin": "protein"}\n]', 'prediction': {'VLA-5': 'protein', 'CD4 cells': 'cell_type', 'CD3 - TCR': 'cell_type', 'fibronectin': 'protein'}}
{'idx': 1375, 'sentence': 'We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .', 'label': {'PBLs': 'cell_type', 'peripheral blood lymphocytes': 'cell_type', 'TCL1 mRNA': 'RNA', 'protein': 'protein'}, 'response1': "['RNA', 'protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[{"TCL1 mRNA": "RNA"}, {"protein": "protein"}, {"peripheral blood lymphocytes": "cell_type"}, {"PBLs": "cell_line"}, {"AT cases": "cell_type"}]', 'prediction': {'TCL1 mRNA': 'RNA', 'protein': 'protein', 'peripheral blood lymphocytes': 'cell_type', 'PBLs': 'cell_line', 'AT cases': 'cell_type'}}
{'idx': 764, 'sentence': 'The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .', 'label': {'CEM-C7': 'cell_line', 'CEM-C7 cells': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 897, 'sentence': 'The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .', 'label': {'transcription of SV40 T-antigen': 'protein', 'NFAT-1': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"NFAT-1": "protein"}, {"SV40 T-antigen": "protein"}]', 'prediction': {'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}}
{'idx': 1842, 'sentence': 'Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .', 'label': {'Ets-1': 'protein', 'TFE-3': 'protein', 'LEF-1': 'protein', 'enhancer-binding proteins': 'protein', 'Sp1': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"LEF-1": "protein"}, {"Ets-1": "protein"}, {"TFE-3": "protein"}, {"Sp1": "protein"}]', 'prediction': {'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}}
{'idx': 1059, 'sentence': 'Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .', 'label': {'NF-kappa B family': 'protein', 'Transcription factors': 'protein', 'I kappa B beta': 'protein', 'inhibitory I kappa B proteins': 'protein', 'I kappa B alpha': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"I kappa B beta": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}}
{'idx': 924, 'sentence': 'We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .', 'label': {'hsp70': 'protein', 'untransformed steroid receptors': 'protein', 'hsp90': 'protein', 'p56': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"p56": "protein"}, {"cytosol": "cell_type"}, {"hsp70": "protein"}, {"hsp90": "protein"}, {"steroid receptors": "protein"}]', 'prediction': {'p56': 'protein', 'cytosol': 'cell_type', 'hsp70': 'protein', 'hsp90': 'protein', 'steroid receptors': 'protein'}}
{'idx': 247, 'sentence': 'Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .', 'label': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[{"Antigen B27": "protein"}, {"glucocorticoid receptors": "protein"}, {"blood lymphocytes": "cell_type"}]', 'prediction': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}}
{'idx': 507, 'sentence': 'Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .', 'label': {'TCF-2 alpha': 'protein', 'TCR alpha enhancer': 'DNA', 'CREB': 'protein', 'transcription factors': 'protein', 'T alpha 1': 'protein', 'TCR': 'protein', 'TCF-1 alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[\n{"TCF-1 alpha": "protein"},\n{"TCF-2 alpha": "protein"},\n{"T alpha 1 (CREB)": "protein"},\n{"TCR alpha enhancer": "DNA"}\n]', 'prediction': {'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1 (CREB)': 'protein', 'TCR alpha enhancer': 'DNA'}}
{'idx': 460, 'sentence': "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.", 'label': {'HIV LTRs': 'DNA', 'regulatory elements': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[]\n[]', 'response3': '[{"HIV LTRs": "DNA"}]', 'prediction': {'HIV LTRs': 'DNA'}}
{'idx': 131, 'sentence': 'Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .', 'label': {'TRs': 'protein', 'carboxyl-terminus': 'protein', 'TR alpha 1': 'protein', 'nuclear proteins': 'protein', 'amino acid 210': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[]\n[]', 'response3': '[{"TR alpha 1": "protein"}, {"DNA": "DNA"}, {"TRs": "protein"}]', 'prediction': {'TR alpha 1': 'protein', 'DNA': 'DNA', 'TRs': 'protein'}}
{'idx': 692, 'sentence': 'The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .', 'label': {'virally encoded transactivator protein': 'protein', 'Tax -response element': 'DNA', 'TRE': 'DNA', 'human T-cell leukemia virus type I ( HTLV-I ) promoter': 'DNA', 'Tax': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 1},\n    {"Example 3": 1}\n]', 'response3': '[{"TRE": "DNA"}, {"Tax": "protein"}]', 'prediction': {'TRE': 'DNA', 'Tax': 'protein'}}
{'idx': 43, 'sentence': 'T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .', 'label': {'cysteine-rich antigen segments': 'protein', 'T-helper-cell determinants': 'protein', 'protein antigens': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[{"T-helper-cell": "cell_type"}, {"protein": "protein"}, {"cysteine-rich antigen segments": "protein"}, {"cathepsin B": "protein"}, {"cathepsin L": "protein"}, {"cathepsin D": "protein"}]', 'prediction': {'T-helper-cell': 'cell_type', 'protein': 'protein', 'cysteine-rich antigen segments': 'protein', 'cathepsin B': 'protein', 'cathepsin L': 'protein', 'cathepsin D': 'protein'}}
{'idx': 1204, 'sentence': 'Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.', 'label': {}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1134, 'sentence': 'Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .', 'label': {'LCLs': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"Reverse transcriptase": "protein"}, {"LCLs": "cell_line"}]', 'prediction': {'Reverse transcriptase': 'protein', 'LCLs': 'cell_line'}}
{'idx': 471, 'sentence': 'The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).', 'label': {'lymphocyte nuclear T3 receptor': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[]\n[]', 'response3': '[{"T3 receptor": "protein"}, {"DNA": "DNA"}]', 'prediction': {'T3 receptor': 'protein', 'DNA': 'DNA'}}
{'idx': 1205, 'sentence': 'Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 14, 'sentence': 'Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .', 'label': {'c-fos': 'DNA', 'nuclear proto-oncogenes': 'DNA', 'c-jun': 'DNA', 'platelet-activating factor': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"platelet-activating factor": "protein"}, {"c-fos": "protein"}, {"c-jun": "protein"}]', 'prediction': {'platelet-activating factor': 'protein', 'c-fos': 'protein', 'c-jun': 'protein'}}
{'idx': 145, 'sentence': 'Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .', 'label': {'nuclear proteins': 'protein', 'major histocompatibility complex (MHC) class II promoters': 'DNA', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the entity types in the target sentence are present in this example."},\n    {"Example 2": 1},\n    {"Reason 2": "None of the entity types in the target sentence are present in this example."},\n    {"Example 3": 1},\n    {"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1449, 'sentence': 'DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.', 'label': {'upstream stimulatory factor': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"DNA binding specificity": "DNA"}, {"complex 3": "protein"}, {"upstream stimulatory factor": "protein"}]', 'prediction': {'DNA binding specificity': 'DNA', 'complex 3': 'protein', 'upstream stimulatory factor': 'protein'}}
{'idx': 1292, 'sentence': "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .", 'label': {'thromboxane receptor': 'protein', 'thromboxane receptor gene': 'DNA', 'CAT': 'protein', 'chloramphenicol acetyltransferase': 'protein', "5' flanking region": 'DNA', 'thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids': 'DNA', 'K562 cells': 'cell_line'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types in the target sentence are present in this example."},\n{"Example 2": 1},\n{"Reason 2": "None of the entity types in the target sentence are present in this example."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[\n{"thromboxane receptor gene": "DNA"},\n{"thromboxane receptor gene promoter": "DNA"},\n{"chloramphenicol acetyltransferase (CAT)": "protein"},\n{"K562 cells": "cell_line"}\n]', 'prediction': {'thromboxane receptor gene': 'DNA', 'thromboxane receptor gene promoter': 'DNA', 'chloramphenicol acetyltransferase (CAT)': 'protein', 'K562 cells': 'cell_line'}}
{'idx': 120, 'sentence': 'Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.', 'label': {'RPMI 8402': 'cell_line', 'T cell lines': 'cell_line', 'CEM': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"CEM": "cell_line"},\n{"RPMI 8402": "cell_line"}\n]', 'prediction': {'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}}
{'idx': 468, 'sentence': 'A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 138, 'sentence': 'The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .', 'label': {'beta interferon promoter': 'DNA', 'regulatory elements': 'DNA', 'HIV long terminal repeat': 'DNA', 'TNF-alpha': 'protein', 'LTR': 'DNA', 'reporter chloramphenicol acetyltransferase plasmids': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV long terminal repeat (LTR)": "DNA"}, {"beta interferon promoter": "DNA"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV long terminal repeat (LTR)': 'DNA', 'beta interferon promoter': 'DNA'}}
{'idx': 64, 'sentence': 'Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .', 'label': {'IFN beta promoter deletions': 'DNA'}, 'response1': "['cell_line', 'protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1760, 'sentence': 'This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 676, 'sentence': 'The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein', 'interleukin 2 ( IL-2 ) gene promoter': 'DNA', 'T-cell': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 2},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 3},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence, but does not contain \'protein\'. It provides some relevance but not complete overlap."},\n{"Example 3": 2},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"interleukin 2": "protein"}, {"IL-2": "protein"}, {"cell-type-specific": "cell_type"}, {"T-cell": "cell_type"}]', 'prediction': {'interleukin 2': 'protein', 'IL-2': 'protein', 'cell-type-specific': 'cell_type', 'T-cell': 'cell_type'}}
{'idx': 1052, 'sentence': 'Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.', 'label': {'IL-2R alpha': 'protein', 'SEA': 'protein', 'IL-2R gamma': 'protein', 'SEB': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"IL-2R alpha": "protein"}]', 'prediction': {'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}}
{'idx': 487, 'sentence': 'Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.', 'label': {'human monocytes': 'cell_type', 'normal human monocytes': 'cell_type', 'M-CSF': 'protein', 'immediate early response genes': 'DNA'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"M-CSF": "protein"}]', 'prediction': {'M-CSF': 'protein'}}
{'idx': 570, 'sentence': 'Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1370, 'sentence': 'Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .', 'label': {'CD28': 'protein', 'anti- CD28 MoAb': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NF kappa B": "protein"}, {"IL-2": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'IL-2': 'protein'}}
{'idx': 994, 'sentence': 'The role of BSAP ( Pax-5 ) in B-cell development .', 'label': {'BSAP': 'protein', 'Pax-5': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 438, 'sentence': 'This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).', 'label': {'OTF factors': 'protein', 'nuclear proteins': 'protein', 'sequence motif': 'DNA', 'octamer transcription factors': 'protein', 'Oct': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"octamer transcription factors": "protein"}]', 'prediction': {'octamer transcription factors': 'protein'}}
{'idx': 270, 'sentence': 'There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"autosomal recessive": "cell_type"}, {"autosomal dominant": "cell_type"}]', 'prediction': {'autosomal recessive': 'cell_type', 'autosomal dominant': 'cell_type'}}
{'idx': 1481, 'sentence': 'We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1807, 'sentence': 'We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .', 'label': {'cell genes': 'DNA', 'cyclin E': 'DNA', 'cyclin D2': 'DNA', 'CD23': 'DNA', 'cdc-2': 'DNA'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"cdc-2": "protein"}, {"cyclin E": "protein"}, {"CD23": "protein"}, {"cyclin D2": "protein"}]', 'prediction': {'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein'}}
{'idx': 1169, 'sentence': 'However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .', 'label': {'SPXX motifs': 'protein', 'nuclear targeting sequence': 'protein', 'gene regulatory proteins': 'protein', 'B4-2': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"B4-2": "protein"}, {"proline": "protein"}, {"nuclear targeting sequence": "protein"}, {"SPXX motifs": "protein"}, {"gene regulatory proteins": "protein"}]', 'prediction': {'B4-2': 'protein', 'proline': 'protein', 'nuclear targeting sequence': 'protein', 'SPXX motifs': 'protein', 'gene regulatory proteins': 'protein'}}
{'idx': 1180, 'sentence': 'We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .', 'label': {'IL-2R': 'protein', 'IL-2': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'IL-2 receptor': 'protein', 'JAK1': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 968, 'sentence': 'These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.', 'label': {'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 497, 'sentence': 'The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .', 'label': {'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"T cells": "cell_type"}, {"proteins": "protein"}]', 'prediction': {'T cells': 'cell_type', 'proteins': 'protein'}}
{'idx': 1606, 'sentence': 'Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .', 'label': {'CD11b/CD18': 'protein', 'CD35': 'protein', 'p50/p65': 'protein', 'CR1': 'protein', 'HIV-infected monocytic cells': 'cell_type', 'complement receptors': 'protein', 'human monocytes': 'cell_type', 'NF-kappa B': 'protein', 'CR3': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[{"CR1": "protein"}, {"CD35": "protein"}, {"CR3": "protein"}, {"CD11b/CD18": "protein"}, {"NF-kappa B": "protein"}, {"p50/p65": "protein"}, {"monocytes": "cell_type"}, {"HIV-infected monocytic cells": "cell_type"}]', 'prediction': {'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}}
{'idx': 1653, 'sentence': 'Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .', 'label': {'nonmyeloid cells': 'cell_type', 'GM-CSF': 'protein', 'PU.1': 'protein', 'GM-CSF receptor alpha promoter': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 833, 'sentence': 'Mapping of B-cell epitopes of the human hepatitis B virus X protein .', 'label': {'human hepatitis B virus X protein': 'protein', 'B-cell epitopes': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"hepatitis B virus X protein": "protein"}]', 'prediction': {'hepatitis B virus X protein': 'protein'}}
{'idx': 389, 'sentence': 'The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .', 'label': {'periplasmic domain': 'protein', 'PhoQ protein': 'protein', 'cationic proteins': 'protein', 'defensin': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"PhoQ protein": "protein"}, {"defensin": "protein"}]', 'prediction': {'PhoQ protein': 'protein', 'defensin': 'protein'}}
{'idx': 193, 'sentence': 'The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .', 'label': {'c-myc': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1349, 'sentence': 'Its expression was always restricted to the nucleus .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 882, 'sentence': 'This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .', 'label': {'c-Jun': 'protein', 'heterodimeric activator protein-1 transcription complex': 'protein', 'c-Fos': 'protein', 'cDNA': 'DNA', 'human c-Jun protein': 'protein', 'cDNA clone': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"cDNA clone": "DNA"}, {"human c-Jun protein": "protein"}, {"c-Fos": "protein"}, {"activator protein-1": "protein"}]', 'prediction': {'cDNA clone': 'DNA', 'human c-Jun protein': 'protein', 'c-Fos': 'protein', 'activator protein-1': 'protein'}}
{'idx': 725, 'sentence': 'Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .', 'label': {'Rex': 'protein', 'HTLV-infected cells': 'cell_type', 'gag/pol': 'protein', 'env mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"Rex": "protein"},\n{"gag/pol": "protein"},\n{"env mRNA": "RNA"},\n{"HTLV-infected cells": "cell_line"}\n]', 'prediction': {'Rex': 'protein', 'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_line'}}
{'idx': 867, 'sentence': 'In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).', 'label': {'conserved binding sites': 'DNA', 'nuclear factor kappa B': 'protein', 'long terminal repeat': 'DNA', 'LTR': 'DNA', 'NF kappa B': 'protein', 'transcriptional enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"long terminal repeat": "DNA"}, {"transcriptional enhancer": "DNA"}, {"nuclear factor kappa B": "protein"}]', 'prediction': {'long terminal repeat': 'DNA', 'transcriptional enhancer': 'DNA', 'nuclear factor kappa B': 'protein'}}
{'idx': 841, 'sentence': 'Such tests may become useful diagnostic tools .', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 1, "Reason 1": "The sentence does not contain any entities related to the entity types in the target sentence."},\n{"Example 2": 1, "Reason 2": "The sentence does not contain any entities related to the entity types in the target sentence."},\n{"Example 3": 1, "Reason 3": "The sentence does not contain any entities related to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 956, 'sentence': 'BSAP : a key regulator of B-cell development and differentiation .', 'label': {'BSAP': 'protein', 'B-cell': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[{"BSAP": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'B-cell': 'cell_type'}}
{'idx': 1769, 'sentence': 'We have tried to find out whether these receptors could show any difference in sex or age distribution.', 'label': {}, 'response1': 'None.', 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 110, 'sentence': 'Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .', 'label': {'long terminal repeat': 'DNA', 'NF-KB': 'protein', 'double repeat-KB enhancer sequence': 'DNA', 'cellular transactivation factor': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NF-KB": "protein"}]', 'prediction': {'NF-KB': 'protein'}}
{'idx': 1379, 'sentence': 'Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .', 'label': {'TCL1': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"TCL1": "protein"}]', 'prediction': {'TCL1': 'protein'}}
{'idx': 1338, 'sentence': 'The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .', 'label': {'Bcl-2 family': 'protein', 'cellular proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Bcl-2": "protein"}]', 'prediction': {'Bcl-2': 'protein'}}
{'idx': 1323, 'sentence': 'PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .', 'label': {'PRE-I': 'DNA', 'Jurkat cells': 'cell_line', 'multiple DNA-protein complexes': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[]', 'response3': '[{"PRE-I": "protein"}, {"DNA": "DNA"}, {"protein": "protein"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'PRE-I': 'protein', 'DNA': 'DNA', 'protein': 'protein', 'Jurkat cells': 'cell_line'}}
{'idx': 1309, 'sentence': 'Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .', 'label': {'cruciform DNA': 'DNA', 'HMG boxes': 'protein', 'cross-over DNA': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is not present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"HMG boxes": "protein"},\n{"DNA": "DNA"},\n{"DNA": "DNA"}\n]', 'prediction': {'HMG boxes': 'protein', 'DNA': 'DNA'}}
{'idx': 228, 'sentence': 'We have carried out experiments to define the nature of the higher affinity CVZ binding site .', 'label': {'higher affinity CVZ binding site': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 51, 'sentence': 'Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.', 'label': {'T-cell determinants': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1518, 'sentence': 'Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .', 'label': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type', 'Anti-immunoglobulin M': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"nuclear calcium/calmodulin-dependent protein kinase II": "protein"}, {"human B lymphocytes": "cell_type"}]', 'prediction': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type'}}
{'idx': 563, 'sentence': 'The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .', 'label': {'PDGF(B)': 'protein', 'PDGF(B) mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"PDGF(B) mRNA": "RNA"},\n{"cytochalasin D": "protein"}\n]', 'prediction': {'PDGF(B) mRNA': 'RNA', 'cytochalasin D': 'protein'}}
{'idx': 501, 'sentence': 'Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .', 'label': {'CCRF-CEM': 'cell_line', 'TCF-1 alpha': 'protein', 'nonlymphoid (HeLa) cell lines': 'cell_line', 'mature B cells': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]', 'response3': '[{"TCF-1 alpha": "protein"}, {"Jurkat": "cell_line"}, {"CCRF-CEM": "cell_line"}, {"JY": "cell_line"}, {"Namalwa": "cell_line"}, {"HeLa": "cell_line"}]', 'prediction': {'TCF-1 alpha': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}}
{'idx': 457, 'sentence': 'TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .', 'label': {'T lymphocytes': 'cell_type', 'TAR': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 285, 'sentence': 'ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .', 'label': {'ER': 'protein', 'lymphocyte DNA': 'DNA', 'lymphocytes': 'cell_type', 'lymphocyte cytosolic protein': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[{"lymphocyte cytosolic protein": "protein"}, {"lymphocyte DNA": "DNA"}]', 'prediction': {'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}}
{'idx': 1508, 'sentence': 'Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .', 'label': {'BOB.1/OBF.1': 'protein', 'B cell-specific coactivator': 'protein', 'murine homolog': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"BOB.1/OBF.1": "protein"}]', 'prediction': {'BOB.1/OBF.1': 'protein'}}
{'idx': 209, 'sentence': 'Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.', 'label': {'lymphoblastoid cell line': 'cell_line', 'IM-9': 'cell_line', 'type-II EBS': 'protein', 'Type-II estrogen -binding sites': 'protein', 'human lymphoblastoid cell line': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1385, 'sentence': "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.", 'label': {'LTR': 'DNA', 'HIV-1 LTR': 'DNA', 'C/EBP sites': 'DNA', 'C/EBP site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 3},\n    {"Example 3": 4}\n]', 'response3': '[\n    {"HIV-1 LTR": "DNA"},\n    {"C/EBP site": "protein"},\n    {"3\' C/EBP sites": "protein"}\n]', 'prediction': {'HIV-1 LTR': 'DNA', 'C/EBP site': 'protein', "3' C/EBP sites": 'protein'}}
{'idx': 1516, 'sentence': 'Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .', 'label': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'protein', 'COOH-terminal domain': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1827, 'sentence': 'A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .', 'label': {'human interleukin 2 gene promoter': 'DNA', 'EGR-1': 'protein', 'Sp1': 'protein', 'regulatory element': 'DNA', 'binding site': 'DNA', 'zinc finger proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"zinc finger proteins Sp1": "protein"}, {"EGR-1": "protein"}]', 'prediction': {'zinc finger proteins Sp1': 'protein', 'EGR-1': 'protein'}}
{'idx': 1116, 'sentence': 'The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .', 'label': {'thymocytes': 'cell_type', 'p53': 'protein', 'mitogen-activated mature T lymphocytes': 'cell_line', 'tumour suppressor p53': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"p53": "protein"}, {"apoptosis": "cell_type"}, {"thymocytes": "cell_type"}, {"T lymphocytes": "cell_type"}]', 'prediction': {'p53': 'protein', 'apoptosis': 'cell_type', 'thymocytes': 'cell_type', 'T lymphocytes': 'cell_type'}}
{'idx': 178, 'sentence': 'T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .', 'label': {'T lymphocytes': 'cell_type', 'lavage cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1209, 'sentence': 'A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 864, 'sentence': 'Differences in transcriptional enhancers of HIV-1 and HIV-2 .', 'label': {'transcriptional enhancers': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[]', 'response3': '[{"HIV-1": "RNA"}, {"HIV-2": "RNA"}]', 'prediction': {'HIV-1': 'RNA', 'HIV-2': 'RNA'}}
{'idx': 65, 'sentence': 'Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .', 'label': {'promoter': 'DNA', 'PRDII element': 'DNA'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 61, 'sentence': 'From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.', 'label': {'82': 'protein', '43-47 kD': 'protein', 'major protein': 'protein', 'T-cells': 'cell_type', 'minor proteins': 'protein', '67': 'protein', 'HeLa cells': 'cell_line', '52 kD': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 191, 'sentence': 'A block to RNA elongation is largely responsible for decreased c-myc transcription .', 'label': {'c-myc': 'DNA'}, 'response1': "['RNA']", 'response2': '[]', 'response3': '[{"RNA": "RNA"}, {"c-myc": "protein"}]', 'prediction': {'RNA': 'RNA', 'c-myc': 'protein'}}
{'idx': 447, 'sentence': 'Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.', 'label': {'enhancer': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 476, 'sentence': 'A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .', 'label': {'protooncogenes': 'DNA', 'immediate early response genes': 'DNA', 'growth factor': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"protooncogenes": "protein"}, {"cytoskeletal": "protein"}, {"extracellular matrix genes": "protein"}, {"immediate early response genes": "protein"}, {"growth factor": "protein"}, {"cell proliferation": "cell_type"}]', 'prediction': {'protooncogenes': 'protein', 'cytoskeletal': 'protein', 'extracellular matrix genes': 'protein', 'immediate early response genes': 'protein', 'growth factor': 'protein', 'cell proliferation': 'cell_type'}}
{'idx': 1034, 'sentence': 'p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .', 'label': {'Stat1': 'protein', 'phosphorylation site': 'protein', 'Src homology 2 (SH2) domain': 'protein', 'p94': 'protein', 'p95': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"p94": "protein"}, {"p95": "protein"}, {"Stat1": "protein"}, {"Src homology 2 (SH2)": "protein"}]', 'prediction': {'p94': 'protein', 'p95': 'protein', 'Stat1': 'protein', 'Src homology 2 (SH2)': 'protein'}}
{'idx': 1232, 'sentence': 'IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).', 'label': {'IBR': 'protein', 'transcription factors': 'protein', 'erected wing gene product': 'protein', 'human NRF-1/alpha-Pal factor': 'protein', 'EWG': 'protein', 'P3A2': 'protein', '503-amino-acid-long acidic protein': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"IBR": "protein"}, {"NRF-1/alpha-Pal": "protein"}, {"P3A2": "protein"}, {"EWG": "protein"}]', 'prediction': {'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'EWG': 'protein'}}
{'idx': 54, 'sentence': 'Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .', 'label': {'LTR': 'DNA', 'human T-cell types': 'cell_type', 'T-cell types': 'cell_type', 'element': 'DNA'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1149, 'sentence': 'The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .', 'label': {'Sp1': 'protein', 'DCs': 'cell_type', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"Sp1": "protein"}, {"T cells": "cell_type"}, {"DCs": "cell_type"}]', 'prediction': {'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type'}}
{'idx': 407, 'sentence': 'Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"VDR": "protein"},\n    {"VDR": "protein"},\n    {"XLH": "None"}\n]', 'prediction': {'VDR': 'protein', 'XLH': 'None'}}
{'idx': 1466, 'sentence': 'As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .', 'label': {'endothelial cells': 'cell_type', 'NFAT': 'protein', 'activated endothelial cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"NFAT": "protein"}, {"CsA": "protein"}]', 'prediction': {'NFAT': 'protein', 'CsA': 'protein'}}
{'idx': 1330, 'sentence': 'Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .', 'label': {'I kappa B alpha': 'protein', 'I kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1436, 'sentence': 'Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .', 'label': {'hTR beta 1 mRNA': 'RNA', 'hTR beta 1': 'protein'}, 'response1': "['RNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 859, 'sentence': 'We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .', 'label': {'inducible': 'protein', 'Jurkat cells': 'cell_line', 'C1': 'protein', 'HIV enhancer': 'DNA', 'C2': 'protein', 'constitutive, C2 , protein': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[]', 'response3': '[{"HIV enhancer": "protein"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'HIV enhancer': 'protein', 'Jurkat cells': 'cell_line'}}
{'idx': 451, 'sentence': 'However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .', 'label': {'NF-muE3': 'protein', 'B cells': 'cell_type', 'lymphoid cells': 'cell_type', 'transfected reporter gene': 'DNA', 'Ig heavy chain enhancer': 'DNA', 'non- lymphoid cells': 'cell_type', 'non-B cells': 'cell_type', 'endogenous Ig heavy chain enhancer': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 919, 'sentence': 'The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .', 'label': {'56-kDa protein': 'protein', 'p56': 'protein', 'EC1 antibody': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1206, 'sentence': 'In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.', 'label': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 569, 'sentence': 'In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .', 'label': {'PDGF(B)': 'protein', 'EGR2': 'DNA', 'c-jun': 'DNA'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"c-jun": "protein"}, {"EGR2": "protein"}, {"PDGF(B)": "protein"}]', 'prediction': {'c-jun': 'protein', 'EGR2': 'protein', 'PDGF(B)': 'protein'}}
{'idx': 1657, 'sentence': 'HMG-I binds to GATA motifs : implications for an HPFH syndrome .', 'label': {'HMG-I': 'protein', 'GATA motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"HMG-I": "protein"}, {"GATA motifs": "DNA"}, {"HPFH syndrome": "cell_type"}]', 'prediction': {'HMG-I': 'protein', 'GATA motifs': 'DNA', 'HPFH syndrome': 'cell_type'}}
{'idx': 1780, 'sentence': 'Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .', 'label': {'Id3': 'protein', 'Mo': 'cell_line', 'Id2': 'protein', '4/5 T-cell lines': 'cell_line', 'S-LB1': 'cell_line', 'MT-2': 'cell_line', 'ATL-1k': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"Id2": "RNA"},\n{"Id3": "None"},\n{"T-cell lines": "cell_line"},\n{"human T-cell leukemia virus type I (HTLV-I)": "cell_type"},\n{"ATL-1k": "cell_line"},\n{"MT-2": "cell_line"},\n{"S-LB1": "cell_line"},\n{"type II (Mo)": "None"}\n]', 'prediction': {'Id2': 'RNA', 'Id3': 'None', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'None'}}
{'idx': 13, 'sentence': 'We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.', 'label': {'platelet-activating factor': 'protein', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1554, 'sentence': 'The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .', 'label': {'GP': 'protein', 'normal platelets': 'cell_type', 'cis-acting elements': 'DNA', 'GP Ib alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[{"GP Ib alpha": "protein"}]', 'prediction': {'GP Ib alpha': 'protein'}}
{'idx': 1650, 'sentence': 'This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .', 'label': {'PU.1': 'protein', 'myeloid PU.1 binding site': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 326, 'sentence': 'We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .', 'label': {'EB1': 'protein', 'R-responsive element': 'DNA', 'HeLa cells': 'cell_line', 'domain B': 'DNA', 'EB1 -responsive B-cell-specific element': 'DNA'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence, but does not provide specific named entities for extraction."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1429, 'sentence': 'Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .', 'label': {'TR': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 865, 'sentence': 'Response to T cell activation signals .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 696, 'sentence': 'First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .', 'label': {'TRE -DNA fragment': 'DNA', 'nuclear proteins': 'protein', 'TRE': 'DNA'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[\n{"cell_line": "cell_line"},\n{"protein": "protein"},\n{"DNA": "DNA"}\n]', 'prediction': {'cell_line': 'cell_line', 'protein': 'protein', 'DNA': 'DNA'}}
{'idx': 318, 'sentence': 'Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.', 'label': {'estrogen receptor': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"estrogen receptor": "protein"}]', 'prediction': {'estrogen receptor': 'protein'}}
{'idx': 440, 'sentence': 'All three proteins show the same sequence specificity and binding affinity .', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1563, 'sentence': 'Pathogenesis of atherosclerosis .', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 689, 'sentence': 'High-risk patients can be recognized morphologically.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence mentions tumors and clinical course, but does not contain any named entities related to the entity types in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence mentions genes and isoforms, but does not contain any named entities related to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 189, 'sentence': 'Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .', 'label': {'human T lymphoblastic tumor cell line': 'cell_line', 'c-myc': 'DNA'}, 'response1': "['protein', 'cell_line']", 'response2': '[]', 'response3': '[{"c-myc": "protein"}, {"T lymphoblastic tumor cell line": "cell_line"}]', 'prediction': {'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}}
{'idx': 778, 'sentence': 'Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .', 'label': {'OTF-1': 'protein', 'pre-B cells': 'cell_line', 'immunoglobulin gene': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"OTF-1": "protein"}, {"pre-B cells": "cell_type"}, {"HeLa cells": "cell_line"}, {"immunoglobulin gene": "DNA"}]', 'prediction': {'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'DNA'}}
{'idx': 198, 'sentence': "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.", 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 735, 'sentence': 'This prompted us to analyze the octamer-binding proteins in the latter cells.', 'label': {'octamer-binding proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"octamer-binding proteins": "protein"}, {"latter cells": "cell_line"}]', 'prediction': {'octamer-binding proteins': 'protein', 'latter cells': 'cell_line'}}
{'idx': 1735, 'sentence': 'We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .', 'label': {'VDR': 'protein', 'IL-2 promoter/reporter constructs': 'DNA', 'Jurkat cells': 'cell_line', 'VDR overexpression vector': 'DNA', 'IL-2': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"Jurkat cells": "cell_line"}, {"IL-2": "protein"}, {"VDR": "protein"}, {"DNA": "DNA"}]', 'prediction': {'Jurkat cells': 'cell_line', 'IL-2': 'protein', 'VDR': 'protein', 'DNA': 'DNA'}}
{'idx': 704, 'sentence': 'Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .', 'label': {'ubiquitous and developmentally regulated proteins': 'protein', 'ubiquitous': 'protein', 'developmentally regulated proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"immunoglobulin heavy": "protein"}, {"kappa light chain": "protein"}]', 'prediction': {'immunoglobulin heavy': 'protein', 'kappa light chain': 'protein'}}
{'idx': 1236, 'sentence': 'Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .', 'label': {'direct-repeat palindrome': 'DNA', 'IBR/F': 'protein', 'IBR/F binding sites': 'DNA', 'optimal site': 'DNA', 'alternating RCGCRYGCGY consensus': 'protein'}, 'response1': "['DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any specific entities mentioned in the target sentence."}\n]', 'response3': '[{"RCGCRYGCGY": "DNA"}, {"TGCGCATGCGCA": "DNA"}]', 'prediction': {'RCGCRYGCGY': 'DNA', 'TGCGCATGCGCA': 'DNA'}}
{'idx': 541, 'sentence': 'To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 2},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 3},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1652, 'sentence': 'Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.', 'label': {'PU.1': 'protein', 'PU-SF complex': 'protein', 'myeloid promoters': 'DNA', 'PU.1 site': 'DNA', 'PU-SF': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"PU-SF complex": "protein"}, {"PU.1": "protein"}, {"PU.1": "protein"}]', 'prediction': {'PU-SF complex': 'protein', 'PU.1': 'protein'}}
{'idx': 88, 'sentence': 'TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .', 'label': {'TNF alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"TNF alpha": "protein"}, {"cAMP": "cell_type"}, {"cAMP": "cell_type"}]', 'prediction': {'TNF alpha': 'protein', 'cAMP': 'cell_type'}}
{'idx': 1494, 'sentence': 'Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .', 'label': {'latent NF-kappa B': 'protein', 'cytokine': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 940, 'sentence': 'Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .', 'label': {'PBMC': 'cell_type', 'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1098, 'sentence': 'Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .', 'label': {'microtubules': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 255, 'sentence': 'c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.', 'label': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[]', 'response3': '[{"c-myc RNA": "RNA"}, {"RWLeu-4 cells": "cell_line"}, {"VD3": "protein"}]', 'prediction': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line', 'VD3': 'protein'}}
{'idx': 775, 'sentence': 'Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.', 'label': {'OTF-1': 'protein', 'OTF-2': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"OTF-2": "protein"}, {"OTF-1": "protein"}]', 'prediction': {'OTF-2': 'protein', 'OTF-1': 'protein'}}
{'idx': 161, 'sentence': 'Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1130, 'sentence': 'B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .', 'label': {'B-lymphoblastoid cell lines': 'cell_line'}, 'response1': "['cell_line', 'virus']", 'response2': '[]', 'response3': '[{"B-lymphoblastoid cell lines": "cell_line"}, {"Epstein-Barr virus": "virus"}]', 'prediction': {'B-lymphoblastoid cell lines': 'cell_line', 'Epstein-Barr virus': 'virus'}}
{'idx': 600, 'sentence': 'Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .', 'label': {'immunoglobulin heavy-chain gene': 'DNA', 'lymphoid-specific enhancer element': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"lymphoid-specific enhancer element": "DNA"}, {"immunoglobulin heavy-chain gene": "protein"}]', 'prediction': {'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'protein'}}
{'idx': 1698, 'sentence': 'Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .', 'label': {'natural killer cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1287, 'sentence': 'Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .', 'label': {'Platelet thromboxane receptors': 'protein', 'Platelet': 'cell_type'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Platelet thromboxane receptors": "protein"}]', 'prediction': {'Platelet thromboxane receptors': 'protein'}}
{'idx': 1266, 'sentence': 'Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .', 'label': {'EBV -positive B cell lines': 'cell_line'}, 'response1': "['virus', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"Human herpesvirus 6": "virus"},\n{"T lymphotropic virus": "cell_type"},\n{"EBV-positive B cell lines": "cell_line"},\n{"EBV lytic cycle": "cell_line"}\n]', 'prediction': {'Human herpesvirus 6': 'virus', 'T lymphotropic virus': 'cell_type', 'EBV-positive B cell lines': 'cell_line', 'EBV lytic cycle': 'cell_line'}}
{'idx': 1813, 'sentence': 'Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .', 'label': {'BLR2 mRNA': 'RNA', 'BLR2': 'protein'}, 'response1': "['RNA', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[{"BLR2 mRNA": "RNA"}, {"mitogen": "cell_type"}, {"anti-CD3": "cell_type"}, {"peripheral blood lymphocytes": "cell_type"}]', 'prediction': {'BLR2 mRNA': 'RNA', 'mitogen': 'cell_type', 'anti-CD3': 'cell_type', 'peripheral blood lymphocytes': 'cell_type'}}
{'idx': 1764, 'sentence': 'The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .', 'label': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'transcription factor': 'protein', 'mitogen-stimulated cells': 'cell_type'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 740, 'sentence': 'On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.', 'label': {'ubiquitous Oct-1': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein', 'lymphoid-specific Oct-2A': 'protein', 'N-Oct-factors': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"N-Oct-factors": "protein"}, {"Oct-1": "protein"}, {"Oct-2A": "protein"}]', 'prediction': {'N-Oct-factors': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein'}}
{'idx': 1182, 'sentence': 'Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .', 'label': {'IL-2': 'protein', 'T cells': 'cell_type', 'COOH-terminal region': 'protein', 'human T cells': 'cell_type', 'Ser386-Val525': 'protein', 'JAK3': 'protein', 'STAT transcription factor': 'protein', 'STAT5': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types in the target sentence are present in this example."},\n{"Example 2": 1},\n{"Reason 2": "None of the entity types in the target sentence are present in this example."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 393, 'sentence': 'We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.', 'label': {'HNP-1': 'protein', 'pag': 'DNA', 'NP-1': 'protein', 'defensins': 'protein', 'NP-5': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"defensins NP-1": "protein"}, {"NP-5": "protein"}, {"HNP-1": "protein"}, {"pag": "protein"}]', 'prediction': {'defensins NP-1': 'protein', 'NP-5': 'protein', 'HNP-1': 'protein', 'pag': 'protein'}}
{'idx': 1442, 'sentence': 'T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .', 'label': {'interleukin 3': 'protein', 'transcriptional start site': 'DNA', 'IL-3': 'protein'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"interleukin 3": "protein"}, {"IL-3": "protein"}, {"DNA": "DNA"}]', 'prediction': {'interleukin 3': 'protein', 'IL-3': 'protein', 'DNA': 'DNA'}}
{'idx': 142, 'sentence': 'This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .', 'label': {'U937 cells': 'cell_line', 'NF-kappa B': 'protein', 'viral RNA': 'RNA', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"HIV type 1": "RNA"}, {"HIV-1": "RNA"}, {"U937 cells": "cell_line"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'RNA', 'HIV-1': 'RNA', 'U937 cells': 'cell_line'}}
{'idx': 93, 'sentence': 'The Thy-1 gene promoter resembles a "housekeeping" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5\'-end termini of the mRNA .', 'label': {'canonical TATA box': 'DNA', '"housekeeping" promoter': 'DNA', 'methylation-free island': 'DNA', "5'-end termini": 'RNA', 'Thy-1 gene promoter': 'DNA', 'mRNA': 'RNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"Thy-1 gene promoter": "DNA"}, {"TATA box": "DNA"}]', 'prediction': {'Thy-1 gene promoter': 'DNA', 'TATA box': 'DNA'}}
{'idx': 1354, 'sentence': 'In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .', 'label': {'TCF-1': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"TCF-1": "protein"}]', 'prediction': {'TCF-1': 'protein'}}
{'idx': 466, 'sentence': '(ABSTRACT TRUNCATED AT 250 WORDS)', 'label': {}, 'response1': 'None.', 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1583, 'sentence': 'Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.', 'label': {'ribonucleoproteins': 'protein', 'Ro(SSA)': 'protein', 'autoantibodies': 'protein', 'HLA class II antigens': 'protein', 'La(SSB)': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for extracting named entities."}\n]', 'response3': '[{"HLA class II antigens": "protein"},\n{"ribonucleoproteins Ro(SSA)": "protein"},\n{"La(SSB)": "protein"}]', 'prediction': {'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}}
{'idx': 592, 'sentence': 'The DNA isolated contained an open reading frame encoding 108 amino acid residues .', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'protein\', which is present in the target sentence. However, the context and relevance of the entity mention may not be directly related to the entities in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"DNA": "DNA"}]', 'prediction': {'DNA': 'DNA'}}
{'idx': 163, 'sentence': 'This phenomenon can be mimicked by administering MP in divided doses.', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1751, 'sentence': 'This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.', 'label': {'NFAT': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1774, 'sentence': 'Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .', 'label': {'PBMC': 'cell_type', 'PBMC receptors': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1, "Example 2": 2, "Example 3": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is not present in the target sentence."},\n{"Reason 3": "The sentence contains the entity type \'protein\', which is present in the target sentence, but the context and relevance are different."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 206, 'sentence': 'It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"ER": "protein"}, {"ER": "protein"}]', 'prediction': {'ER': 'protein'}}
{'idx': 928, 'sentence': 'A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).', 'label': {'ets-1': 'protein', 'long terminal repeat': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'mouse ets-1 cDNA clone': 'DNA', 'LTR': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[]', 'response3': '[{"mouse ets-1 cDNA clone": "DNA"}, {"mouse thymus cDNA expression library": "DNA"}, {"double-stranded oligonucleotide probe": "DNA"}, {"Moloney murine sarcoma virus (MSV) long terminal repeat (LTR)": "DNA"}]', 'prediction': {'mouse ets-1 cDNA clone': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'Moloney murine sarcoma virus (MSV) long terminal repeat (LTR)': 'DNA'}}
{'idx': 1301, 'sentence': 'It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1708, 'sentence': 'The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .', 'label': {'nuclear factor (NF)-kappa B': 'protein', 'T cell lines': 'cell_line', 'Ca(2+) -dependent phosphatase': 'protein', 'PKC': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the entity types present in the target sentence are mentioned in this example."},\n    {"Example 2": 1},\n    {"Reason 2": "None of the entity types present in the target sentence are mentioned in this example."},\n    {"Example 3": 1},\n    {"Reason 3": "None of the entity types present in the target sentence are mentioned in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 747, 'sentence': 'Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).', 'label': {'unspliced mRNA': 'RNA'}, 'response1': "['protein', 'RNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[{"Protein kinase inhibitor H-7": "protein"}, {"unspliced mRNA": "RNA"}, {"human T-cell leukemia virus type I (HTLV-I)": "cell_type"}]', 'prediction': {'Protein kinase inhibitor H-7': 'protein', 'unspliced mRNA': 'RNA', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type'}}
{'idx': 333, 'sentence': 'These protoenhancers alone are weakly or not responsive to R .', 'label': {'protoenhancers': 'DNA', 'R': 'protein'}, 'response1': "['RNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 758, 'sentence': 'Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.', 'label': {'CEM-C7': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[]', 'response3': '[{"CEM-C7 cells": "cell_line"}]', 'prediction': {'CEM-C7 cells': 'cell_line'}}
{'idx': 727, 'sentence': 'The importance of the internal ATGs to Rex function is not known.', 'label': {'Rex': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 429, 'sentence': 'As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.', 'label': {'TSAP': 'protein', 'mammalian protein': 'protein', 'sea urchin binding sites': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"BSAP": "protein"}, {"TSAP": "protein"}]', 'prediction': {'BSAP': 'protein', 'TSAP': 'protein'}}
{'idx': 1372, 'sentence': 'The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).', 'label': {'14q32.1': 'DNA', 'TCR alpha/beta loci': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 'TCL1 oncogene': 'DNA', 'human chromosome': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inv14(q11;q32.1)': 'DNA'}, 'response1': "['DNA', 'cell_type']", 'response2': '[]', 'response3': '[{"TCL1 oncogene": "protein"}, {"human chromosome 14q32.1": "DNA"}, {"chromosome translocations": "DNA"}, {"t(14;14)(q11;q32.1)": "DNA"}, {"t(7;14)(q35;q32.1)": "DNA"}, {"inversions": "DNA"}, {"inv14(q11;q32.1)": "DNA"}, {"TCR alpha/beta loci": "DNA"}, {"T-cell leukemias": "cell_type"}, {"T-prolymphocytic ( T-PLL )": "cell_type"}]', 'prediction': {'TCL1 oncogene': 'protein', 'human chromosome 14q32.1': 'DNA', 'chromosome translocations': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inversions': 'DNA', 'inv14(q11;q32.1)': 'DNA', 'TCR alpha/beta loci': 'DNA', 'T-cell leukemias': 'cell_type', 'T-prolymphocytic ( T-PLL )': 'cell_type'}}
{'idx': 546, 'sentence': 'Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .', 'label': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"T lymphocytes": "cell_type"}, {"immunophilin": "protein"}, {"FK506": "protein"}, {"rapamycin": "protein"}]', 'prediction': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}}
{'idx': 1437, 'sentence': 'In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.', 'label': {'hTR beta 1': 'protein', 'hTR beta 1 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 1399, 'sentence': 'To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .', 'label': {'hematopoietic cell lineage': 'cell_line', 'human estrogen receptor': 'protein', 'NF-M': 'protein', 'hormone binding domain': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence mentions tumors, which could potentially be related to \'cell_line\', but the context is not specific enough to confidently extract this entity type."},\n{"Example 3": 1},\n{"Reason 3": "The sentence talks about genes and isoforms, which could be related to \'protein\' or \'DNA\', but again, the context is not specific enough to confidently extract these entity types."}\n]', 'response3': '[\n{"NF-M": "protein"},\n{"hormone binding domain": "protein"},\n{"human estrogen receptor": "protein"}\n]', 'prediction': {'NF-M': 'protein', 'hormone binding domain': 'protein', 'human estrogen receptor': 'protein'}}
{'idx': 1327, 'sentence': 'Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .', 'label': {'human IL-4': 'protein', 'human IL-4 promoter': 'DNA', 'NF-IL6': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"NF-IL6": "protein"}, {"IL-4": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}}
{'idx': 146, 'sentence': 'Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the "octamer" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .', 'label': {'"octamer" motif': 'DNA', 'HLA-DR alpha (DRA) promoter': 'DNA', 'class II promoters': 'DNA', 'immunoglobulin variable region promoters': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1247, 'sentence': 'The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .', 'label': {'Janus family tyrosine kinase': 'protein', 'Jak3': 'protein', 'gamma c': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"Jak3": "protein"}, {"gamma c": "protein"}, {"Jak3": "protein"}, {"XSCID": "cell_type"}]', 'prediction': {'Jak3': 'protein', 'gamma c': 'protein', 'XSCID': 'cell_type'}}
{'idx': 1300, 'sentence': 'As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .', 'label': {}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 2},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 3},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is not present in the target sentence."},\n{"Example 3": 2},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 350, 'sentence': 'Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .', 'label': {'control cell line': 'cell_line', 'cell line': 'cell_line', 'Ro-VDR': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1093, 'sentence': 'The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).', 'label': {'VDR': 'protein', 'vitamin D receptor': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"1,25-dihydroxyvitamin D3": "protein"}, {"VDR": "protein"}]', 'prediction': {'1,25-dihydroxyvitamin D3': 'protein', 'VDR': 'protein'}}
{'idx': 1493, 'sentence': 'Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .', 'label': {'myeloid cells': 'cell_type', 'NF-kappa B': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B": "DNA"}]', 'prediction': {'NF-kappa B': 'DNA'}}
{'idx': 334, 'sentence': "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .", 'label': {'protoenhancers': 'DNA', 'overlapping palindromes': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 946, 'sentence': 'Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 777, 'sentence': 'We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.', 'label': {'OTF-2': 'protein', 'immunoglobulin gene': 'DNA', 'steady-state immunoglobulin heavy-chain mRNA': 'RNA', 'human pre-B-cell lines': 'cell_line', 'immunoglobulin heavy-chain': 'protein'}, 'response1': "['cell_line', 'RNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"pre-B-cell lines": "cell_line"}, {"OTF-2": "protein"}, {"immunoglobulin heavy-chain mRNA": "RNA"}, {"immunoglobulin gene": "DNA"}]', 'prediction': {'pre-B-cell lines': 'cell_line', 'OTF-2': 'protein', 'immunoglobulin heavy-chain mRNA': 'RNA', 'immunoglobulin gene': 'DNA'}}
{'idx': 552, 'sentence': 'Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .', 'label': {'IL-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for extracting named entities."}\n]', 'response3': '[{"FK506": "protein"}, {"rapamycin": "protein"}, {"IL-2": "protein"}]', 'prediction': {'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}}
{'idx': 1310, 'sentence': 'The abundant chromosomal protein HMG-1 belongs to this subgroup.', 'label': {'HMG-1': 'protein', 'chromosomal protein': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"HMG-1": "protein"}]', 'prediction': {'HMG-1': 'protein'}}
{'idx': 1409, 'sentence': 'We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .', 'label': {'IL-2': 'protein', 'T cell lines': 'cell_line', 'PRL': 'protein', 'Stat proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_line\', which is present in the target sentence. However, it does not contain the entity type \'protein\' which is also present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"PRL": "protein"},\n{"IL-2": "protein"},\n{"Stat proteins": "protein"},\n{"T cell lines": "cell_line"}\n]', 'prediction': {'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 1140, 'sentence': 'The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .', 'label': {'transcription factors': 'protein', 'conserved cis-acting sequence': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"GGAAAA": "DNA"}]', 'prediction': {'GGAAAA': 'DNA'}}
{'idx': 449, 'sentence': 'We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .', 'label': {'ubiquitous transcription factor': 'protein', 'E3 enhancer motif': 'DNA'}, 'response1': "['DNA']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1402, 'sentence': 'At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .', 'label': {'eosinophil': 'cell_type', 'myeloid lineages': 'cell_type', 'differentiation markers': 'protein', 'progenitor-specific surface markers': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 4},\n    {"Example 3": 3}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 664, 'sentence': 'Interferon-gamma and the sexual dimorphism of autoimmunity .', 'label': {'Interferon-gamma': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1726, 'sentence': 'It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .', 'label': {'NF-kappa B': 'protein', 'cytotoxic cytokine': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1573, 'sentence': 'Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .', 'label': {'estrogen': 'protein', 'eosinophil cationic protein': 'protein', 'positive cells': 'cell_type', 'progesterone receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"estrogen": "protein"}, {"progesterone": "protein"}, {"eosinophil cationic protein": "protein"}, {"eosinophils": "cell_type"}]', 'prediction': {'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1589, 'sentence': 'Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .', 'label': {'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type', 'NF-AT': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 114, 'sentence': 'These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .', 'label': {'NF-KB': 'protein', 'monocytic cell lineage': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 3},\n{"Reason 2": "The sentence contains the entity type \'cell_line\', which is present in the target sentence. This could provide some context or additional information related to cell lines."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"monocytic cell lineage": "cell_line"}, {"HIV-1": "protein"}, {"NF-KB": "protein"}]', 'prediction': {'monocytic cell lineage': 'cell_line', 'HIV-1': 'protein', 'NF-KB': 'protein'}}
{'idx': 469, 'sentence': 'Cardiac and adrenergic diseases were excluded.', 'label': {}, 'response1': 'None.', 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1683, 'sentence': 'These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .', 'label': {'c-jun': 'DNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1648, 'sentence': 'Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.', 'label': {'PU.1 site': 'DNA', 'GM-CSF receptor alpha': 'protein', 'GM-CSF receptor alpha promoter': 'DNA', 'myelomonocytic cells': 'cell_type', 'C/EBP': 'protein', 'PU.1': 'protein', 'GM-CSF': 'protein', 'C/EBP site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 646, 'sentence': 'Surgically confirmed nodal involvement was observed in 42%.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any specific entities mentioned in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence mentions tumors and clinical course, which are not relevant to the entities in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence talks about genes and isoforms, which are not related to the entities in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 821, 'sentence': '(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .', 'label': {'LMP1': 'protein', 'EBNA-2': 'protein', 'EBV type 1 EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"EBV type 2 EBNA-2": "protein"}, {"LMP1": "protein"}, {"EBV type 1 EBNA-2": "protein"}]', 'prediction': {'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}}
{'idx': 548, 'sentence': 'On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 135, 'sentence': 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).', 'label': {'U9-IIIB': 'cell_line', 'monocytic U937 cells': 'cell_line', 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA': 'RNA', 'chronically HIV infected U937 cell line': 'cell_line', 'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'cell_type', 'cell_line']", 'response2': '[]', 'response3': '[{"Tumor necrosis factor alpha": "protein"}, {"TNF-alpha": "protein"}, {"mRNA": "RNA"}, {"polymerase chain reaction": "DNA"}, {"monocytic U937 cells": "cell_type"}, {"HIV": "cell_type"}, {"U937 cell line": "cell_line"}, {"U9-IIIB": "cell_line"}]', 'prediction': {'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein', 'mRNA': 'RNA', 'polymerase chain reaction': 'DNA', 'monocytic U937 cells': 'cell_type', 'HIV': 'cell_type', 'U937 cell line': 'cell_line', 'U9-IIIB': 'cell_line'}}
{'idx': 432, 'sentence': 'Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .', 'label': {'transfected B cells': 'cell_line', 'TSAP': 'protein', 'mutant TSAP -binding site': 'DNA', 'upstream promoter element': 'DNA', 'BSAP': 'protein', 'B-cell-specific transcription factor': 'protein', 'wild-type': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"BSAP": "protein"},\n{"B-cell": "cell_type"},\n{"TSAP": "protein"},\n{"sea urchin": "cell_line"},\n{"B cells": "cell_type"}\n]', 'prediction': {'BSAP': 'protein', 'B-cell': 'cell_type', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B cells': 'cell_type'}}
{'idx': 1161, 'sentence': 'Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .', 'label': {'I kappa B alpha': 'protein', 'NF kappa B': 'protein', 'NF kappa B -I kappa B complex': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NF kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"NF kappa B -I kappa B complex": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'NF kappa B -I kappa B complex': 'protein'}}
{'idx': 1794, 'sentence': 'Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .', 'label': {'STAT': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1470, 'sentence': 'Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .', 'label': {'neutrophil': 'cell_type', 'tumor necrosis factor (TNF)-alpha': 'protein', 'leukocyte adhesion molecule': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entities related to the entity types in the target sentence."},\n    {"Example 2": 3},\n    {"Reason 2": "The sentence mentions tumors, which could potentially be related to \'cell_type\' entity type. However, the other entities are not present."},\n    {"Example 3": 2},\n    {"Reason 3": "The sentence mentions genes and isoforms, which could be related to \'DNA\' or \'protein\' entity types. However, the other entities are not present."}\n]', 'response3': '[\n    {"TNF-alpha": "protein"},\n    {"CsA": "protein"}\n]', 'prediction': {'TNF-alpha': 'protein', 'CsA': 'protein'}}
{'idx': 644, 'sentence': 'Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?', 'label': {'tumor cells': 'cell_type', 'hematopoietic growth factor': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"Oncogene amplification": "DNA"}, {"lymphocyte": "cell_type"}, {"hematopoietic growth factor": "protein"}, {"tumor cells": "cell_line"}]', 'prediction': {'Oncogene amplification': 'DNA', 'lymphocyte': 'cell_type', 'hematopoietic growth factor': 'protein', 'tumor cells': 'cell_line'}}
{'idx': 435, 'sentence': 'Antibodies are produced exclusively in B lymphocytes .', 'label': {'Antibodies': 'protein', 'lymphocytes': 'cell_type', 'B lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"Antibodies": "protein"}, {"B lymphocytes": "cell_type"}]', 'prediction': {'Antibodies': 'protein', 'B lymphocytes': 'cell_type'}}
{'idx': 1342, 'sentence': 'While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.', 'label': {'amino acid domain': 'protein', 'BH1': 'protein', 'BH3': 'protein', 'Bak': 'protein', 'BH2': 'protein', 'Bax': 'protein', 'Bik': 'protein', 'Bcl-2 family': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Bik": "protein"}, {"BH1": "protein"}, {"BH2": "protein"}, {"Bcl-2": "protein"}, {"BH3": "protein"}, {"Bax": "protein"}, {"Bak": "protein"}]', 'prediction': {'Bik': 'protein', 'BH1': 'protein', 'BH2': 'protein', 'Bcl-2': 'protein', 'BH3': 'protein', 'Bax': 'protein', 'Bak': 'protein'}}
{'idx': 1022, 'sentence': 'NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .', 'label': {'NK cell NFAT': 'protein', 'AP-1': 'protein', 'nonstimulated cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence, but does not contain \'protein\'."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"NK cell NFAT": "cell_type"},\n{"cytosol": "cell_type"},\n{"nucleus": "cell_type"},\n{"AP-1": "protein"}\n]', 'prediction': {'NK cell NFAT': 'cell_type', 'cytosol': 'cell_type', 'nucleus': 'cell_type', 'AP-1': 'protein'}}
{'idx': 810, 'sentence': 'Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .', 'label': {'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"CML": "cell_line"},\n{"IFN-alpha": "protein"},\n{"CML cytoplasmic proteins": "protein"},\n{"protein-DNA complexes": "protein"},\n{"DNA": "DNA"}\n]', 'prediction': {'CML': 'cell_line', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'protein-DNA complexes': 'protein', 'DNA': 'DNA'}}
{'idx': 1811, 'sentence': "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .", 'label': {'BLR1': 'protein', 'BLR2': 'protein', 'seven transmembrane receptor': 'protein', 'activated lymphocytes': 'cell_type', 'chemokine receptors': 'protein', "Burkitt's lymphoma receptor 1": 'protein'}, 'response1': "['RNA', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1316, 'sentence': 'Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.', 'label': {'Helix III': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Helix III": "protein"}, {"helices I": "protein"}, {"helices II": "protein"}]', 'prediction': {'Helix III': 'protein', 'helices I': 'protein', 'helices II': 'protein'}}
{'idx': 939, 'sentence': 'However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.', 'label': {'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 292, 'sentence': 'We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.', 'label': {'globin gene': 'DNA', 'mouse embryonic stem (ES) cells': 'cell_type'}, 'response1': "['cell_type', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"mouse embryonic stem (ES) cells": "cell_type"}, {"globin gene": "DNA"}]', 'prediction': {'mouse embryonic stem (ES) cells': 'cell_type', 'globin gene': 'DNA'}}
{'idx': 542, 'sentence': 'Amino acid sequences of all proteins are essays written in the same language.', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"proteins": "protein"}]', 'prediction': {'proteins': 'protein'}}
{'idx': 505, 'sentence': 'The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .', 'label': {'Jurkat': 'cell_line', 'TCF-1 alpha': 'protein', 'TCR': 'protein', 'T-cell-specific transcription factor': 'protein', 'TCF-1 alpha binding site': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCR alpha": "protein"}, {"Jurkat": "cell_line"}, {"HeLa": "cell_line"}, {"TCF-1 alpha": "protein"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line'}}
{'idx': 1525, 'sentence': 'Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .', 'label': {'antibody': 'protein', 'CaM kinase II': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"CaM kinase II": "protein"}]', 'prediction': {'CaM kinase II': 'protein'}}
{'idx': 1103, 'sentence': 'Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.', 'label': {'platelets': 'cell_type', 'Rap1 protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 538, 'sentence': 'Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .', 'label': {'PHA': 'protein', 'phytohaemagglutinin': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1529, 'sentence': 'Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .', 'label': {'Oct-2a': 'protein', 'lymphoid-specific transcription factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1197, 'sentence': 'In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.', 'label': {'ubiquitin': 'protein', 'p105 precursor': 'protein', 'E2-F1': 'protein', '-proteasome': 'protein', 'ubiquitin -carrier protein': 'protein', 'p53': 'protein', 'ubiquitin -protein ligase': 'protein', '320-kDa species': 'protein', 'p105': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"ubiquitin -proteasome system": "protein"},\n    {"p105 precursor": "protein"},\n    {"ubiquitin": "protein"},\n    {"E2-F1": "protein"},\n    {"p53": "protein"},\n    {"ubiquitin -carrier protein": "protein"},\n    {"ubiquitin -protein ligase": "protein"}\n]', 'prediction': {'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}}
{'idx': 877, 'sentence': 'Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .', 'label': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1838, 'sentence': 'First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.', 'label': {'LEF-1 -binding site': 'DNA', 'HIV-1 enhancer': 'DNA', 'LEF-1': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_line', 'multimerized copies': 'DNA', 'LEF-1 /GAL4': 'protein'}, 'response1': "['DNA', 'protein', 'cell_type', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"LEF-1": "protein"}, {"HIV-1 enhancer": "DNA"}, {"Jurkat T cells": "cell_line"}, {"GAL4": "protein"}, {"HIV-1 enhancer": "DNA"}]', 'prediction': {'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_line', 'GAL4': 'protein'}}
{'idx': 1195, 'sentence': 'Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .', 'label': {'60-kDa precursor': 'protein', 'ubiquitin': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 817, 'sentence': '(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .', 'label': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"EBNA-LP": "protein"},\n{"LMP1": "protein"},\n{"EBNA-2": "protein"}\n]', 'prediction': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}}
{'idx': 741, 'sentence': 'In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .', 'label': {'Oct-2A expression vector': 'DNA', 'Oct-2A': 'protein', 'N-Oct-3 factor': 'protein', 'melanoma cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"melanoma cells": "cell_type"}, {"N-Oct-3 factor": "protein"}, {"lymphocyte-specific promoter": "DNA"}, {"Oct-2A expression vector": "protein"}]', 'prediction': {'melanoma cells': 'cell_type', 'N-Oct-3 factor': 'protein', 'lymphocyte-specific promoter': 'DNA', 'Oct-2A expression vector': 'protein'}}
{'idx': 283, 'sentence': '[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]', 'label': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any relevant entities related to the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence mentions tumors and clinical course, which are not relevant to the entities in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence discusses genes and isoforms, which are not related to the entities in the target sentence."}\n]', 'response3': '[{"Estrogen receptor": "protein"}, {"peripheral blood lymphocytes": "cell_type"}, {"systemic lupus erythematosus": "cell_type"}]', 'prediction': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type', 'systemic lupus erythematosus': 'cell_type'}}
{'idx': 1043, 'sentence': 'METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The entity type \'cell_type\' is present in this sentence, which is somewhat relevant to the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1010, 'sentence': 'Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .', 'label': {'murine NFATp': 'protein', 'NFATp protein': 'protein', 'NFATp': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"NFATp": "protein"}, {"NFATp": "protein"}, {"thymus": "cell_type"}, {"spleen": "cell_type"}]', 'prediction': {'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}}
{'idx': 186, 'sentence': 'We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .', 'label': {'erythrocytic lineage': 'cell_type', 'NF-E2': 'protein', 'trans-acting factor': 'protein', 'megakaryocytes': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"NF-E2": "protein"}, {"erythrocytic lineage": "cell_type"}, {"megakaryocytes": "cell_type"}]', 'prediction': {'NF-E2': 'protein', 'erythrocytic lineage': 'cell_type', 'megakaryocytes': 'cell_type'}}
{'idx': 1547, 'sentence': 'Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .', 'label': {'multisubunit adhesion receptor': 'protein', 'Ib-IX-V': 'protein', 'Platelet glycoprotein': 'protein', 'GP': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Platelet glycoprotein": "protein"}]', 'prediction': {'Platelet glycoprotein': 'protein'}}
{'idx': 96, 'sentence': 'We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .', 'label': {'Sp1': 'protein', 'dominant promoter elements': 'DNA', 'minimal Thy-1 promoter': 'DNA', 'transcription factor': 'protein', 'multiple binding sites': 'DNA', 'CCAAT box': 'DNA', 'transcription start site': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Thy-1 promoter": "DNA"}, {"transcription factor Sp1": "protein"}, {"CCAAT box": "DNA"}]', 'prediction': {'Thy-1 promoter': 'DNA', 'transcription factor Sp1': 'protein', 'CCAAT box': 'DNA'}}
{'idx': 1763, 'sentence': 'Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .', 'label': {'IL-2': 'protein', 'IL-2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"IL-2 mRNA": "RNA"},\n{"IL-2": "protein"}\n]', 'prediction': {'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}}
{'idx': 224, 'sentence': 'Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).', 'label': {'CEM C7 cells': 'cell_line', 'human acute lymphoblastic T-cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types in the target sentence are present in this example."},\n{"Example 2": 1},\n{"Reason 2": "None of the entity types in the target sentence are present in this example."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[\n{"CEM C7 cells": "cell_line"}\n]', 'prediction': {'CEM C7 cells': 'cell_line'}}
{'idx': 313, 'sentence': 'Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .', 'label': {'malignant soft tissue tumors': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"steroid hormones": "protein"}, {"estrogen binding assay": "protein"}]', 'prediction': {'steroid hormones': 'protein', 'estrogen binding assay': 'protein'}}
{'idx': 1285, 'sentence': "Characterization of 5' end of human thromboxane receptor gene .", 'label': {"5' end of human thromboxane receptor gene": 'DNA', 'human thromboxane receptor gene': 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[{"5\' end": "DNA"}]', 'prediction': {"5' end": 'DNA'}}
{'idx': 327, 'sentence': 'However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .', 'label': {'R-responsive enhancer region': 'DNA', 'EB1 -binding site': 'DNA', 'EB1': 'protein', 'ZRE-B': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"EB1": "protein"}, {"ZRE-B": "DNA"}, {"R-responsive enhancer region": "DNA"}]', 'prediction': {'EB1': 'protein', 'ZRE-B': 'DNA', 'R-responsive enhancer region': 'DNA'}}
{'idx': 1622, 'sentence': 'Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.', 'label': {'gamma interferon': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"proteins": "protein"}]', 'prediction': {'proteins': 'protein'}}
{'idx': 1393, 'sentence': 'This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .', 'label': {'second enhancer': 'DNA', 'T-cell activation response element': 'DNA', 'enhancer': 'DNA'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[{"T-cell": "cell_type"}, {"HIV-1": "cell_line"}, {"HIV-2": "cell_line"}, {"T-cell": "cell_type"}]', 'prediction': {'T-cell': 'cell_type', 'HIV-1': 'cell_line', 'HIV-2': 'cell_line'}}
{'idx': 1221, 'sentence': 'To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .', 'label': {'mouse osteocalcin gene': 'DNA', 'promoter': 'DNA', 'osteoblast-specific cis-acting elements': 'DNA', 'trans-acting factors': 'protein', 'osteoblast-specific gene': 'DNA'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence, but it does not provide additional context or specific named entities to aid in extraction."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 130, 'sentence': 'At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .', 'label': {'TREp': 'DNA', 'TR': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 788, 'sentence': 'The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).', 'label': {'mineralocorticoid receptors': 'protein'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 781, 'sentence': 'Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1220, 'sentence': 'A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .', 'label': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin promoter': 'DNA', 'osteoblast-specific cis-acting element': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 958, 'sentence': 'Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .', 'label': {'B-cell-specific genes': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"Markus Neurath": "None"}, {"Eckhard Stuber": "None"}, {"Warren Strober": "None"}, {"BSAP": "protein"}, {"B-cell-specific genes": "None"}]', 'prediction': {'Markus Neurath': 'None', 'Eckhard Stuber': 'None', 'Warren Strober': 'None', 'BSAP': 'protein', 'B-cell-specific genes': 'None'}}
{'idx': 1083, 'sentence': 'These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .', 'label': {'cytokine': 'protein', 'NF kappa B': 'protein', 'PBMC': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 514, 'sentence': 'Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .', 'label': {'globin gene': 'DNA', 'enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1133, 'sentence': 'Both LCLs were found by EM to produce RVLP and EBV particles .', 'label': {'LCLs': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1762, 'sentence': 'Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.', 'label': {'IL-2': 'protein', 'early gene': 'DNA', 'NF-kappa B': 'protein', 'Oct1': 'protein', 'transcription factors': 'protein', 'NF-AT': 'protein', 'AP-1': 'protein', 'IL-2 gene': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"IL-2 gene": "DNA"}, {"cysteamine": "protein"}, {"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"NF-AT": "protein"}, {"Oct1": "protein"}, {"IL-2 mRNA": "RNA"}]', 'prediction': {'IL-2 gene': 'DNA', 'cysteamine': 'protein', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein', 'IL-2 mRNA': 'RNA'}}
{'idx': 23, 'sentence': 'Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .', 'label': {'mutant E6 motif': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1476, 'sentence': 'Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .', 'label': {'AP-1 protein': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein', 'cytoplasmic inhibitor': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"AP-1 protein c-Jun": "protein"}, {"I kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1 protein c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 234, 'sentence': 'A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .', 'label': {'cultured': 'cell_line', 'primary cells': 'cell_type', 'adenovirus E2 promoter': 'DNA', 'beta-galactosidase gene': 'DNA', 'beta-galactosidase': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"beta-galactosidase gene": "DNA"}, {"adenovirus E2 promoter": "DNA"}]', 'prediction': {'beta-galactosidase gene': 'DNA', 'adenovirus E2 promoter': 'DNA'}}
{'idx': 1396, 'sentence': 'NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .', 'label': {'hematopoietic progenitor cell line': 'cell_line', 'NF-M': 'protein', 'chicken C/EBP beta': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[]', 'response3': '[{"NF-M": "protein"}, {"C/EBP beta": "protein"}, {"hematopoietic progenitor cell line": "cell_line"}]', 'prediction': {'NF-M': 'protein', 'C/EBP beta': 'protein', 'hematopoietic progenitor cell line': 'cell_line'}}
{'idx': 1812, 'sentence': 'The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .', 'label': {'G-protein coupled chemokine receptors': 'protein', 'chemokine receptors': 'protein', 'G-protein': 'protein', 'receptor EBI1': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"G-protein coupled chemokine receptors": "protein"}, {"EBI1": "protein"}]', 'prediction': {'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}}
{'idx': 1099, 'sentence': 'Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .', 'label': {'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'monocyte': 'cell_type', 'microtubule': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the entity types in the target sentence are present in this example."},\n    {"Example 2": 1},\n    {"Reason 2": "None of the entity types in the target sentence are present in this example."},\n    {"Example 3": 1},\n    {"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1537, 'sentence': 'Furthermore, we identified a repression domain at the N-terminus of Oct-2a .', 'label': {'Oct-2a': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1574, 'sentence': 'CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .', 'label': {'receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entities related to the entity types in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any entities related to the entity types in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any entities related to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1312, 'sentence': 'A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.', 'label': {'HMG-1': 'protein', 'C-terminal HMG box': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 601, 'sentence': 'To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .', 'label': {'murine IgH enhancer': 'DNA', 'putative additional lymphoid-specific transcription factor': 'protein', 'octamer (OCTA)-nucleotide motif': 'DNA', 'NF-microB': 'protein', 'enhancer elements': 'DNA', 'immunoglobulin heavy-chain (IgH) gene': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 3},\n    {"Example 3": 2}\n]', 'response3': '[\n    {"immunoglobulin heavy-chain": "protein"},\n    {"NF-microB": "protein"},\n    {"murine IgH": "protein"}\n]', 'prediction': {'immunoglobulin heavy-chain': 'protein', 'NF-microB': 'protein', 'murine IgH': 'protein'}}
{'idx': 890, 'sentence': 'Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 323, 'sentence': 'The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .', 'label': {'Epstein-Barr virus ( EBV ) ORI1yt enhancer': 'DNA'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[]', 'response3': '[{"Epstein-Barr virus": "DNA"}, {"ORI1yt enhancer": "DNA"}, {"B-cell": "cell_type"}, {"EBV": "protein"}, {"R": "protein"}, {"Z": "protein"}]', 'prediction': {'Epstein-Barr virus': 'DNA', 'ORI1yt enhancer': 'DNA', 'B-cell': 'cell_type', 'EBV': 'protein', 'R': 'protein', 'Z': 'protein'}}
{'idx': 929, 'sentence': 'The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .', 'label': {'ORF': 'DNA', '272 carboxy-terminal amino acids': 'protein', 'ets-1': 'protein', 'human ets-1 protein': 'protein', '813-bp open reading frame': 'DNA', 'cDNA sequence': 'DNA', 'amino acid sequence': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"cDNA sequence": "DNA"}, {"amino acid sequence": "protein"}, {"human ets-1 protein": "protein"}]', 'prediction': {'cDNA sequence': 'DNA', 'amino acid sequence': 'protein', 'human ets-1 protein': 'protein'}}
{'idx': 6, 'sentence': 'Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .', 'label': {'Platelet-activating factor': 'protein', 'oncogene': 'DNA', 'human B cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[\n{"Platelet-activating factor": "protein"},\n{"phospholipid turnover": "cell_type"},\n{"calcium flux": "cell_type"},\n{"arachidonic acid liberation": "cell_type"},\n{"eicosanoid generation": "cell_type"},\n{"oncogene expression": "cell_type"},\n{"human B cell line": "cell_line"}\n]', 'prediction': {'Platelet-activating factor': 'protein', 'phospholipid turnover': 'cell_type', 'calcium flux': 'cell_type', 'arachidonic acid liberation': 'cell_type', 'eicosanoid generation': 'cell_type', 'oncogene expression': 'cell_type', 'human B cell line': 'cell_line'}}
{'idx': 1478, 'sentence': 'Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.', 'label': {'activated T cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[{"T cells": "cell_type"}]', 'prediction': {'T cells': 'cell_type'}}
{'idx': 1793, 'sentence': 'The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1473, 'sentence': 'Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .', 'label': {'NF-kappa B': 'protein', 'T cells': 'cell_type', 'AP-1': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}}
{'idx': 539, 'sentence': 'PMA enhanced slightly the stimulatory effect of PHA .', 'label': {'PHA': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1025, 'sentence': 'NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .', 'label': {'NFATc': 'protein', 'NK cells': 'cell_type', 'NFATc mRNA': 'RNA'}, 'response1': "['RNA', 'cell_type', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"NFATc": "protein"},\n    {"NFATc mRNA": "RNA"},\n    {"NK cells": "cell_type"},\n    {"CD16 ligands": "protein"}\n]', 'prediction': {'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}}
{'idx': 1560, 'sentence': 'Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .', 'label': {'human T helper (Th) clones': 'cell_line', 'CD30+ cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"T helper": "cell_type"}, {"CD30": "protein"}]', 'prediction': {'T helper': 'cell_type', 'CD30': 'protein'}}
{'idx': 365, 'sentence': 'Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.', 'label': {'c-jun': 'DNA', 'HL-60 cells': 'cell_line', 'untreated HL-60 cells': 'cell_line'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence, but does not provide additional context or specific named entities."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1039, 'sentence': 'Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .', 'label': {'Peripheral blood mononuclear cells': 'cell_type', 'pbmc': 'cell_type', 'bone marrow cells': 'cell_type'}, 'response1': "['RNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"Peripheral blood mononuclear cells": "cell_type"}, {"bone marrow cells": "cell_type"}, {"c-fos": "protein"}, {"c-myc": "protein"}, {"p53": "protein"}, {"bcr/abl mRNA": "RNA"}]', 'prediction': {'Peripheral blood mononuclear cells': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl mRNA': 'RNA'}}
{'idx': 217, 'sentence': 'Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .', 'label': {'GCR': 'protein', 'glucocorticoid receptors': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1782, 'sentence': 'In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .', 'label': {'Id3': 'protein', 'resting PBL': 'cell_type', 'Id3 mRNA': 'RNA', 'PBL': 'cell_type', 'Id2': 'protein', 'Id2 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"Id2 mRNA": "RNA"}, {"Id3 mRNA": "RNA"}]', 'prediction': {'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}}
{'idx': 1280, 'sentence': "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.", 'label': {'NF-kappa B': 'protein', 'TATA element': 'DNA', 'transcription factors': 'protein', 'CD69': 'protein', 'AP-1': 'protein', '30 base pairs upstream': 'DNA', 'CD69 gene': 'DNA', "5'-flanking region": 'DNA', 'transcription initiation site': 'DNA', 'Egr-1': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"CD69 gene": "DNA"}, {"TATA element": "DNA"}, {"NF-kappa B": "protein"}, {"Egr-1": "protein"}, {"AP-1": "protein"}]', 'prediction': {'CD69 gene': 'DNA', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}}
{'idx': 611, 'sentence': 'Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"DNA viruses": "DNA"}, {"HIV-1": "RNA"}]', 'prediction': {'DNA viruses': 'DNA', 'HIV-1': 'RNA'}}
{'idx': 1723, 'sentence': 'In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .', 'label': {'tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA': 'RNA', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['cell_line', 'protein', 'RNA']", 'response2': '[]\n[]', 'response3': '[{"monocyte/macrophage cell line": "cell_line"}, {"NF-kappa B": "protein"}, {"tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA": "RNA"}]', 'prediction': {'monocyte/macrophage cell line': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA': 'RNA'}}
{'idx': 1308, 'sentence': 'Two groups of HMG box proteins are distinguished.', 'label': {'HMG box proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 765, 'sentence': 'Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1561, 'sentence': 'In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .', 'label': {'CD30': 'protein', 'NF-kappa B complexes': 'protein', 'p65 RelA': 'protein', 'p50 NF-kappa B1': 'protein', 'NF-kappa B': 'protein', 'transcription factors': 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B complexes": "protein"}, {"p50 NF-kappa B1": "protein"}, {"p65 RelA": "protein"}, {"transcription factors": "protein"}]', 'prediction': {'NF-kappa B complexes': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein', 'transcription factors': 'protein'}}
{'idx': 330, 'sentence': 'ZRE-B is therefore not part of the R- inducible enhancer .', 'label': {'ZRE-B': 'DNA', 'R- inducible enhancer': 'DNA'}, 'response1': 'None.', 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1104, 'sentence': 'Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1594, 'sentence': 'Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .', 'label': {'Jurkat cells': 'cell_line', 'NF-kappa B -activating cytokine': 'protein', 'Human IL4 promoter': 'DNA', 'tumor necrosis factor alpha': 'protein', 'RelA -overexpressing cells': 'cell_line', 'NF-kappa B': 'protein', 'RelA': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1086, 'sentence': 'Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .', 'label': {'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'human I kappa B alpha protein': 'protein', 'mouse 70Z/3 cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the examples contain entity types present in the target sentence, so they are not helpful in aiding the extraction of named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1, 'sentence': 'When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.', 'label': {'homeodomain': 'DNA', 'HB24': 'DNA', 'Drosophila homeodomain': 'DNA'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1226, 'sentence': 'Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .', 'label': {'transcription factors': 'protein', 'T-cell nuclear extract-DNA complexes': 'protein', 'OSF2': 'protein', 'osteoblast nuclear extract-DNA complexes': 'protein', 'PEBP2 alpha factors': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"OSF2": "protein"}, {"PEBP2 alpha factors": "protein"}]', 'prediction': {'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}}
{'idx': 663, 'sentence': 'The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .', 'label': {}, 'response1': "['cell_line', 'cell_type', 'gene expression']", 'response2': '[]\n[]', 'response3': '[{"cells lines": "cell_line"}, {"signaling pathways": "cell_type"}, {"gene expression": "DNA"}]', 'prediction': {'cells lines': 'cell_line', 'signaling pathways': 'cell_type', 'gene expression': 'DNA'}}
{'idx': 1000, 'sentence': 'Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.', 'label': {'HSF2': 'protein', 'HSF3': 'protein', 'HSFs': 'protein', 'HSF1': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"HSF3": "protein"}, {"HSF1": "protein"}, {"HSF2": "protein"}]', 'prediction': {'HSF3': 'protein', 'HSF1': 'protein', 'HSF2': 'protein'}}
{'idx': 39, 'sentence': 'Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .', 'label': {'KBF1': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 229, 'sentence': "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .", 'label': {'B-cell line': 'cell_line', 'IM-9': 'cell_line', 'GR': 'protein', "CVZ 's binding sites": 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types in the target sentence are present in this example."},\n{"Example 2": 1},\n{"Reason 2": "None of the entity types in the target sentence are present in this example."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 743, 'sentence': 'Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .', 'label': {'erythroid cell transcription factor': 'protein', 'non-erythroid cells': 'cell_type', 'EF1': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[{"EF1": "protein"}]', 'prediction': {'EF1': 'protein'}}
{'idx': 1799, 'sentence': 'These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .', 'label': {'GAS': 'DNA', 'IFN-gamma-activated sequence': 'DNA', 'STAT proteins': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[]\n[]', 'response3': '[{"STAT proteins": "protein"}, {"IFN-gamma-activated sequence": "DNA"}, {"oligonucleotides": "DNA"}]', 'prediction': {'STAT proteins': 'protein', 'IFN-gamma-activated sequence': 'DNA', 'oligonucleotides': 'DNA'}}
{'idx': 1703, 'sentence': "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .", 'label': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'IFN -activated NK cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"E1A": "protein"}, {"IFN": "protein"}, {"adenovirus-transformed cells": "cell_line"}, {"IFN-activated NK cells": "cell_type"}]', 'prediction': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'IFN-activated NK cells': 'cell_type'}}
{'idx': 629, 'sentence': 'Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .', 'label': {'progesterone receptor': 'protein', 'CD8+ cells': 'cell_line', 'lymphocytes': 'cell_line', 'progesterone receptor -bearing cells': 'cell_line', 'CD4+ cells': 'cell_line'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[{"CD8+ cells": "cell_type"}, {"progesterone receptor-bearing cells": "protein"}, {"CD4+ cells": "cell_type"}, {"positively staining lymphocytes": "cell_type"}]', 'prediction': {'CD8+ cells': 'cell_type', 'progesterone receptor-bearing cells': 'protein', 'CD4+ cells': 'cell_type', 'positively staining lymphocytes': 'cell_type'}}
{'idx': 490, 'sentence': 'Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .', 'label': {'lymphokine genes': 'DNA', 'interleukin-2': 'protein'}, 'response1': "['protein', 'RNA']", 'response2': '[]\n[]', 'response3': '[{"Cyclosporin A": "protein"}, {"CsA": "protein"}, {"lymphokine genes": "protein"}, {"interleukin-2": "protein"}]', 'prediction': {'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'protein', 'interleukin-2': 'protein'}}
{'idx': 118, 'sentence': "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .", 'label': {'SCL': 'protein', "SCL 5' regulatory region": 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 493, 'sentence': 'Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .', 'label': {'NFAT-1 complex': 'protein', 'mitogen-inducible DNA-binding complexes': 'protein', 'kappa B complex': 'protein', 'interleukin-2': 'protein', 'interleukin-2 enhancer': 'DNA', 'HIV enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"DNA-binding complexes": "DNA"}, {"kappa B complex": "protein"}, {"NFAT-1 complex": "protein"}]', 'prediction': {'DNA-binding complexes': 'DNA', 'kappa B complex': 'protein', 'NFAT-1 complex': 'protein'}}
{'idx': 1798, 'sentence': 'In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .', 'label': {'purified human peripheral blood T cells': 'cell_type', 'anti-CD3 Abs': 'protein', 'nuclear STAT proteins': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"STAT proteins": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'STAT proteins': 'protein', 'T cells': 'cell_type'}}
{'idx': 175, 'sentence': 'To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.', 'label': {'blood mononuclear cells': 'cell_type', 'uncultured cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for extracting named entities."}\n]', 'response3': '[\n{"bronchoalveolar lavage": "cell_type"},\n{"blood mononuclear cells": "cell_type"},\n{"sarcoidosis": "cell_type"},\n{"tuberculosis": "cell_type"}\n]', 'prediction': {'bronchoalveolar lavage': 'cell_type', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}}
{'idx': 1498, 'sentence': 'Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.', 'label': {'lymphoblasts': 'cell_type'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"DNA binding region": "DNA"}, {"lymphoblasts": "cell_type"}]', 'prediction': {'DNA binding region': 'DNA', 'lymphoblasts': 'cell_type'}}
{'idx': 995, 'sentence': 'The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[{"B-cell": "cell_type"}, {"mouse": "cell_line"}]', 'prediction': {'B-cell': 'cell_type', 'mouse': 'cell_line'}}
{'idx': 1671, 'sentence': 'Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .', 'label': {'IL-6 neutralizing antibodies': 'protein', 'IL-6': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 141, 'sentence': 'TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .', 'label': {'monocytic cells': 'cell_type', 'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV LTR": "DNA"}, {"T cells": "cell_type"}, {"monocytic cells": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}}
{'idx': 1557, 'sentence': "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .", 'label': {"Hodgkin's disease -derived, T cell-like, CD30 + cells": 'cell_line', 'nuclear factor (NF)-kappa B': 'protein', 'M44': 'protein', 'L540 cells': 'cell_line', 'M67': 'protein', 'mAb': 'protein', 'agonistic anti- CD30 monoclonal antibodies': 'protein', 'CD30': 'protein'}, 'response1': "['cell_line', 'protein', 'DNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the examples contain entity types present in the target sentence, so they are not helpful in predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1090, 'sentence': 'Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.', 'label': {'N terminus': 'protein', 'I kappa B alpha': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1568, 'sentence': 'The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .', 'label': {'enzymes': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"high density lipoprotein": "protein"}, {"HDL": "protein"}, {"enzymes": "protein"}, {"biologically active lipids": "protein"}, {"LDL": "protein"}]', 'prediction': {'high density lipoprotein': 'protein', 'HDL': 'protein', 'enzymes': 'protein', 'biologically active lipids': 'protein', 'LDL': 'protein'}}
{'idx': 257, 'sentence': 'Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .', 'label': {}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 262, 'sentence': 'This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .', 'label': {'complementary DNA': 'DNA', 'c-jun proto-oncogene product': 'protein', 'palindromic target sequence': 'DNA', 'c-jun': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"complementary DNA": "DNA"}, {"protein": "protein"}, {"c-jun": "protein"}, {"target sequence": "protein"}, {"palindromic target sequence": "protein"}, {"c-jun": "protein"}]', 'prediction': {'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun': 'protein', 'target sequence': 'protein', 'palindromic target sequence': 'protein'}}
{'idx': 1351, 'sentence': 'Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"25 kD": "protein"}, {"55 kD": "protein"}, {"alternative splicing": "RNA"}]', 'prediction': {'25 kD': 'protein', '55 kD': 'protein', 'alternative splicing': 'RNA'}}
{'idx': 973, 'sentence': 'To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .', 'label': {'MZF-1': 'DNA', 'DNA binding domain': 'protein', 'yeast transactivator GAL4': 'protein', 'GAL4': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"MZF-1": "protein"}, {"DNA": "DNA"}, {"GAL4": "protein"}]', 'prediction': {'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}}
{'idx': 1125, 'sentence': 'This indicates that the CR of GR may be of functional significance.', 'label': {'GR': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 338, 'sentence': 'Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .', 'label': {'T3R': 'protein', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any entities relevant to the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any entities relevant to the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any entities relevant to the target sentence."}\n]', 'response3': '[{"Nuclear T3R": "protein"}, {"lymphocytes": "cell_type"}]', 'prediction': {'Nuclear T3R': 'protein', 'lymphocytes': 'cell_type'}}
{'idx': 1080, 'sentence': 'However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1786, 'sentence': 'Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .', 'label': {'coagulation protease': 'protein', 'tissue factor (TF) receptor': 'protein', 'plasma Factor VII/VIIa': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"Factor VII/VIIa": "protein"}, {"tissue factor (TF)": "protein"}]', 'prediction': {'Factor VII/VIIa': 'protein', 'tissue factor (TF)': 'protein'}}
{'idx': 1242, 'sentence': 'LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .', 'label': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"NF kappa B": "protein"}, {"p50/p65 heterodimers": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}}
{'idx': 866, 'sentence': 'T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entities relevant to the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence talks about tumors and clinical course, which are not relevant entities in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence discusses genes and isoforms, which are not relevant entities in the target sentence."}\n]', 'response3': '[{"T cell": "cell_type"}, {"HIV": "protein"}]', 'prediction': {'T cell': 'cell_type', 'HIV': 'protein'}}
{'idx': 433, 'sentence': 'Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .', 'label': {'regulatory regions': 'DNA', 'BSAP': 'protein', 'high-affinity binding site': 'DNA', 'B-lymphoid-specific genes': 'DNA'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"BSAP": "protein"}, {"immunoglobulin": "protein"}, {"class II major histocompatibility (MHC) genes": "protein"}, {"B-lymphoid-specific genes": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'protein', 'B-lymphoid-specific genes': 'cell_type'}}
{'idx': 1546, 'sentence': 'Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .', 'label': {'platelet glycoprotein Ib alpha gene': 'DNA', 'GATA': 'DNA', 'Ets binding motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 1},\n    {"Example 3": 1},\n    {"Reasons": "The sentences do not contain any of the entity types present in the target sentence, so they are not helpful in aiding the extraction of named entities."}\n]', 'response3': '[{"GATA": "protein"}, {"Ets": "protein"}, {"platelet glycoprotein Ib alpha gene": "protein"}]', 'prediction': {'GATA': 'protein', 'Ets': 'protein', 'platelet glycoprotein Ib alpha gene': 'protein'}}
{'idx': 1412, 'sentence': 'We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"PRL": "protein"}, {"IL-2": "protein"}]', 'prediction': {'PRL': 'protein', 'IL-2': 'protein'}}
{'idx': 411, 'sentence': 'There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1460, 'sentence': 'In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.', 'label': {'multiple myeloma cell lines': 'cell_line', 'PU.1': 'protein', 'Pu box': 'DNA', 'differentiated, plasma cell-like B cells': 'cell_type'}, 'response1': "['cell_line', 'DNA', 'protein', 'RNA']", 'response2': '[]\n[]', 'response3': '[{"PU.1 DNA binding activity": "DNA"}, {"mRNA expression": "RNA"}, {"Pu box -dependent transactivation": "protein"}]', 'prediction': {'PU.1 DNA binding activity': 'DNA', 'mRNA expression': 'RNA', 'Pu box -dependent transactivation': 'protein'}}
{'idx': 638, 'sentence': 'Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .', 'label': {'CD3': 'protein', 'TCR': 'protein', 'VLA-5 fibronectin receptor': 'protein', 'fibronectin': 'protein', 'CD4 cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1375, 'sentence': 'We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .', 'label': {'PBLs': 'cell_type', 'peripheral blood lymphocytes': 'cell_type', 'TCL1 mRNA': 'RNA', 'protein': 'protein'}, 'response1': "['RNA', 'protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[{"TCL1 mRNA": "RNA"}, {"protein": "protein"}, {"peripheral blood lymphocytes": "cell_type"}, {"PBLs": "cell_line"}, {"AT cases": "cell_type"}]', 'prediction': {'TCL1 mRNA': 'RNA', 'protein': 'protein', 'peripheral blood lymphocytes': 'cell_type', 'PBLs': 'cell_line', 'AT cases': 'cell_type'}}
{'idx': 764, 'sentence': 'The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .', 'label': {'CEM-C7': 'cell_line', 'CEM-C7 cells': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[]\n[]', 'response3': '[{"CEM-C7 cells": "cell_line"}]', 'prediction': {'CEM-C7 cells': 'cell_line'}}
{'idx': 897, 'sentence': 'The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .', 'label': {'transcription of SV40 T-antigen': 'protein', 'NFAT-1': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"NFAT-1": "protein"}, {"SV40 T-antigen": "protein"}]', 'prediction': {'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}}
{'idx': 1842, 'sentence': 'Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .', 'label': {'Ets-1': 'protein', 'TFE-3': 'protein', 'LEF-1': 'protein', 'enhancer-binding proteins': 'protein', 'Sp1': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"LEF-1": "protein"}, {"Ets-1": "protein"}, {"TFE-3": "protein"}, {"Sp1": "protein"}]', 'prediction': {'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}}
{'idx': 1059, 'sentence': 'Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .', 'label': {'NF-kappa B family': 'protein', 'Transcription factors': 'protein', 'I kappa B beta': 'protein', 'inhibitory I kappa B proteins': 'protein', 'I kappa B alpha': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B": "protein"}, {"I kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"I kappa B beta": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'I kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}}
{'idx': 924, 'sentence': 'We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .', 'label': {'hsp70': 'protein', 'untransformed steroid receptors': 'protein', 'hsp90': 'protein', 'p56': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"p56": "protein"}, {"cytosol": "cell_type"}, {"hsp70": "protein"}, {"hsp90": "protein"}, {"steroid receptors": "protein"}]', 'prediction': {'p56': 'protein', 'cytosol': 'cell_type', 'hsp70': 'protein', 'hsp90': 'protein', 'steroid receptors': 'protein'}}
{'idx': 247, 'sentence': 'Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .', 'label': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[{"Antigen B27": "protein"}, {"glucocorticoid receptors": "protein"}, {"blood lymphocytes": "cell_type"}]', 'prediction': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}}
{'idx': 507, 'sentence': 'Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .', 'label': {'TCF-2 alpha': 'protein', 'TCR alpha enhancer': 'DNA', 'CREB': 'protein', 'transcription factors': 'protein', 'T alpha 1': 'protein', 'TCR': 'protein', 'TCF-1 alpha': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCF-2 alpha": "protein"}, {"T alpha 1 (CREB)": "protein"}, {"TCR alpha enhancer": "DNA"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1 (CREB)': 'protein', 'TCR alpha enhancer': 'DNA'}}
{'idx': 460, 'sentence': "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.", 'label': {'HIV LTRs': 'DNA', 'regulatory elements': 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 131, 'sentence': 'Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .', 'label': {'TRs': 'protein', 'carboxyl-terminus': 'protein', 'TR alpha 1': 'protein', 'nuclear proteins': 'protein', 'amino acid 210': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[]\n[]', 'response3': '[{"TR alpha 1": "protein"}, {"DNA": "DNA"}, {"TRs": "protein"}]', 'prediction': {'TR alpha 1': 'protein', 'DNA': 'DNA', 'TRs': 'protein'}}
{'idx': 692, 'sentence': 'The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .', 'label': {'virally encoded transactivator protein': 'protein', 'Tax -response element': 'DNA', 'TRE': 'DNA', 'human T-cell leukemia virus type I ( HTLV-I ) promoter': 'DNA', 'Tax': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 1},\n    {"Example 3": 1},\n    {"Reasons": "The sentences do not contain any of the entity types present in the target sentence, making them not helpful for predicting named entities."}\n]', 'response3': '[{"TRE": "DNA"}, {"Tax": "protein"}]', 'prediction': {'TRE': 'DNA', 'Tax': 'protein'}}
{'idx': 43, 'sentence': 'T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .', 'label': {'cysteine-rich antigen segments': 'protein', 'T-helper-cell determinants': 'protein', 'protein antigens': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[{"T-helper-cell": "cell_type"}, {"protein": "protein"}, {"cysteine-rich antigen segments": "protein"}, {"cathepsin B": "protein"}, {"L": "protein"}, {"D": "protein"}]', 'prediction': {'T-helper-cell': 'cell_type', 'protein': 'protein', 'cysteine-rich antigen segments': 'protein', 'cathepsin B': 'protein', 'L': 'protein', 'D': 'protein'}}
{'idx': 1204, 'sentence': 'Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.', 'label': {}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1134, 'sentence': 'Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .', 'label': {'LCLs': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"Reverse transcriptase": "protein"}, {"RT": "protein"}, {"LCLs": "cell_line"}]', 'prediction': {'Reverse transcriptase': 'protein', 'RT': 'protein', 'LCLs': 'cell_line'}}
{'idx': 471, 'sentence': 'The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).', 'label': {'lymphocyte nuclear T3 receptor': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"T3 receptor": "protein"},\n    {"DNA": "DNA"}\n]', 'prediction': {'T3 receptor': 'protein', 'DNA': 'DNA'}}
{'idx': 1205, 'sentence': 'Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 14, 'sentence': 'Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .', 'label': {'c-fos': 'DNA', 'nuclear proto-oncogenes': 'DNA', 'c-jun': 'DNA', 'platelet-activating factor': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"platelet-activating factor": "protein"}, {"c-fos": "protein"}, {"c-jun": "protein"}]', 'prediction': {'platelet-activating factor': 'protein', 'c-fos': 'protein', 'c-jun': 'protein'}}
{'idx': 145, 'sentence': 'Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .', 'label': {'nuclear proteins': 'protein', 'major histocompatibility complex (MHC) class II promoters': 'DNA', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1449, 'sentence': 'DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.', 'label': {'upstream stimulatory factor': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"DNA": "DNA"}, {"complex 3": "protein"}, {"upstream stimulatory factor": "protein"}]', 'prediction': {'DNA': 'DNA', 'complex 3': 'protein', 'upstream stimulatory factor': 'protein'}}
{'idx': 1292, 'sentence': "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .", 'label': {'thromboxane receptor': 'protein', 'thromboxane receptor gene': 'DNA', 'CAT': 'protein', 'chloramphenicol acetyltransferase': 'protein', "5' flanking region": 'DNA', 'thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids': 'DNA', 'K562 cells': 'cell_line'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"thromboxane receptor gene": "DNA"}, {"thromboxane receptor gene": "DNA"}, {"chloramphenicol acetyltransferase ( CAT )": "protein"}, {"K562 cells": "cell_line"}]', 'prediction': {'thromboxane receptor gene': 'DNA', 'chloramphenicol acetyltransferase ( CAT )': 'protein', 'K562 cells': 'cell_line'}}
{'idx': 120, 'sentence': 'Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.', 'label': {'RPMI 8402': 'cell_line', 'T cell lines': 'cell_line', 'CEM': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"CEM": "cell_line"},\n{"RPMI 8402": "cell_line"}\n]', 'prediction': {'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}}
{'idx': 468, 'sentence': 'A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 138, 'sentence': 'The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .', 'label': {'beta interferon promoter': 'DNA', 'regulatory elements': 'DNA', 'HIV long terminal repeat': 'DNA', 'TNF-alpha': 'protein', 'LTR': 'DNA', 'reporter chloramphenicol acetyltransferase plasmids': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 64, 'sentence': 'Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .', 'label': {'IFN beta promoter deletions': 'DNA'}, 'response1': "['cell_line', 'protein']", 'response2': '[]', 'response3': '[{"HeLa": "cell_line"}, {"IFN beta": "protein"}]', 'prediction': {'HeLa': 'cell_line', 'IFN beta': 'protein'}}
{'idx': 1760, 'sentence': 'This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 676, 'sentence': 'The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein', 'interleukin 2 ( IL-2 ) gene promoter': 'DNA', 'T-cell': 'cell_type'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"interleukin 2": "protein"}, {"IL-2": "protein"}, {"cell-type-specific": "cell_type"}, {"ubiquitous": "cell_type"}, {"transcriptional regulators": "protein"}, {"signaling systems": "cell_type"}, {"T-cell": "cell_type"}]', 'prediction': {'interleukin 2': 'protein', 'IL-2': 'protein', 'cell-type-specific': 'cell_type', 'ubiquitous': 'cell_type', 'transcriptional regulators': 'protein', 'signaling systems': 'cell_type', 'T-cell': 'cell_type'}}
{'idx': 1052, 'sentence': 'Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.', 'label': {'IL-2R alpha': 'protein', 'SEA': 'protein', 'IL-2R gamma': 'protein', 'SEB': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"IL-2R alpha": "protein"}]', 'prediction': {'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}}
{'idx': 487, 'sentence': 'Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.', 'label': {'human monocytes': 'cell_type', 'normal human monocytes': 'cell_type', 'M-CSF': 'protein', 'immediate early response genes': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[{"M-CSF": "protein"}, {"monocytes": "cell_type"}]', 'prediction': {'M-CSF': 'protein', 'monocytes': 'cell_type'}}
{'idx': 570, 'sentence': 'Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1370, 'sentence': 'Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .', 'label': {'CD28': 'protein', 'anti- CD28 MoAb': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NF kappa B": "protein"}, {"IL-2": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'IL-2': 'protein'}}
{'idx': 994, 'sentence': 'The role of BSAP ( Pax-5 ) in B-cell development .', 'label': {'BSAP': 'protein', 'Pax-5': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"BSAP": "protein"}, {"Pax-5": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}}
{'idx': 438, 'sentence': 'This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).', 'label': {'OTF factors': 'protein', 'nuclear proteins': 'protein', 'sequence motif': 'DNA', 'octamer transcription factors': 'protein', 'Oct': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"octamer transcription factors": "protein"}]', 'prediction': {'octamer transcription factors': 'protein'}}
{'idx': 270, 'sentence': 'There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .', 'label': {}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1481, 'sentence': 'We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1807, 'sentence': 'We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .', 'label': {'cell genes': 'DNA', 'cyclin E': 'DNA', 'cyclin D2': 'DNA', 'CD23': 'DNA', 'cdc-2': 'DNA'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"cdc-2": "protein"}, {"cyclin E": "protein"}, {"CD23": "protein"}, {"cyclin D2": "protein"}]', 'prediction': {'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein'}}
{'idx': 1169, 'sentence': 'However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .', 'label': {'SPXX motifs': 'protein', 'nuclear targeting sequence': 'protein', 'gene regulatory proteins': 'protein', 'B4-2': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"B4-2": "protein"}, {"proline": "protein"}, {"nuclear targeting sequence": "protein"}, {"SPXX motifs": "protein"}, {"gene regulatory proteins": "protein"}]', 'prediction': {'B4-2': 'protein', 'proline': 'protein', 'nuclear targeting sequence': 'protein', 'SPXX motifs': 'protein', 'gene regulatory proteins': 'protein'}}
{'idx': 1180, 'sentence': 'We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .', 'label': {'IL-2R': 'protein', 'IL-2': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'IL-2 receptor': 'protein', 'JAK1': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 968, 'sentence': 'These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.', 'label': {'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 497, 'sentence': 'The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .', 'label': {'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"T cells": "cell_type"}, {"proteins": "protein"}]', 'prediction': {'T cells': 'cell_type', 'proteins': 'protein'}}
{'idx': 1606, 'sentence': 'Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .', 'label': {'CD11b/CD18': 'protein', 'CD35': 'protein', 'p50/p65': 'protein', 'CR1': 'protein', 'HIV-infected monocytic cells': 'cell_type', 'complement receptors': 'protein', 'human monocytes': 'cell_type', 'NF-kappa B': 'protein', 'CR3': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1653, 'sentence': 'Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .', 'label': {'nonmyeloid cells': 'cell_type', 'GM-CSF': 'protein', 'PU.1': 'protein', 'GM-CSF receptor alpha promoter': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 833, 'sentence': 'Mapping of B-cell epitopes of the human hepatitis B virus X protein .', 'label': {'human hepatitis B virus X protein': 'protein', 'B-cell epitopes': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"hepatitis B virus X protein": "protein"}]', 'prediction': {'hepatitis B virus X protein': 'protein'}}
{'idx': 389, 'sentence': 'The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .', 'label': {'periplasmic domain': 'protein', 'PhoQ protein': 'protein', 'cationic proteins': 'protein', 'defensin': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"PhoQ protein": "protein"}, {"defensin": "protein"}]', 'prediction': {'PhoQ protein': 'protein', 'defensin': 'protein'}}
{'idx': 193, 'sentence': 'The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .', 'label': {'c-myc': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1349, 'sentence': 'Its expression was always restricted to the nucleus .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 882, 'sentence': 'This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .', 'label': {'c-Jun': 'protein', 'heterodimeric activator protein-1 transcription complex': 'protein', 'c-Fos': 'protein', 'cDNA': 'DNA', 'human c-Jun protein': 'protein', 'cDNA clone': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"cDNA clone": "DNA"}, {"human c-Jun protein": "protein"}, {"c-Fos": "protein"}, {"activator protein-1": "protein"}]', 'prediction': {'cDNA clone': 'DNA', 'human c-Jun protein': 'protein', 'c-Fos': 'protein', 'activator protein-1': 'protein'}}
{'idx': 725, 'sentence': 'Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .', 'label': {'Rex': 'protein', 'HTLV-infected cells': 'cell_type', 'gag/pol': 'protein', 'env mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"Rex": "protein"},\n{"gag/pol": "protein"},\n{"env mRNA": "RNA"},\n{"HTLV-infected cells": "cell_line"}\n]', 'prediction': {'Rex': 'protein', 'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_line'}}
{'idx': 867, 'sentence': 'In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).', 'label': {'conserved binding sites': 'DNA', 'nuclear factor kappa B': 'protein', 'long terminal repeat': 'DNA', 'LTR': 'DNA', 'NF kappa B': 'protein', 'transcriptional enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"long terminal repeat": "DNA"}, {"transcriptional enhancer": "DNA"}, {"nuclear factor kappa B": "protein"}]', 'prediction': {'long terminal repeat': 'DNA', 'transcriptional enhancer': 'DNA', 'nuclear factor kappa B': 'protein'}}
{'idx': 841, 'sentence': 'Such tests may become useful diagnostic tools .', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 1, "Reason 1": "The sentence does not contain any entities related to the given entity labels."},\n{"Example 2": 1, "Reason 2": "The sentence does not contain any entities related to the given entity labels."},\n{"Example 3": 1, "Reason 3": "The sentence does not contain any entities related to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 956, 'sentence': 'BSAP : a key regulator of B-cell development and differentiation .', 'label': {'BSAP': 'protein', 'B-cell': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[{"BSAP": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'B-cell': 'cell_type'}}
{'idx': 1769, 'sentence': 'We have tried to find out whether these receptors could show any difference in sex or age distribution.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 3},\n{"Reason 1": "Mentions \'genes\' which could be labeled as \'DNA\' or \'RNA\' entities."},\n{"Example 2": 2},\n{"Reason 2": "Mentions \'tumors\' which could be labeled as \'cell_type\' entities."},\n{"Example 3": 2},\n{"Reason 3": "Mentions \'isoforms\' which could be labeled as \'protein\' entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 110, 'sentence': 'Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .', 'label': {'long terminal repeat': 'DNA', 'NF-KB': 'protein', 'double repeat-KB enhancer sequence': 'DNA', 'cellular transactivation factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"NF-KB": "protein"}\n]', 'prediction': {'NF-KB': 'protein'}}
{'idx': 1379, 'sentence': 'Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .', 'label': {'TCL1': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"TCL1": "protein"}]', 'prediction': {'TCL1': 'protein'}}
{'idx': 1338, 'sentence': 'The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .', 'label': {'Bcl-2 family': 'protein', 'cellular proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Bcl-2": "protein"}]', 'prediction': {'Bcl-2': 'protein'}}
{'idx': 1323, 'sentence': 'PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .', 'label': {'PRE-I': 'DNA', 'Jurkat cells': 'cell_line', 'multiple DNA-protein complexes': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"DNA": "DNA"}, {"protein": "protein"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'DNA': 'DNA', 'protein': 'protein', 'Jurkat cells': 'cell_line'}}
{'idx': 1309, 'sentence': 'Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .', 'label': {'cruciform DNA': 'DNA', 'HMG boxes': 'protein', 'cross-over DNA': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"HMG boxes": "protein"},\n{"cruciform DNA": "DNA"},\n{"cross-over DNA": "DNA"}\n]', 'prediction': {'HMG boxes': 'protein', 'cruciform DNA': 'DNA', 'cross-over DNA': 'DNA'}}
{'idx': 228, 'sentence': 'We have carried out experiments to define the nature of the higher affinity CVZ binding site .', 'label': {'higher affinity CVZ binding site': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 51, 'sentence': 'Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.', 'label': {'T-cell determinants': 'protein'}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[{"T-cell": "cell_type"}]', 'prediction': {'T-cell': 'cell_type'}}
{'idx': 1518, 'sentence': 'Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .', 'label': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'human B lymphocytes': 'cell_type', 'Anti-immunoglobulin M': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"nuclear calcium/calmodulin-dependent protein kinase II": "protein"}, {"B lymphocytes": "cell_type"}]', 'prediction': {'nuclear calcium/calmodulin-dependent protein kinase II': 'protein', 'B lymphocytes': 'cell_type'}}
{'idx': 563, 'sentence': 'The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .', 'label': {'PDGF(B)': 'protein', 'PDGF(B) mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[\n{"PDGF(B) mRNA": "RNA"},\n{"cytoskeletal": "cell_type"},\n{"cytochalasin D": "protein"}\n]', 'prediction': {'PDGF(B) mRNA': 'RNA', 'cytoskeletal': 'cell_type', 'cytochalasin D': 'protein'}}
{'idx': 501, 'sentence': 'Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .', 'label': {'CCRF-CEM': 'cell_line', 'TCF-1 alpha': 'protein', 'nonlymphoid (HeLa) cell lines': 'cell_line', 'mature B cells': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 457, 'sentence': 'TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .', 'label': {'T lymphocytes': 'cell_type', 'TAR': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 285, 'sentence': 'ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .', 'label': {'ER': 'protein', 'lymphocyte DNA': 'DNA', 'lymphocytes': 'cell_type', 'lymphocyte cytosolic protein': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[{"lymphocyte cytosolic protein": "protein"}, {"lymphocyte DNA": "DNA"}]', 'prediction': {'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}}
{'idx': 1508, 'sentence': 'Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .', 'label': {'BOB.1/OBF.1': 'protein', 'B cell-specific coactivator': 'protein', 'murine homolog': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"BOB.1/OBF.1": "protein"}]', 'prediction': {'BOB.1/OBF.1': 'protein'}}
{'idx': 209, 'sentence': 'Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.', 'label': {'lymphoblastoid cell line': 'cell_line', 'IM-9': 'cell_line', 'type-II EBS': 'protein', 'Type-II estrogen -binding sites': 'protein', 'human lymphoblastoid cell line': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1385, 'sentence': "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.", 'label': {'LTR': 'DNA', 'HIV-1 LTR': 'DNA', 'C/EBP sites': 'DNA', 'C/EBP site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"HIV-1 LTR": "DNA"}, {"C/EBP site": "protein"}, {"3\' C/EBP sites": "protein"}]', 'prediction': {'HIV-1 LTR': 'DNA', 'C/EBP site': 'protein', "3' C/EBP sites": 'protein'}}
{'idx': 1516, 'sentence': 'Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .', 'label': {'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'protein', 'COOH-terminal domain': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1827, 'sentence': 'A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .', 'label': {'human interleukin 2 gene promoter': 'DNA', 'EGR-1': 'protein', 'Sp1': 'protein', 'regulatory element': 'DNA', 'binding site': 'DNA', 'zinc finger proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"zinc finger proteins Sp1": "protein"}, {"EGR-1": "protein"}]', 'prediction': {'zinc finger proteins Sp1': 'protein', 'EGR-1': 'protein'}}
{'idx': 1116, 'sentence': 'The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .', 'label': {'thymocytes': 'cell_type', 'p53': 'protein', 'mitogen-activated mature T lymphocytes': 'cell_line', 'tumour suppressor p53': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"p53": "protein"},\n{"apoptosis": "cell_type"},\n{"thymocytes": "cell_type"},\n{"T lymphocytes": "cell_type"}\n]', 'prediction': {'p53': 'protein', 'apoptosis': 'cell_type', 'thymocytes': 'cell_type', 'T lymphocytes': 'cell_type'}}
{'idx': 178, 'sentence': 'T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .', 'label': {'T lymphocytes': 'cell_type', 'lavage cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1209, 'sentence': 'A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 864, 'sentence': 'Differences in transcriptional enhancers of HIV-1 and HIV-2 .', 'label': {'transcriptional enhancers': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entities related to the entity labels provided."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 65, 'sentence': 'Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .', 'label': {'promoter': 'DNA', 'PRDII element': 'DNA'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 61, 'sentence': 'From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.', 'label': {'82': 'protein', '43-47 kD': 'protein', 'major protein': 'protein', 'T-cells': 'cell_type', 'minor proteins': 'protein', '67': 'protein', 'HeLa cells': 'cell_line', '52 kD': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 191, 'sentence': 'A block to RNA elongation is largely responsible for decreased c-myc transcription .', 'label': {'c-myc': 'DNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"RNA": "RNA"}, {"c-myc": "protein"}]', 'prediction': {'RNA': 'RNA', 'c-myc': 'protein'}}
{'idx': 447, 'sentence': 'Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.', 'label': {'enhancer': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 476, 'sentence': 'A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .', 'label': {'protooncogenes': 'DNA', 'immediate early response genes': 'DNA', 'growth factor': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"protooncogenes": "protein"}, {"cytoskeletal": "protein"}, {"extracellular matrix genes": "protein"}, {"immediate early response genes": "protein"}, {"growth factor": "protein"}, {"cell proliferation": "cell_type"}]', 'prediction': {'protooncogenes': 'protein', 'cytoskeletal': 'protein', 'extracellular matrix genes': 'protein', 'immediate early response genes': 'protein', 'growth factor': 'protein', 'cell proliferation': 'cell_type'}}
{'idx': 1034, 'sentence': 'p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .', 'label': {'Stat1': 'protein', 'phosphorylation site': 'protein', 'Src homology 2 (SH2) domain': 'protein', 'p94': 'protein', 'p95': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"p94": "protein"}, {"p95": "protein"}, {"Stat1": "protein"}, {"Src homology 2 (SH2)": "protein"}]', 'prediction': {'p94': 'protein', 'p95': 'protein', 'Stat1': 'protein', 'Src homology 2 (SH2)': 'protein'}}
{'idx': 1232, 'sentence': 'IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).', 'label': {'IBR': 'protein', 'transcription factors': 'protein', 'erected wing gene product': 'protein', 'human NRF-1/alpha-Pal factor': 'protein', 'EWG': 'protein', 'P3A2': 'protein', '503-amino-acid-long acidic protein': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"IBR": "protein"}, {"NRF-1/alpha-Pal": "protein"}, {"P3A2": "protein"}, {"EWG": "protein"}]', 'prediction': {'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'EWG': 'protein'}}
{'idx': 54, 'sentence': 'Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .', 'label': {'LTR': 'DNA', 'human T-cell types': 'cell_type', 'T-cell types': 'cell_type', 'element': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1149, 'sentence': 'The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .', 'label': {'Sp1': 'protein', 'DCs': 'cell_type', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"NF-kappa B": "protein"},\n{"Sp1": "protein"},\n{"T cells": "cell_type"},\n{"DCs": "cell_type"}\n]', 'prediction': {'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type'}}
{'idx': 407, 'sentence': 'Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"VDR": "protein"}, {"VDR": "protein"}, {"XLH": "cell_type"}]', 'prediction': {'VDR': 'protein', 'XLH': 'cell_type'}}
{'idx': 1466, 'sentence': 'As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .', 'label': {'endothelial cells': 'cell_type', 'NFAT': 'protein', 'activated endothelial cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"NFAT": "protein"}, {"CsA": "protein"}]', 'prediction': {'NFAT': 'protein', 'CsA': 'protein'}}
{'idx': 1330, 'sentence': 'Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .', 'label': {'I kappa B alpha': 'protein', 'I kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1436, 'sentence': 'Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .', 'label': {'hTR beta 1 mRNA': 'RNA', 'hTR beta 1': 'protein'}, 'response1': "['RNA']", 'response2': '[]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 859, 'sentence': 'We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .', 'label': {'inducible': 'protein', 'Jurkat cells': 'cell_line', 'C1': 'protein', 'HIV enhancer': 'DNA', 'C2': 'protein', 'constitutive, C2 , protein': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[]', 'response3': '[{"HIV enhancer": "protein"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'HIV enhancer': 'protein', 'Jurkat cells': 'cell_line'}}
{'idx': 451, 'sentence': 'However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .', 'label': {'NF-muE3': 'protein', 'B cells': 'cell_type', 'lymphoid cells': 'cell_type', 'transfected reporter gene': 'DNA', 'Ig heavy chain enhancer': 'DNA', 'non- lymphoid cells': 'cell_type', 'non-B cells': 'cell_type', 'endogenous Ig heavy chain enhancer': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 919, 'sentence': 'The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .', 'label': {'56-kDa protein': 'protein', 'p56': 'protein', 'EC1 antibody': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"protein": "protein"}\n]', 'prediction': {'protein': 'protein'}}
{'idx': 1206, 'sentence': 'In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.', 'label': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"androgen receptors": "protein"}, {"mononuclear leukocytes": "cell_type"}, {"follicular": "cell_type"}, {"luteal": "cell_type"}, {"menstrual cycle": "cell_type"}, {"flutamide": "protein"}]', 'prediction': {'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type', 'follicular': 'cell_type', 'luteal': 'cell_type', 'menstrual cycle': 'cell_type', 'flutamide': 'protein'}}
{'idx': 569, 'sentence': 'In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .', 'label': {'PDGF(B)': 'protein', 'EGR2': 'DNA', 'c-jun': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"c-jun": "protein"}, {"EGR2": "protein"}, {"PDGF(B)": "protein"}]', 'prediction': {'c-jun': 'protein', 'EGR2': 'protein', 'PDGF(B)': 'protein'}}
{'idx': 1657, 'sentence': 'HMG-I binds to GATA motifs : implications for an HPFH syndrome .', 'label': {'HMG-I': 'protein', 'GATA motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1780, 'sentence': 'Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .', 'label': {'Id3': 'protein', 'Mo': 'cell_line', 'Id2': 'protein', '4/5 T-cell lines': 'cell_line', 'S-LB1': 'cell_line', 'MT-2': 'cell_line', 'ATL-1k': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[\n{"Id2": "RNA"},\n{"Id3": "None"},\n{"T-cell lines": "cell_line"},\n{"human T-cell leukemia virus type I (HTLV-I)": "cell_type"},\n{"ATL-1k": "cell_line"},\n{"MT-2": "cell_line"},\n{"S-LB1": "cell_line"},\n{"type II (Mo)": "None"}\n]', 'prediction': {'Id2': 'RNA', 'Id3': 'None', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'None'}}
{'idx': 13, 'sentence': 'We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.', 'label': {'platelet-activating factor': 'protein', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"platelet-activating factor": "protein"}, {"B cells": "cell_type"}, {"platelet-activating factor": "protein"}, {"arachidonic acid": "protein"}, {"5-hydroxyeicosatetraenoic acid": "protein"}]', 'prediction': {'platelet-activating factor': 'protein', 'B cells': 'cell_type', 'arachidonic acid': 'protein', '5-hydroxyeicosatetraenoic acid': 'protein'}}
{'idx': 1554, 'sentence': 'The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .', 'label': {'GP': 'protein', 'normal platelets': 'cell_type', 'cis-acting elements': 'DNA', 'GP Ib alpha': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"GP Ib alpha": "protein"}]', 'prediction': {'GP Ib alpha': 'protein'}}
{'idx': 1650, 'sentence': 'This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .', 'label': {'PU.1': 'protein', 'myeloid PU.1 binding site': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"PU.1": "protein"}, {"myeloid": "cell_type"}, {"PU.1": "protein"}]', 'prediction': {'PU.1': 'protein', 'myeloid': 'cell_type'}}
{'idx': 326, 'sentence': 'We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .', 'label': {'EB1': 'protein', 'R-responsive element': 'DNA', 'HeLa cells': 'cell_line', 'domain B': 'DNA', 'EB1 -responsive B-cell-specific element': 'DNA'}, 'response1': "['cell_line', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 3},\n{"Reason 2": "The sentence contains the entity type \'cell_line\', which is present in the target sentence. This could provide some context for extracting named entities related to cell lines."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1429, 'sentence': 'Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .', 'label': {'TR': 'protein'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[{"TR": "protein"}]', 'prediction': {'TR': 'protein'}}
{'idx': 865, 'sentence': 'Response to T cell activation signals .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 696, 'sentence': 'First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .', 'label': {'TRE -DNA fragment': 'DNA', 'nuclear proteins': 'protein', 'TRE': 'DNA'}, 'response1': "['protein', 'DNA', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."},\n{"Example 2": 2},\n{"Reason 2": "This sentence contains the entity type \'protein\', which is present in the target sentence. However, it does not contain the other entity types, so it is somewhat helpful for predicting named entities."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[{"cell_line": "cell_line"}, {"protein": "protein"}, {"DNA": "DNA"}]', 'prediction': {'cell_line': 'cell_line', 'protein': 'protein', 'DNA': 'DNA'}}
{'idx': 318, 'sentence': 'Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.', 'label': {'estrogen receptor': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"estrogen receptor": "protein"}]', 'prediction': {'estrogen receptor': 'protein'}}
{'idx': 440, 'sentence': 'All three proteins show the same sequence specificity and binding affinity .', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"proteins": "protein"}]', 'prediction': {'proteins': 'protein'}}
{'idx': 1563, 'sentence': 'Pathogenesis of atherosclerosis .', 'label': {}, 'response1': 'None.', 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entity types from the given label set, making it not helpful for predicting named entities in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 689, 'sentence': 'High-risk patients can be recognized morphologically.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence mentions tumors and clinical course, but does not contain any named entities related to the entity types in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence mentions genes and isoforms, but does not contain any named entities related to the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 189, 'sentence': 'Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .', 'label': {'human T lymphoblastic tumor cell line': 'cell_line', 'c-myc': 'DNA'}, 'response1': "['protein', 'cell_line']", 'response2': '[]', 'response3': '[{"c-myc": "protein"}, {"T lymphoblastic tumor cell line": "cell_line"}]', 'prediction': {'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}}
{'idx': 778, 'sentence': 'Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .', 'label': {'OTF-1': 'protein', 'pre-B cells': 'cell_line', 'immunoglobulin gene': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"OTF-1": "protein"}, {"pre-B cells": "cell_type"}, {"HeLa cells": "cell_line"}, {"immunoglobulin gene": "DNA"}]', 'prediction': {'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'DNA'}}
{'idx': 198, 'sentence': "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.", 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 735, 'sentence': 'This prompted us to analyze the octamer-binding proteins in the latter cells.', 'label': {'octamer-binding proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"octamer-binding proteins": "protein"}]', 'prediction': {'octamer-binding proteins': 'protein'}}
{'idx': 1735, 'sentence': 'We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .', 'label': {'VDR': 'protein', 'IL-2 promoter/reporter constructs': 'DNA', 'Jurkat cells': 'cell_line', 'VDR overexpression vector': 'DNA', 'IL-2': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"Jurkat cells": "cell_line"}, {"IL-2": "protein"}, {"IL-2 promoter/reporter constructs": "DNA"}, {"VDR": "protein"}, {"DNA": "DNA"}]', 'prediction': {'Jurkat cells': 'cell_line', 'IL-2': 'protein', 'IL-2 promoter/reporter constructs': 'DNA', 'VDR': 'protein', 'DNA': 'DNA'}}
{'idx': 704, 'sentence': 'Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .', 'label': {'ubiquitous and developmentally regulated proteins': 'protein', 'ubiquitous': 'protein', 'developmentally regulated proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"immunoglobulin heavy": "protein"}, {"kappa light chain": "protein"}]', 'prediction': {'immunoglobulin heavy': 'protein', 'kappa light chain': 'protein'}}
{'idx': 1236, 'sentence': 'Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .', 'label': {'direct-repeat palindrome': 'DNA', 'IBR/F': 'protein', 'IBR/F binding sites': 'DNA', 'optimal site': 'DNA', 'alternating RCGCRYGCGY consensus': 'protein'}, 'response1': "['DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any specific entities mentioned in the target sentence."}\n]', 'response3': '[{"RCGCRYGCGY": "DNA"}, {"TGCGCATGCGCA": "DNA"}]', 'prediction': {'RCGCRYGCGY': 'DNA', 'TGCGCATGCGCA': 'DNA'}}
{'idx': 541, 'sentence': 'To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1652, 'sentence': 'Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.', 'label': {'PU.1': 'protein', 'PU-SF complex': 'protein', 'myeloid promoters': 'DNA', 'PU.1 site': 'DNA', 'PU-SF': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"PU-SF complex": "protein"}, {"PU.1": "protein"}, {"PU.1": "protein"}]', 'prediction': {'PU-SF complex': 'protein', 'PU.1': 'protein'}}
{'idx': 88, 'sentence': 'TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .', 'label': {'TNF alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1494, 'sentence': 'Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .', 'label': {'latent NF-kappa B': 'protein', 'cytokine': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 940, 'sentence': 'Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .', 'label': {'PBMC': 'cell_type', 'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the entity types in the target sentence are present in this example."},\n    {"Example 2": 1},\n    {"Reason 2": "None of the entity types in the target sentence are present in this example."},\n    {"Example 3": 1},\n    {"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1098, 'sentence': 'Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .', 'label': {'microtubules': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 255, 'sentence': 'c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.', 'label': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line'}, 'response1': "['RNA', 'cell_line']", 'response2': '[]', 'response3': '[{"c-myc RNA": "RNA"}, {"RWLeu-4 cells": "cell_line"}, {"50 nM VD3": "protein"}]', 'prediction': {'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line', '50 nM VD3': 'protein'}}
{'idx': 775, 'sentence': 'Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.', 'label': {'OTF-1': 'protein', 'OTF-2': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"OTF-2": "protein"}, {"OTF-1": "protein"}]', 'prediction': {'OTF-2': 'protein', 'OTF-1': 'protein'}}
{'idx': 161, 'sentence': 'Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1130, 'sentence': 'B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .', 'label': {'B-lymphoblastoid cell lines': 'cell_line'}, 'response1': "['cell_line', 'virus']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"B-lymphoblastoid cell lines": "cell_line"}, {"Epstein-Barr virus": "virus"}]', 'prediction': {'B-lymphoblastoid cell lines': 'cell_line', 'Epstein-Barr virus': 'virus'}}
{'idx': 600, 'sentence': 'Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .', 'label': {'immunoglobulin heavy-chain gene': 'DNA', 'lymphoid-specific enhancer element': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1698, 'sentence': 'Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .', 'label': {'natural killer cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1287, 'sentence': 'Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .', 'label': {'Platelet thromboxane receptors': 'protein', 'Platelet': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1266, 'sentence': 'Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .', 'label': {'EBV -positive B cell lines': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[]', 'response3': '[{"EBV": "cell_line"}, {"EBV": "cell_line"}]', 'prediction': {'EBV': 'cell_line'}}
{'idx': 1813, 'sentence': 'Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .', 'label': {'BLR2 mRNA': 'RNA', 'BLR2': 'protein'}, 'response1': "['RNA', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for extracting named entities."}\n]', 'response3': '[\n{"BLR2 mRNA": "RNA"},\n{"mitogen": "cell_type"},\n{"anti-CD3": "cell_type"},\n{"peripheral blood lymphocytes": "cell_type"}\n]', 'prediction': {'BLR2 mRNA': 'RNA', 'mitogen': 'cell_type', 'anti-CD3': 'cell_type', 'peripheral blood lymphocytes': 'cell_type'}}
{'idx': 1764, 'sentence': 'The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .', 'label': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'transcription factor': 'protein', 'mitogen-stimulated cells': 'cell_type'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"DNA": "DNA"}, {"AP-1": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'DNA': 'DNA', 'AP-1': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 740, 'sentence': 'On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.', 'label': {'ubiquitous Oct-1': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein', 'lymphoid-specific Oct-2A': 'protein', 'N-Oct-factors': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"N-Oct-factors": "protein"}, {"Oct-1": "protein"}, {"Oct-2A": "protein"}]', 'prediction': {'N-Oct-factors': 'protein', 'Oct-1': 'protein', 'Oct-2A': 'protein'}}
{'idx': 1182, 'sentence': 'Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .', 'label': {'IL-2': 'protein', 'T cells': 'cell_type', 'COOH-terminal region': 'protein', 'human T cells': 'cell_type', 'Ser386-Val525': 'protein', 'JAK3': 'protein', 'STAT transcription factor': 'protein', 'STAT5': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 4},\n    {"Example 3": 3}\n]', 'response3': '[\n    {"STAT5": "protein"},\n    {"IL-2": "protein"},\n    {"IL-2R beta": "protein"},\n    {"IL-2R gamma": "protein"},\n    {"JAK3": "protein"}\n]', 'prediction': {'STAT5': 'protein', 'IL-2': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein'}}
{'idx': 393, 'sentence': 'We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.', 'label': {'HNP-1': 'protein', 'pag': 'DNA', 'NP-1': 'protein', 'defensins': 'protein', 'NP-5': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1442, 'sentence': 'T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .', 'label': {'interleukin 3': 'protein', 'transcriptional start site': 'DNA', 'IL-3': 'protein'}, 'response1': "['DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 142, 'sentence': 'This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .', 'label': {'U937 cells': 'cell_line', 'NF-kappa B': 'protein', 'viral RNA': 'RNA', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B": "protein"}, {"TNF-alpha": "protein"}, {"HIV type 1": "RNA"}, {"HIV-1": "RNA"}, {"U937 cells": "cell_line"}]', 'prediction': {'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'RNA', 'HIV-1': 'RNA', 'U937 cells': 'cell_line'}}
{'idx': 93, 'sentence': 'The Thy-1 gene promoter resembles a "housekeeping" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5\'-end termini of the mRNA .', 'label': {'canonical TATA box': 'DNA', '"housekeeping" promoter': 'DNA', 'methylation-free island': 'DNA', "5'-end termini": 'RNA', 'Thy-1 gene promoter': 'DNA', 'mRNA': 'RNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"Thy-1 gene": "DNA"}]', 'prediction': {'Thy-1 gene': 'DNA'}}
{'idx': 1354, 'sentence': 'In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .', 'label': {'TCF-1': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"nuclear TCF-1": "protein"}]', 'prediction': {'nuclear TCF-1': 'protein'}}
{'idx': 466, 'sentence': '(ABSTRACT TRUNCATED AT 250 WORDS)', 'label': {}, 'response1': 'None.', 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1583, 'sentence': 'Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.', 'label': {'ribonucleoproteins': 'protein', 'Ro(SSA)': 'protein', 'autoantibodies': 'protein', 'HLA class II antigens': 'protein', 'La(SSB)': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entities related to the given entity labels."}\n]', 'response3': '[\n    {"HLA class II antigens": "protein"},\n    {"ribonucleoproteins Ro(SSA)": "protein"},\n    {"La(SSB)": "protein"}\n]', 'prediction': {'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}}
{'idx': 592, 'sentence': 'The DNA isolated contained an open reading frame encoding 108 amino acid residues .', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"DNA": "DNA"}, {"108 amino acid residues": "protein"}]', 'prediction': {'DNA': 'DNA', '108 amino acid residues': 'protein'}}
{'idx': 163, 'sentence': 'This phenomenon can be mimicked by administering MP in divided doses.', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1751, 'sentence': 'This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.', 'label': {'NFAT': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"calcineurin": "protein"}, {"NFAT": "protein"}]', 'prediction': {'calcineurin': 'protein', 'NFAT': 'protein'}}
{'idx': 1774, 'sentence': 'Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .', 'label': {'PBMC': 'cell_type', 'PBMC receptors': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 206, 'sentence': 'It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 928, 'sentence': 'A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).', 'label': {'ets-1': 'protein', 'long terminal repeat': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'mouse ets-1 cDNA clone': 'DNA', 'LTR': 'DNA'}, 'response1': "['DNA', 'RNA']", 'response2': '[]', 'response3': '[{"mouse ets-1 cDNA clone": "DNA"}, {"mouse thymus cDNA expression library": "DNA"}, {"double-stranded oligonucleotide probe": "DNA"}, {"Moloney murine sarcoma virus (MSV) long terminal repeat (LTR)": "DNA"}]', 'prediction': {'mouse ets-1 cDNA clone': 'DNA', 'mouse thymus cDNA expression library': 'DNA', 'double-stranded oligonucleotide probe': 'DNA', 'Moloney murine sarcoma virus (MSV) long terminal repeat (LTR)': 'DNA'}}
{'idx': 1301, 'sentence': 'It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .', 'label': {'ER': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NK activity": "protein"}, {"tumor ER concentration": "protein"}, {"ER": "protein"}]', 'prediction': {'NK activity': 'protein', 'tumor ER concentration': 'protein', 'ER': 'protein'}}
{'idx': 1708, 'sentence': 'The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .', 'label': {'nuclear factor (NF)-kappa B': 'protein', 'T cell lines': 'cell_line', 'Ca(2+) -dependent phosphatase': 'protein', 'PKC': 'protein', 'calcineurin': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"calcineurin": "protein"}, {"PKC": "protein"}, {"NF-kappa B": "protein"}, {"T cell lines": "cell_line"}]', 'prediction': {'calcineurin': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}}
{'idx': 747, 'sentence': 'Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).', 'label': {'unspliced mRNA': 'RNA'}, 'response1': "['protein', 'RNA']", 'response2': '[]', 'response3': '[{"Protein kinase inhibitor H-7": "protein"}, {"unspliced mRNA": "RNA"}, {"human T-cell leukemia virus type I (HTLV-I)": "cell_type"}]', 'prediction': {'Protein kinase inhibitor H-7': 'protein', 'unspliced mRNA': 'RNA', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type'}}
{'idx': 333, 'sentence': 'These protoenhancers alone are weakly or not responsive to R .', 'label': {'protoenhancers': 'DNA', 'R': 'protein'}, 'response1': "['RNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 758, 'sentence': 'Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.', 'label': {'CEM-C7': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[]', 'response3': '[{"CEM-C7 cells": "cell_line"}]', 'prediction': {'CEM-C7 cells': 'cell_line'}}
{'idx': 727, 'sentence': 'The importance of the internal ATGs to Rex function is not known.', 'label': {'Rex': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 429, 'sentence': 'As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.', 'label': {'TSAP': 'protein', 'mammalian protein': 'protein', 'sea urchin binding sites': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"BSAP": "protein"}, {"TSAP": "protein"}]', 'prediction': {'BSAP': 'protein', 'TSAP': 'protein'}}
{'idx': 1372, 'sentence': 'The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).', 'label': {'14q32.1': 'DNA', 'TCR alpha/beta loci': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 'TCL1 oncogene': 'DNA', 'human chromosome': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inv14(q11;q32.1)': 'DNA'}, 'response1': "['DNA', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"TCL1 oncogene": "protein"},\n    {"human chromosome 14q32.1": "DNA"},\n    {"chromosome translocations": "DNA"},\n    {"t(14;14)(q11;q32.1)": "DNA"},\n    {"t(7;14)(q35;q32.1)": "DNA"},\n    {"inversions": "DNA"},\n    {"inv14(q11;q32.1)": "DNA"},\n    {"TCR alpha/beta loci": "DNA"},\n    {"T-cell leukemias": "cell_type"},\n    {"T-prolymphocytic": "cell_type"},\n    {"T-PLL": "cell_type"}\n]', 'prediction': {'TCL1 oncogene': 'protein', 'human chromosome 14q32.1': 'DNA', 'chromosome translocations': 'DNA', 't(14;14)(q11;q32.1)': 'DNA', 't(7;14)(q35;q32.1)': 'DNA', 'inversions': 'DNA', 'inv14(q11;q32.1)': 'DNA', 'TCR alpha/beta loci': 'DNA', 'T-cell leukemias': 'cell_type', 'T-prolymphocytic': 'cell_type', 'T-PLL': 'cell_type'}}
{'idx': 546, 'sentence': 'Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .', 'label': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"T lymphocytes": "cell_type"}, {"immunophilin": "protein"}, {"FK506": "protein"}, {"rapamycin": "protein"}]', 'prediction': {'T lymphocytes': 'cell_type', 'immunophilin': 'protein', 'FK506': 'protein', 'rapamycin': 'protein'}}
{'idx': 1437, 'sentence': 'In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.', 'label': {'hTR beta 1': 'protein', 'hTR beta 1 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[]', 'response3': '[{"hTR beta 1 mRNA": "RNA"}]', 'prediction': {'hTR beta 1 mRNA': 'RNA'}}
{'idx': 1399, 'sentence': 'To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .', 'label': {'hematopoietic cell lineage': 'cell_line', 'human estrogen receptor': 'protein', 'NF-M': 'protein', 'hormone binding domain': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_line\', which is present in the target sentence. However, it does not contain the entity type \'protein\'."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"NF-M": "protein"},\n{"hormone binding domain": "protein"},\n{"human estrogen receptor": "protein"}\n]', 'prediction': {'NF-M': 'protein', 'hormone binding domain': 'protein', 'human estrogen receptor': 'protein'}}
{'idx': 1327, 'sentence': 'Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .', 'label': {'human IL-4': 'protein', 'human IL-4 promoter': 'DNA', 'NF-IL6': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence. However, the context and relevance of the entity in this sentence may not directly aid in extracting named entities from the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[{"NF-IL6": "protein"}, {"IL-4": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}}
{'idx': 146, 'sentence': 'Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the "octamer" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .', 'label': {'"octamer" motif': 'DNA', 'HLA-DR alpha (DRA) promoter': 'DNA', 'class II promoters': 'DNA', 'immunoglobulin variable region promoters': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types in the target sentence are present in this example."},\n{"Example 2": 2},\n{"Reason 2": "The entity type \'cell_type\' is present in this example, which is somewhat relevant to the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1247, 'sentence': 'The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .', 'label': {'Janus family tyrosine kinase': 'protein', 'Jak3': 'protein', 'gamma c': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"Jak3": "protein"},\n    {"gamma c": "protein"},\n    {"Jak3": "protein"},\n    {"XSCID": "cell_type"}\n]', 'prediction': {'Jak3': 'protein', 'gamma c': 'protein', 'XSCID': 'cell_type'}}
{'idx': 1300, 'sentence': 'As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"NK activity": "protein"}]', 'prediction': {'NK activity': 'protein'}}
{'idx': 350, 'sentence': 'Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .', 'label': {'control cell line': 'cell_line', 'cell line': 'cell_line', 'Ro-VDR': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types in the target sentence are present in this example."},\n{"Example 2": 1},\n{"Reason 2": "None of the entity types in the target sentence are present in this example."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1093, 'sentence': 'The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).', 'label': {'VDR': 'protein', 'vitamin D receptor': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"1,25-dihydroxyvitamin D3": "protein"}, {"VDR": "protein"}]', 'prediction': {'1,25-dihydroxyvitamin D3': 'protein', 'VDR': 'protein'}}
{'idx': 1493, 'sentence': 'Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .', 'label': {'myeloid cells': 'cell_type', 'NF-kappa B': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B": "DNA"}]', 'prediction': {'NF-kappa B': 'DNA'}}
{'idx': 334, 'sentence': "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .", 'label': {'protoenhancers': 'DNA', 'overlapping palindromes': 'DNA'}, 'response1': "['DNA']", 'response2': '[]\n[]', 'response3': '[{"5\'-TTGTCCcgtGGACAAaTGTCC-3\'": "DNA"}]', 'prediction': {"5'-TTGTCCcgtGGACAAaTGTCC-3'": 'DNA'}}
{'idx': 946, 'sentence': 'Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 777, 'sentence': 'We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.', 'label': {'OTF-2': 'protein', 'immunoglobulin gene': 'DNA', 'steady-state immunoglobulin heavy-chain mRNA': 'RNA', 'human pre-B-cell lines': 'cell_line', 'immunoglobulin heavy-chain': 'protein'}, 'response1': "['cell_line', 'RNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"pre-B-cell lines": "cell_line"}, {"OTF-2": "protein"}, {"immunoglobulin heavy-chain mRNA": "RNA"}, {"immunoglobulin gene": "DNA"}]', 'prediction': {'pre-B-cell lines': 'cell_line', 'OTF-2': 'protein', 'immunoglobulin heavy-chain mRNA': 'RNA', 'immunoglobulin gene': 'DNA'}}
{'idx': 552, 'sentence': 'Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .', 'label': {'IL-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1310, 'sentence': 'The abundant chromosomal protein HMG-1 belongs to this subgroup.', 'label': {'HMG-1': 'protein', 'chromosomal protein': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"HMG-1": "protein"}]', 'prediction': {'HMG-1': 'protein'}}
{'idx': 1409, 'sentence': 'We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .', 'label': {'IL-2': 'protein', 'T cell lines': 'cell_line', 'PRL': 'protein', 'Stat proteins': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1140, 'sentence': 'The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .', 'label': {'transcription factors': 'protein', 'conserved cis-acting sequence': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 449, 'sentence': 'We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .', 'label': {'ubiquitous transcription factor': 'protein', 'E3 enhancer motif': 'DNA'}, 'response1': "['DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any specific entities mentioned in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence mentions tumors, ovary, and clinical course, but none of the entity types in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence talks about genes and isoforms, but does not contain any of the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1402, 'sentence': 'At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .', 'label': {'eosinophil': 'cell_type', 'myeloid lineages': 'cell_type', 'differentiation markers': 'protein', 'progenitor-specific surface markers': 'protein'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 664, 'sentence': 'Interferon-gamma and the sexual dimorphism of autoimmunity .', 'label': {'Interferon-gamma': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1726, 'sentence': 'It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .', 'label': {'NF-kappa B': 'protein', 'cytotoxic cytokine': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1573, 'sentence': 'Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .', 'label': {'estrogen': 'protein', 'eosinophil cationic protein': 'protein', 'positive cells': 'cell_type', 'progesterone receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"estrogen": "protein"}, {"progesterone": "protein"}, {"eosinophil cationic protein": "protein"}, {"eosinophils": "cell_type"}]', 'prediction': {'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}}
{'idx': 1589, 'sentence': 'Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .', 'label': {'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type', 'NF-AT': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 114, 'sentence': 'These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .', 'label': {'NF-KB': 'protein', 'monocytic cell lineage': 'cell_line'}, 'response1': "['cell_line', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 469, 'sentence': 'Cardiac and adrenergic diseases were excluded.', 'label': {}, 'response1': 'None.', 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1683, 'sentence': 'These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .', 'label': {'c-jun': 'DNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1648, 'sentence': 'Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.', 'label': {'PU.1 site': 'DNA', 'GM-CSF receptor alpha': 'protein', 'GM-CSF receptor alpha promoter': 'DNA', 'myelomonocytic cells': 'cell_type', 'C/EBP': 'protein', 'PU.1': 'protein', 'GM-CSF': 'protein', 'C/EBP site': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "None of the entity types in the target sentence are present in this example."},\n{"Example 2": 1},\n{"Reason 2": "None of the entity types in the target sentence are present in this example."},\n{"Example 3": 1},\n{"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 646, 'sentence': 'Surgically confirmed nodal involvement was observed in 42%.', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any specific entities mentioned in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence talks about tumors and clinical course, but does not mention any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence discusses genes and isoforms, but does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 821, 'sentence': '(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .', 'label': {'LMP1': 'protein', 'EBNA-2': 'protein', 'EBV type 1 EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"EBV type 2 EBNA-2": "protein"}, {"LMP1": "protein"}, {"EBV type 1 EBNA-2": "protein"}]', 'prediction': {'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}}
{'idx': 548, 'sentence': 'On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 135, 'sentence': 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).', 'label': {'U9-IIIB': 'cell_line', 'monocytic U937 cells': 'cell_line', 'Tumor necrosis factor alpha ( TNF-alpha ) mRNA': 'RNA', 'chronically HIV infected U937 cell line': 'cell_line', 'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['RNA', 'cell_type', 'cell_line']", 'response2': '[]', 'response3': '[{"Tumor necrosis factor alpha": "protein"}, {"TNF-alpha": "protein"}, {"mRNA": "RNA"}, {"polymerase chain reaction": "DNA"}, {"monocytic U937 cells": "cell_type"}, {"HIV infected U937 cell line": "cell_line"}, {"U9-IIIB": "cell_line"}]', 'prediction': {'Tumor necrosis factor alpha': 'protein', 'TNF-alpha': 'protein', 'mRNA': 'RNA', 'polymerase chain reaction': 'DNA', 'monocytic U937 cells': 'cell_type', 'HIV infected U937 cell line': 'cell_line', 'U9-IIIB': 'cell_line'}}
{'idx': 432, 'sentence': 'Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .', 'label': {'transfected B cells': 'cell_line', 'TSAP': 'protein', 'mutant TSAP -binding site': 'DNA', 'upstream promoter element': 'DNA', 'BSAP': 'protein', 'B-cell-specific transcription factor': 'protein', 'wild-type': 'DNA'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence. However, it does not contain any other entity types."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"BSAP": "protein"},\n{"B-cell": "cell_type"},\n{"TSAP": "protein"},\n{"sea urchin": "cell_line"},\n{"B cells": "cell_type"}\n]', 'prediction': {'BSAP': 'protein', 'B-cell': 'cell_type', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B cells': 'cell_type'}}
{'idx': 1161, 'sentence': 'Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .', 'label': {'I kappa B alpha': 'protein', 'NF kappa B': 'protein', 'NF kappa B -I kappa B complex': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1794, 'sentence': 'Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .', 'label': {'STAT': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"STAT": "protein"}, {"T cell": "cell_type"}]', 'prediction': {'STAT': 'protein', 'T cell': 'cell_type'}}
{'idx': 1470, 'sentence': 'Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .', 'label': {'neutrophil': 'cell_type', 'tumor necrosis factor (TNF)-alpha': 'protein', 'leukocyte adhesion molecule': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any entities related to the entity types in the target sentence."},\n{"Example 2": 3},\n{"Reason 2": "The sentence contains the entity type \'cell_type\' (tumors) which is relevant to the target sentence. However, it does not contain other entity types like \'protein\' or \'cell_line\'."},\n{"Example 3": 2},\n{"Reason 3": "The sentence mentions genes and family members, which could be related to the entity type \'protein\'. However, it does not contain other entity types like \'cell_type\' or \'cell_line\'."}\n]', 'response3': '[\n{"TNF-alpha": "protein"},\n{"CsA": "protein"}\n]', 'prediction': {'TNF-alpha': 'protein', 'CsA': 'protein'}}
{'idx': 644, 'sentence': 'Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?', 'label': {'tumor cells': 'cell_type', 'hematopoietic growth factor': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"lymphocyte": "cell_type"}, {"hematopoietic growth factor": "protein"}, {"tumor cells": "cell_line"}]', 'prediction': {'lymphocyte': 'cell_type', 'hematopoietic growth factor': 'protein', 'tumor cells': 'cell_line'}}
{'idx': 435, 'sentence': 'Antibodies are produced exclusively in B lymphocytes .', 'label': {'Antibodies': 'protein', 'lymphocytes': 'cell_type', 'B lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"Antibodies": "protein"}, {"B lymphocytes": "cell_type"}]', 'prediction': {'Antibodies': 'protein', 'B lymphocytes': 'cell_type'}}
{'idx': 1342, 'sentence': 'While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.', 'label': {'amino acid domain': 'protein', 'BH1': 'protein', 'BH3': 'protein', 'Bak': 'protein', 'BH2': 'protein', 'Bax': 'protein', 'Bik': 'protein', 'Bcl-2 family': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Bik": "protein"}, {"BH1": "protein"}, {"BH2": "protein"}, {"Bcl-2": "protein"}, {"BH3": "protein"}, {"Bax": "protein"}, {"Bak": "protein"}]', 'prediction': {'Bik': 'protein', 'BH1': 'protein', 'BH2': 'protein', 'Bcl-2': 'protein', 'BH3': 'protein', 'Bax': 'protein', 'Bak': 'protein'}}
{'idx': 1022, 'sentence': 'NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .', 'label': {'NK cell NFAT': 'protein', 'AP-1': 'protein', 'nonstimulated cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"NK cell NFAT": "cell_type"}, {"cytosol": "cell_type"}, {"nucleus": "cell_type"}, {"AP-1": "protein"}]', 'prediction': {'NK cell NFAT': 'cell_type', 'cytosol': 'cell_type', 'nucleus': 'cell_type', 'AP-1': 'protein'}}
{'idx': 810, 'sentence': 'Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .', 'label': {'CML cells': 'cell_type', 'IFN-alpha': 'protein', 'CML cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'protein'}, 'response1': "['protein', 'cell_line', 'DNA']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1811, 'sentence': "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .", 'label': {'BLR1': 'protein', 'BLR2': 'protein', 'seven transmembrane receptor': 'protein', 'activated lymphocytes': 'cell_type', 'chemokine receptors': 'protein', "Burkitt's lymphoma receptor 1": 'protein'}, 'response1': "['DNA', 'RNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"Burkitt\'s lymphoma receptor 1 (BLR1)": "protein"}, {"BLR2": "protein"}, {"cDNA": "DNA"}, {"RT-PCR": "RNA"}]', 'prediction': {"Burkitt's lymphoma receptor 1 (BLR1)": 'protein', 'BLR2': 'protein', 'cDNA': 'DNA', 'RT-PCR': 'RNA'}}
{'idx': 1316, 'sentence': 'Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.', 'label': {'Helix III': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Helix III": "protein"}, {"helices I": "protein"}, {"helices II": "protein"}]', 'prediction': {'Helix III': 'protein', 'helices I': 'protein', 'helices II': 'protein'}}
{'idx': 939, 'sentence': 'However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.', 'label': {'type II EBS': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 292, 'sentence': 'We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.', 'label': {'globin gene': 'DNA', 'mouse embryonic stem (ES) cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 542, 'sentence': 'Amino acid sequences of all proteins are essays written in the same language.', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"proteins": "protein"}]', 'prediction': {'proteins': 'protein'}}
{'idx': 505, 'sentence': 'The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .', 'label': {'Jurkat': 'cell_line', 'TCF-1 alpha': 'protein', 'TCR': 'protein', 'T-cell-specific transcription factor': 'protein', 'TCF-1 alpha binding site': 'DNA', 'HeLa cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"TCF-1 alpha": "protein"}, {"TCR alpha": "protein"}, {"Jurkat": "cell_line"}, {"HeLa": "cell_line"}, {"TCF-1 alpha": "protein"}]', 'prediction': {'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line'}}
{'idx': 1525, 'sentence': 'Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .', 'label': {'antibody': 'protein', 'CaM kinase II': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"CaM kinase II": "protein"}]', 'prediction': {'CaM kinase II': 'protein'}}
{'idx': 1103, 'sentence': 'Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.', 'label': {'platelets': 'cell_type', 'Rap1 protein': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 538, 'sentence': 'Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .', 'label': {'PHA': 'protein', 'phytohaemagglutinin': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1529, 'sentence': 'Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .', 'label': {'Oct-2a': 'protein', 'lymphoid-specific transcription factor': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1197, 'sentence': 'In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.', 'label': {'ubiquitin': 'protein', 'p105 precursor': 'protein', 'E2-F1': 'protein', '-proteasome': 'protein', 'ubiquitin -carrier protein': 'protein', 'p53': 'protein', 'ubiquitin -protein ligase': 'protein', '320-kDa species': 'protein', 'p105': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"ubiquitin -proteasome system": "protein"},\n    {"p105 precursor": "protein"},\n    {"ubiquitin": "protein"},\n    {"E2-F1": "protein"},\n    {"p53": "protein"},\n    {"ubiquitin -carrier protein": "protein"},\n    {"ubiquitin -protein ligase": "protein"}\n]', 'prediction': {'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}}
{'idx': 877, 'sentence': 'Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .', 'label': {'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1838, 'sentence': 'First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.', 'label': {'LEF-1 -binding site': 'DNA', 'HIV-1 enhancer': 'DNA', 'LEF-1': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_line', 'multimerized copies': 'DNA', 'LEF-1 /GAL4': 'protein'}, 'response1': "['DNA', 'protein', 'cell_type', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"LEF-1": "protein"}, {"HIV-1 enhancer": "DNA"}, {"Jurkat T cells": "cell_line"}, {"GAL4": "protein"}, {"HIV-1 enhancer": "DNA"}]', 'prediction': {'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_line', 'GAL4': 'protein'}}
{'idx': 1195, 'sentence': 'Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .', 'label': {'60-kDa precursor': 'protein', 'ubiquitin': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 817, 'sentence': '(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .', 'label': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[\n{"EBNA-LP": "protein"},\n{"LMP1": "protein"},\n{"EBNA-2": "protein"}\n]', 'prediction': {'EBNA-LP': 'protein', 'LMP1': 'protein', 'EBNA-2': 'protein'}}
{'idx': 741, 'sentence': 'In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .', 'label': {'Oct-2A expression vector': 'DNA', 'Oct-2A': 'protein', 'N-Oct-3 factor': 'protein', 'melanoma cells': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"melanoma cells": "cell_type"}, {"N-Oct-3 factor": "protein"}, {"lymphocyte-specific promoter": "DNA"}, {"Oct-2A expression vector": "protein"}]', 'prediction': {'melanoma cells': 'cell_type', 'N-Oct-3 factor': 'protein', 'lymphocyte-specific promoter': 'DNA', 'Oct-2A expression vector': 'protein'}}
{'idx': 283, 'sentence': '[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]', 'label': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any relevant entities related to the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence discusses tumors and clinical course, which are not relevant to the entities in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence talks about genes and isoforms, which are not related to the entities in the target sentence."}\n]', 'response3': '[{"Estrogen receptor": "protein"}, {"peripheral blood lymphocytes": "cell_type"}, {"systemic lupus erythematosus": "cell_type"}]', 'prediction': {'Estrogen receptor': 'protein', 'peripheral blood lymphocytes': 'cell_type', 'systemic lupus erythematosus': 'cell_type'}}
{'idx': 1043, 'sentence': 'METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 3},\n{"Reason 2": "This sentence contains the entity type \'cell_type\', which is present in the target sentence, but the context is not directly related to the entities in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1010, 'sentence': 'Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .', 'label': {'murine NFATp': 'protein', 'NFATp protein': 'protein', 'NFATp': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NFATp": "protein"}, {"NFATp": "protein"}, {"thymus": "cell_type"}, {"spleen": "cell_type"}]', 'prediction': {'NFATp': 'protein', 'thymus': 'cell_type', 'spleen': 'cell_type'}}
{'idx': 186, 'sentence': 'We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .', 'label': {'erythrocytic lineage': 'cell_type', 'NF-E2': 'protein', 'trans-acting factor': 'protein', 'megakaryocytes': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[{"NF-E2": "protein"}, {"erythrocytic lineage": "cell_type"}, {"megakaryocytes": "cell_type"}]', 'prediction': {'NF-E2': 'protein', 'erythrocytic lineage': 'cell_type', 'megakaryocytes': 'cell_type'}}
{'idx': 1547, 'sentence': 'Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .', 'label': {'multisubunit adhesion receptor': 'protein', 'Ib-IX-V': 'protein', 'Platelet glycoprotein': 'protein', 'GP': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Platelet glycoprotein": "protein"}]', 'prediction': {'Platelet glycoprotein': 'protein'}}
{'idx': 96, 'sentence': 'We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .', 'label': {'Sp1': 'protein', 'dominant promoter elements': 'DNA', 'minimal Thy-1 promoter': 'DNA', 'transcription factor': 'protein', 'multiple binding sites': 'DNA', 'CCAAT box': 'DNA', 'transcription start site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"Thy-1 promoter": "DNA"}, {"transcription factor Sp1": "protein"}, {"CCAAT box": "DNA"}]', 'prediction': {'Thy-1 promoter': 'DNA', 'transcription factor Sp1': 'protein', 'CCAAT box': 'DNA'}}
{'idx': 1763, 'sentence': 'Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .', 'label': {'IL-2': 'protein', 'IL-2 mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"IL-2 mRNA": "RNA"},\n{"IL-2": "protein"}\n]', 'prediction': {'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}}
{'idx': 224, 'sentence': 'Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).', 'label': {'CEM C7 cells': 'cell_line', 'human acute lymphoblastic T-cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"Cortivazol": "protein"}, {"CVZ": "protein"}, {"phenylpyrazol": "protein"}, {"steroid nucleus": "protein"}, {"CEM C7 cells": "cell_line"}]', 'prediction': {'Cortivazol': 'protein', 'CVZ': 'protein', 'phenylpyrazol': 'protein', 'steroid nucleus': 'protein', 'CEM C7 cells': 'cell_line'}}
{'idx': 313, 'sentence': 'Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .', 'label': {'malignant soft tissue tumors': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"steroid hormones": "protein"}, {"estrogen binding assay": "protein"}]', 'prediction': {'steroid hormones': 'protein', 'estrogen binding assay': 'protein'}}
{'idx': 1285, 'sentence': "Characterization of 5' end of human thromboxane receptor gene .", 'label': {"5' end of human thromboxane receptor gene": 'DNA', 'human thromboxane receptor gene': 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 327, 'sentence': 'However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .', 'label': {'R-responsive enhancer region': 'DNA', 'EB1 -binding site': 'DNA', 'EB1': 'protein', 'ZRE-B': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"EB1": "protein"}, {"ZRE-B": "DNA"}, {"R-responsive enhancer region": "DNA"}]', 'prediction': {'EB1': 'protein', 'ZRE-B': 'DNA', 'R-responsive enhancer region': 'DNA'}}
{'idx': 1622, 'sentence': 'Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.', 'label': {'gamma interferon': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"proteins": "protein"}]', 'prediction': {'proteins': 'protein'}}
{'idx': 1393, 'sentence': 'This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .', 'label': {'second enhancer': 'DNA', 'T-cell activation response element': 'DNA', 'enhancer': 'DNA'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"HIV-1": "cell_type"},\n{"T-cell": "cell_type"},\n{"HIV-2": "cell_type"},\n{"T-cell": "cell_type"}\n]', 'prediction': {'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}}
{'idx': 1221, 'sentence': 'To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .', 'label': {'mouse osteocalcin gene': 'DNA', 'promoter': 'DNA', 'osteoblast-specific cis-acting elements': 'DNA', 'trans-acting factors': 'protein', 'osteoblast-specific gene': 'DNA'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 130, 'sentence': 'At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .', 'label': {'TREp': 'DNA', 'TR': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 788, 'sentence': 'The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).', 'label': {'mineralocorticoid receptors': 'protein'}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 781, 'sentence': 'Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1220, 'sentence': 'A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .', 'label': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin promoter': 'DNA', 'osteoblast-specific cis-acting element': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"PEBP2 alpha/AML-1-related factor": "protein"}, {"osteocalcin promoter": "DNA"}, {"osteoblast-specific cis-acting element": "cell_type"}]', 'prediction': {'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin promoter': 'DNA', 'osteoblast-specific cis-acting element': 'cell_type'}}
{'idx': 958, 'sentence': 'Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .', 'label': {'B-cell-specific genes': 'DNA', 'BSAP': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"Markus Neurath": "protein"}, {"Eckhard Stuber": "protein"}, {"Warren Strober": "protein"}, {"BSAP": "protein"}, {"B-cell-specific genes": "protein"}]', 'prediction': {'Markus Neurath': 'protein', 'Eckhard Stuber': 'protein', 'Warren Strober': 'protein', 'BSAP': 'protein', 'B-cell-specific genes': 'protein'}}
{'idx': 1083, 'sentence': 'These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .', 'label': {'cytokine': 'protein', 'NF kappa B': 'protein', 'PBMC': 'cell_type'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"tepoxalin": "protein"}, {"PBMC": "cell_type"}, {"iron": "protein"}, {"NF kappa B": "protein"}, {"cytokine": "protein"}]', 'prediction': {'tepoxalin': 'protein', 'PBMC': 'cell_type', 'iron': 'protein', 'NF kappa B': 'protein', 'cytokine': 'protein'}}
{'idx': 514, 'sentence': 'Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .', 'label': {'globin gene': 'DNA', 'enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1133, 'sentence': 'Both LCLs were found by EM to produce RVLP and EBV particles .', 'label': {'LCLs': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[]', 'response3': '[{"LCLs": "cell_line"}, {"RVLP": "protein"}, {"EBV": "protein"}]', 'prediction': {'LCLs': 'cell_line', 'RVLP': 'protein', 'EBV': 'protein'}}
{'idx': 1762, 'sentence': 'Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.', 'label': {'IL-2': 'protein', 'early gene': 'DNA', 'NF-kappa B': 'protein', 'Oct1': 'protein', 'transcription factors': 'protein', 'NF-AT': 'protein', 'AP-1': 'protein', 'IL-2 gene': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"IL-2 gene": "DNA"}, {"cysteamine": "protein"}, {"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"NF-AT": "protein"}, {"Oct1": "protein"}, {"IL-2 mRNA": "RNA"}]', 'prediction': {'IL-2 gene': 'DNA', 'cysteamine': 'protein', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein', 'IL-2 mRNA': 'RNA'}}
{'idx': 23, 'sentence': 'Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .', 'label': {'mutant E6 motif': 'DNA'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"E6 motif": "protein"}]', 'prediction': {'E6 motif': 'protein'}}
{'idx': 1476, 'sentence': 'Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .', 'label': {'AP-1 protein': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein', 'cytoplasmic inhibitor': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"AP-1 protein c-Jun": "protein"}, {"I kappa B": "protein"}, {"NF-kappa B": "protein"}]', 'prediction': {'AP-1 protein c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}}
{'idx': 234, 'sentence': 'A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .', 'label': {'cultured': 'cell_line', 'primary cells': 'cell_type', 'adenovirus E2 promoter': 'DNA', 'beta-galactosidase gene': 'DNA', 'beta-galactosidase': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"beta-galactosidase gene": "DNA"}, {"adenovirus E2 promoter": "DNA"}]', 'prediction': {'beta-galactosidase gene': 'DNA', 'adenovirus E2 promoter': 'DNA'}}
{'idx': 1396, 'sentence': 'NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .', 'label': {'hematopoietic progenitor cell line': 'cell_line', 'NF-M': 'protein', 'chicken C/EBP beta': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"NF-M": "protein"}, {"C/EBP beta": "protein"}, {"hematopoietic progenitor cell line": "cell_line"}]', 'prediction': {'NF-M': 'protein', 'C/EBP beta': 'protein', 'hematopoietic progenitor cell line': 'cell_line'}}
{'idx': 1812, 'sentence': 'The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .', 'label': {'G-protein coupled chemokine receptors': 'protein', 'chemokine receptors': 'protein', 'G-protein': 'protein', 'receptor EBI1': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"protein": "protein"}, {"G-protein coupled chemokine receptors": "protein"}, {"receptor EBI1": "protein"}]', 'prediction': {'protein': 'protein', 'G-protein coupled chemokine receptors': 'protein', 'receptor EBI1': 'protein'}}
{'idx': 1099, 'sentence': 'Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .', 'label': {'monocyte mitochondrial 1 alpha-hydroxylase': 'protein', 'monocyte': 'cell_type', 'microtubule': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the entity types in the target sentence are present in this example."},\n    {"Example 2": 1},\n    {"Reason 2": "None of the entity types in the target sentence are present in this example."},\n    {"Example 3": 1},\n    {"Reason 3": "None of the entity types in the target sentence are present in this example."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1537, 'sentence': 'Furthermore, we identified a repression domain at the N-terminus of Oct-2a .', 'label': {'Oct-2a': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Oct-2a": "protein"}]', 'prediction': {'Oct-2a': 'protein'}}
{'idx': 1574, 'sentence': 'CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .', 'label': {'receptors': 'protein', 'eosinophils': 'cell_type'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1312, 'sentence': 'A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.', 'label': {'HMG-1': 'protein', 'C-terminal HMG box': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 601, 'sentence': 'To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .', 'label': {'murine IgH enhancer': 'DNA', 'putative additional lymphoid-specific transcription factor': 'protein', 'octamer (OCTA)-nucleotide motif': 'DNA', 'NF-microB': 'protein', 'enhancer elements': 'DNA', 'immunoglobulin heavy-chain (IgH) gene': 'DNA', 'binding site': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"immunoglobulin heavy-chain": "protein"}, {"NF-microB": "protein"}]', 'prediction': {'immunoglobulin heavy-chain': 'protein', 'NF-microB': 'protein'}}
{'idx': 890, 'sentence': 'Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 323, 'sentence': 'The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .', 'label': {'Epstein-Barr virus ( EBV ) ORI1yt enhancer': 'DNA'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[]', 'response3': '[{"Epstein-Barr virus": "DNA"}, {"ORI1yt enhancer": "DNA"}, {"B-cell": "cell_type"}, {"EBV": "protein"}, {"R": "protein"}, {"Z": "protein"}]', 'prediction': {'Epstein-Barr virus': 'DNA', 'ORI1yt enhancer': 'DNA', 'B-cell': 'cell_type', 'EBV': 'protein', 'R': 'protein', 'Z': 'protein'}}
{'idx': 929, 'sentence': 'The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .', 'label': {'ORF': 'DNA', '272 carboxy-terminal amino acids': 'protein', 'ets-1': 'protein', 'human ets-1 protein': 'protein', '813-bp open reading frame': 'DNA', 'cDNA sequence': 'DNA', 'amino acid sequence': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"cDNA sequence": "DNA"}, {"amino acid sequence": "protein"}, {"human ets-1 protein": "protein"}]', 'prediction': {'cDNA sequence': 'DNA', 'amino acid sequence': 'protein', 'human ets-1 protein': 'protein'}}
{'idx': 6, 'sentence': 'Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .', 'label': {'Platelet-activating factor': 'protein', 'oncogene': 'DNA', 'human B cell line': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"Platelet-activating factor": "protein"}, {"phospholipid turnover": "cell_type"}, {"calcium flux": "cell_type"}, {"arachidonic acid liberation": "cell_type"}, {"eicosanoid generation": "cell_type"}, {"oncogene expression": "cell_type"}, {"human B cell line": "cell_line"}]', 'prediction': {'Platelet-activating factor': 'protein', 'phospholipid turnover': 'cell_type', 'calcium flux': 'cell_type', 'arachidonic acid liberation': 'cell_type', 'eicosanoid generation': 'cell_type', 'oncogene expression': 'cell_type', 'human B cell line': 'cell_line'}}
{'idx': 1478, 'sentence': 'Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.', 'label': {'activated T cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1793, 'sentence': 'The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .', 'label': {}, 'response1': "['protein', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 2},\n    {"Reason 2": "This sentence contains the entity type \'cell_type\', which is present in the target sentence. However, it does not contain other entity types like \'protein\'."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1473, 'sentence': 'Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .', 'label': {'NF-kappa B': 'protein', 'T cells': 'cell_type', 'AP-1': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"AP-1": "protein"}, {"NF-kappa B": "protein"}, {"T cells": "cell_type"}]', 'prediction': {'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}}
{'idx': 539, 'sentence': 'PMA enhanced slightly the stimulatory effect of PHA .', 'label': {'PHA': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1025, 'sentence': 'NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .', 'label': {'NFATc': 'protein', 'NK cells': 'cell_type', 'NFATc mRNA': 'RNA'}, 'response1': "['RNA', 'cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"NFATc": "protein"}, {"NFATc mRNA": "RNA"}, {"NK cells": "cell_type"}, {"CD16 ligands": "protein"}]', 'prediction': {'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}}
{'idx': 1560, 'sentence': 'Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .', 'label': {'human T helper (Th) clones': 'cell_line', 'CD30+ cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"T helper": "cell_type"}, {"CD30": "protein"}]', 'prediction': {'T helper': 'cell_type', 'CD30': 'protein'}}
{'idx': 365, 'sentence': 'Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.', 'label': {'c-jun': 'DNA', 'HL-60 cells': 'cell_line', 'untreated HL-60 cells': 'cell_line'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\', which is present in the target sentence, but it does not provide additional context or examples of named entities."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"c-jun gene": "DNA"}, {"HL-60 cells": "cell_line"}, {"TPA": "protein"}]', 'prediction': {'c-jun gene': 'DNA', 'HL-60 cells': 'cell_line', 'TPA': 'protein'}}
{'idx': 1039, 'sentence': 'Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .', 'label': {'Peripheral blood mononuclear cells': 'cell_type', 'pbmc': 'cell_type', 'bone marrow cells': 'cell_type'}, 'response1': "['RNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"Peripheral blood mononuclear cells": "cell_type"}, {"bone marrow cells": "cell_type"}, {"c-fos": "protein"}, {"c-myc": "protein"}, {"p53": "protein"}, {"bcr/abl mRNA": "RNA"}]', 'prediction': {'Peripheral blood mononuclear cells': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl mRNA': 'RNA'}}
{'idx': 217, 'sentence': 'Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .', 'label': {'GCR': 'protein', 'glucocorticoid receptors': 'protein', 'peripheral blood lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[\n{"glucocorticoid receptors": "protein"},\n{"glucocorticosteroids": "protein"},\n{"peripheral blood lymphocytes": "cell_type"},\n{"bronchial asthma": "cell_type"},\n{"GCR": "protein"},\n{"GCS": "protein"},\n{"endogenous cortisol": "protein"}\n]', 'prediction': {'glucocorticoid receptors': 'protein', 'glucocorticosteroids': 'protein', 'peripheral blood lymphocytes': 'cell_type', 'bronchial asthma': 'cell_type', 'GCR': 'protein', 'GCS': 'protein', 'endogenous cortisol': 'protein'}}
{'idx': 1782, 'sentence': 'In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .', 'label': {'Id3': 'protein', 'resting PBL': 'cell_type', 'Id3 mRNA': 'RNA', 'PBL': 'cell_type', 'Id2': 'protein', 'Id2 mRNA': 'RNA'}, 'response1': "['RNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"Id2 mRNA": "RNA"}, {"Id3 mRNA": "RNA"}]', 'prediction': {'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}}
{'idx': 1280, 'sentence': "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.", 'label': {'NF-kappa B': 'protein', 'TATA element': 'DNA', 'transcription factors': 'protein', 'CD69': 'protein', 'AP-1': 'protein', '30 base pairs upstream': 'DNA', 'CD69 gene': 'DNA', "5'-flanking region": 'DNA', 'transcription initiation site': 'DNA', 'Egr-1': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"CD69 gene": "DNA"}, {"TATA element": "DNA"}, {"NF-kappa B": "protein"}, {"Egr-1": "protein"}, {"AP-1": "protein"}]', 'prediction': {'CD69 gene': 'DNA', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}}
{'idx': 611, 'sentence': 'Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.', 'label': {}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"DNA viruses": "DNA"}, {"HIV-1": "RNA"}]', 'prediction': {'DNA viruses': 'DNA', 'HIV-1': 'RNA'}}
{'idx': 1723, 'sentence': 'In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .', 'label': {'tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA': 'RNA', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha': 'protein', 'TNF-alpha': 'protein'}, 'response1': "['cell_line', 'protein', 'RNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"monocyte/macrophage cell line": "cell_line"},\n    {"NF-kappa B": "protein"},\n    {"tumor necrosis factor-alpha (TNF-alpha) messenger RNA": "RNA"}\n]', 'prediction': {'monocyte/macrophage cell line': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor-alpha (TNF-alpha) messenger RNA': 'RNA'}}
{'idx': 1308, 'sentence': 'Two groups of HMG box proteins are distinguished.', 'label': {'HMG box proteins': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"HMG box proteins": "protein"}]', 'prediction': {'HMG box proteins': 'protein'}}
{'idx': 765, 'sentence': 'Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1561, 'sentence': 'In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .', 'label': {'CD30': 'protein', 'NF-kappa B complexes': 'protein', 'p65 RelA': 'protein', 'p50 NF-kappa B1': 'protein', 'NF-kappa B': 'protein', 'transcription factors': 'protein'}, 'response1': "['cell_line', 'protein']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B complexes": "protein"}, {"p50 NF-kappa B1": "protein"}, {"p65 RelA": "protein"}, {"transcription factors": "protein"}]', 'prediction': {'NF-kappa B complexes': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein', 'transcription factors': 'protein'}}
{'idx': 330, 'sentence': 'ZRE-B is therefore not part of the R- inducible enhancer .', 'label': {'ZRE-B': 'DNA', 'R- inducible enhancer': 'DNA'}, 'response1': 'None.', 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any specific named entities related to the entity labels provided."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1104, 'sentence': 'Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Ca2+": "protein"}, {"cyclic AMP": "protein"}]', 'prediction': {'Ca2+': 'protein', 'cyclic AMP': 'protein'}}
{'idx': 1594, 'sentence': 'Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .', 'label': {'Jurkat cells': 'cell_line', 'NF-kappa B -activating cytokine': 'protein', 'Human IL4 promoter': 'DNA', 'tumor necrosis factor alpha': 'protein', 'RelA -overexpressing cells': 'cell_line', 'NF-kappa B': 'protein', 'RelA': 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1086, 'sentence': 'Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .', 'label': {'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'human I kappa B alpha protein': 'protein', 'mouse 70Z/3 cells': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the examples contain entity types present in the target sentence, so they are not helpful in aiding the extraction of named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1, 'sentence': 'When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.', 'label': {'homeodomain': 'DNA', 'HB24': 'DNA', 'Drosophila homeodomain': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1226, 'sentence': 'Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .', 'label': {'transcription factors': 'protein', 'T-cell nuclear extract-DNA complexes': 'protein', 'OSF2': 'protein', 'osteoblast nuclear extract-DNA complexes': 'protein', 'PEBP2 alpha factors': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"DNA": "DNA"},\n    {"OSF2": "protein"},\n    {"PEBP2 alpha factors": "protein"}\n]', 'prediction': {'DNA': 'DNA', 'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}}
{'idx': 663, 'sentence': 'The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .', 'label': {}, 'response1': "['cell_line', 'cell_type', 'gene expression']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 1000, 'sentence': 'Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.', 'label': {'HSF2': 'protein', 'HSF3': 'protein', 'HSFs': 'protein', 'HSF1': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"HSF3": "protein"}, {"HSF1": "protein"}, {"HSF2": "protein"}]', 'prediction': {'HSF3': 'protein', 'HSF1': 'protein', 'HSF2': 'protein'}}
{'idx': 39, 'sentence': 'Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .', 'label': {'KBF1': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 229, 'sentence': "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .", 'label': {'B-cell line': 'cell_line', 'IM-9': 'cell_line', 'GR': 'protein', "CVZ 's binding sites": 'protein'}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"CVZ": "protein"}, {"IM-9": "cell_line"}, {"RU 38486": "protein"}, {"GR": "protein"}, {"CVZ": "protein"}, {"CVZ": "protein"}]', 'prediction': {'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'GR': 'protein'}}
{'idx': 743, 'sentence': 'Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .', 'label': {'erythroid cell transcription factor': 'protein', 'non-erythroid cells': 'cell_type', 'EF1': 'protein'}, 'response1': "['cell_type', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any specific entities mentioned in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence talks about tumors and clinical course, which are not relevant to the entities in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence mentions genes and isoforms, which are not related to the entities in the target sentence."}\n]', 'response3': '[{"EF1": "protein"}]', 'prediction': {'EF1': 'protein'}}
{'idx': 1799, 'sentence': 'These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .', 'label': {'GAS': 'DNA', 'IFN-gamma-activated sequence': 'DNA', 'STAT proteins': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[]\n[]', 'response3': '[{"STAT proteins": "protein"}, {"IFN-gamma-activated sequence": "DNA"}, {"oligonucleotides": "DNA"}]', 'prediction': {'STAT proteins': 'protein', 'IFN-gamma-activated sequence': 'DNA', 'oligonucleotides': 'DNA'}}
{'idx': 1703, 'sentence': "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .", 'label': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'IFN -activated NK cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"E1A": "protein"}, {"IFN": "protein"}, {"adenovirus-transformed cells": "cell_line"}, {"IFN": "protein"}, {"NK cells": "cell_type"}]', 'prediction': {'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}}
{'idx': 629, 'sentence': 'Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .', 'label': {'progesterone receptor': 'protein', 'CD8+ cells': 'cell_line', 'lymphocytes': 'cell_line', 'progesterone receptor -bearing cells': 'cell_line', 'CD4+ cells': 'cell_line'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"CD8+ cells": "cell_type"}, {"progesterone receptor-bearing cells": "protein"}, {"CD4+ cells": "cell_type"}, {"positively staining lymphocytes": "cell_type"}]', 'prediction': {'CD8+ cells': 'cell_type', 'progesterone receptor-bearing cells': 'protein', 'CD4+ cells': 'cell_type', 'positively staining lymphocytes': 'cell_type'}}
{'idx': 490, 'sentence': 'Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .', 'label': {'lymphokine genes': 'DNA', 'interleukin-2': 'protein'}, 'response1': "['protein', 'RNA']", 'response2': '[]', 'response3': '[{"Cyclosporin A": "protein"}, {"CsA": "protein"}, {"lymphokine genes": "DNA"}, {"interleukin-2": "protein"}]', 'prediction': {'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'DNA', 'interleukin-2': 'protein'}}
{'idx': 118, 'sentence': "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .", 'label': {'SCL': 'protein', "SCL 5' regulatory region": 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 493, 'sentence': 'Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .', 'label': {'NFAT-1 complex': 'protein', 'mitogen-inducible DNA-binding complexes': 'protein', 'kappa B complex': 'protein', 'interleukin-2': 'protein', 'interleukin-2 enhancer': 'DNA', 'HIV enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"DNA-binding complexes": "DNA"}, {"kappa B complex": "protein"}, {"NFAT-1 complex": "protein"}]', 'prediction': {'DNA-binding complexes': 'DNA', 'kappa B complex': 'protein', 'NFAT-1 complex': 'protein'}}
{'idx': 1798, 'sentence': 'In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .', 'label': {'purified human peripheral blood T cells': 'cell_type', 'anti-CD3 Abs': 'protein', 'nuclear STAT proteins': 'protein', 'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n    {"STAT proteins": "protein"},\n    {"T cells": "cell_type"},\n    {"anti-CD3 Abs": "protein"}\n]', 'prediction': {'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}}
{'idx': 175, 'sentence': 'To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.', 'label': {'blood mononuclear cells': 'cell_type', 'uncultured cells': 'cell_type'}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "This sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "This sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1498, 'sentence': 'Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.', 'label': {'lymphoblasts': 'cell_type'}, 'response1': "['DNA', 'cell_type']", 'response2': '[]', 'response3': '[{"DNA binding region": "DNA"}, {"steroid hormone receptor": "protein"}]', 'prediction': {'DNA binding region': 'DNA', 'steroid hormone receptor': 'protein'}}
{'idx': 995, 'sentence': 'The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[{"B-cell": "cell_type"}, {"mouse": "cell_line"}]', 'prediction': {'B-cell': 'cell_type', 'mouse': 'cell_line'}}
{'idx': 1671, 'sentence': 'Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .', 'label': {'IL-6 neutralizing antibodies': 'protein', 'IL-6': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 141, 'sentence': 'TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .', 'label': {'monocytic cells': 'cell_type', 'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV LTR": "DNA"}, {"T cells": "cell_type"}, {"monocytic cells": "cell_type"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV LTR': 'DNA', 'T cells': 'cell_type', 'monocytic cells': 'cell_type'}}
{'idx': 1557, 'sentence': "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .", 'label': {"Hodgkin's disease -derived, T cell-like, CD30 + cells": 'cell_line', 'nuclear factor (NF)-kappa B': 'protein', 'M44': 'protein', 'L540 cells': 'cell_line', 'M67': 'protein', 'mAb': 'protein', 'agonistic anti- CD30 monoclonal antibodies': 'protein', 'CD30': 'protein'}, 'response1': "['cell_line', 'protein', 'DNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "None of the examples contain entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1090, 'sentence': 'Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.', 'label': {'N terminus': 'protein', 'I kappa B alpha': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"I kappa B alpha": "protein"}]', 'prediction': {'I kappa B alpha': 'protein'}}
{'idx': 1568, 'sentence': 'The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .', 'label': {'enzymes': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 257, 'sentence': 'Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .', 'label': {}, 'response1': "['protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 262, 'sentence': 'This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .', 'label': {'complementary DNA': 'DNA', 'c-jun proto-oncogene product': 'protein', 'palindromic target sequence': 'DNA', 'c-jun': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"complementary DNA": "DNA"}, {"protein": "protein"}, {"c-jun": "protein"}, {"target sequence": "protein"}, {"palindromic target sequence": "protein"}, {"c-jun": "protein"}]', 'prediction': {'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun': 'protein', 'target sequence': 'protein', 'palindromic target sequence': 'protein'}}
{'idx': 1351, 'sentence': 'Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"25 kD": "protein"}, {"55 kD": "protein"}, {"alternative splicing": "RNA"}]', 'prediction': {'25 kD': 'protein', '55 kD': 'protein', 'alternative splicing': 'RNA'}}
{'idx': 973, 'sentence': 'To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .', 'label': {'MZF-1': 'DNA', 'DNA binding domain': 'protein', 'yeast transactivator GAL4': 'protein', 'GAL4': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"MZF-1": "protein"}, {"DNA": "DNA"}, {"GAL4": "protein"}]', 'prediction': {'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}}
{'idx': 1125, 'sentence': 'This indicates that the CR of GR may be of functional significance.', 'label': {'GR': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 338, 'sentence': 'Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .', 'label': {'T3R': 'protein', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any entities that match the entity types in the target sentence."},\n{"Example 2": 2},\n{"Reason 2": "The sentence contains the entity type \'cell_type\' which matches one of the entity types in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any entities that match the entity types in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1080, 'sentence': 'However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1786, 'sentence': 'Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .', 'label': {'coagulation protease': 'protein', 'tissue factor (TF) receptor': 'protein', 'plasma Factor VII/VIIa': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"Factor VII/VIIa": "protein"}, {"tissue factor (TF)": "protein"}]', 'prediction': {'Factor VII/VIIa': 'protein', 'tissue factor (TF)': 'protein'}}
{'idx': 1242, 'sentence': 'LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .', 'label': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"NF kappa B": "protein"}, {"p50/p65 heterodimers": "protein"}]', 'prediction': {'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}}
{'idx': 866, 'sentence': 'T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .', 'label': {'T cell': 'cell_type'}, 'response1': "['cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"T cell": "cell_type"}, {"HIV": "protein"}]', 'prediction': {'T cell': 'cell_type', 'HIV': 'protein'}}
{'idx': 433, 'sentence': 'Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .', 'label': {'regulatory regions': 'DNA', 'BSAP': 'protein', 'high-affinity binding site': 'DNA', 'B-lymphoid-specific genes': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"BSAP": "protein"}, {"immunoglobulin": "protein"}, {"class II major histocompatibility (MHC) genes": "protein"}, {"B-lymphoid-specific genes": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'protein', 'B-lymphoid-specific genes': 'cell_type'}}
{'idx': 1546, 'sentence': 'Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .', 'label': {'platelet glycoprotein Ib alpha gene': 'DNA', 'GATA': 'DNA', 'Ets binding motifs': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1412, 'sentence': 'We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .', 'label': {}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 411, 'sentence': 'There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).', 'label': {'VDR': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"VDR": "protein"}, {"serum phosphate": "cell_type"}]', 'prediction': {'VDR': 'protein', 'serum phosphate': 'cell_type'}}
{'idx': 1460, 'sentence': 'In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.', 'label': {'multiple myeloma cell lines': 'cell_line', 'PU.1': 'protein', 'Pu box': 'DNA', 'differentiated, plasma cell-like B cells': 'cell_type'}, 'response1': "['cell_line', 'DNA', 'protein', 'RNA']", 'response2': '[]\n[]', 'response3': '[{"PU.1 DNA binding activity": "DNA"}, {"mRNA expression": "RNA"}, {"Pu box -dependent transactivation": "DNA"}]', 'prediction': {'PU.1 DNA binding activity': 'DNA', 'mRNA expression': 'RNA', 'Pu box -dependent transactivation': 'DNA'}}
{'idx': 638, 'sentence': 'Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .', 'label': {'CD3': 'protein', 'TCR': 'protein', 'VLA-5 fibronectin receptor': 'protein', 'fibronectin': 'protein', 'CD4 cells': 'cell_line'}, 'response1': "['protein', 'cell_type']", 'response2': '[]\n[]', 'response3': '[{"VLA-5 fibronectin receptor": "protein"}, {"CD4 cells": "cell_type"}, {"CD3 - TCR": "cell_type"}, {"fibronectin": "protein"}]', 'prediction': {'VLA-5 fibronectin receptor': 'protein', 'CD4 cells': 'cell_type', 'CD3 - TCR': 'cell_type', 'fibronectin': 'protein'}}
{'idx': 1375, 'sentence': 'We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .', 'label': {'PBLs': 'cell_type', 'peripheral blood lymphocytes': 'cell_type', 'TCL1 mRNA': 'RNA', 'protein': 'protein'}, 'response1': "['RNA', 'protein', 'cell_type']", 'response2': '[\n    {"Example 1": 1},\n    {"Example 2": 3},\n    {"Example 3": 2}\n]', 'response3': '[\n    {"TCL1 mRNA": "RNA"},\n    {"protein": "protein"},\n    {"peripheral blood lymphocytes": "cell_type"},\n    {"PBLs": "cell_line"}\n]', 'prediction': {'TCL1 mRNA': 'RNA', 'protein': 'protein', 'peripheral blood lymphocytes': 'cell_type', 'PBLs': 'cell_line'}}
{'idx': 764, 'sentence': 'The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .', 'label': {'CEM-C7': 'cell_line', 'CEM-C7 cells': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 897, 'sentence': 'The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .', 'label': {'transcription of SV40 T-antigen': 'protein', 'NFAT-1': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"NFAT-1": "protein"}, {"SV40 T-antigen": "protein"}]', 'prediction': {'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}}
{'idx': 1842, 'sentence': 'Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .', 'label': {'Ets-1': 'protein', 'TFE-3': 'protein', 'LEF-1': 'protein', 'enhancer-binding proteins': 'protein', 'Sp1': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"LEF-1": "protein"}, {"Ets-1": "protein"}, {"TFE-3": "protein"}, {"Sp1": "protein"}]', 'prediction': {'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}}
{'idx': 1059, 'sentence': 'Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .', 'label': {'NF-kappa B family': 'protein', 'Transcription factors': 'protein', 'I kappa B beta': 'protein', 'inhibitory I kappa B proteins': 'protein', 'I kappa B alpha': 'protein', 'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NF-kappa B": "protein"}, {"I kappa B": "protein"}, {"I kappa B alpha": "protein"}, {"I kappa B beta": "protein"}]', 'prediction': {'NF-kappa B': 'protein', 'I kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}}
{'idx': 924, 'sentence': 'We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .', 'label': {'hsp70': 'protein', 'untransformed steroid receptors': 'protein', 'hsp90': 'protein', 'p56': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"p56": "protein"}, {"cytosol": "cell_type"}, {"hsp70": "protein"}, {"hsp90": "protein"}, {"steroid receptors": "protein"}]', 'prediction': {'p56': 'protein', 'cytosol': 'cell_type', 'hsp70': 'protein', 'hsp90': 'protein', 'steroid receptors': 'protein'}}
{'idx': 247, 'sentence': 'Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .', 'label': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type', 'lymphocytes': 'cell_type'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[{"Antigen B27": "protein"}, {"glucocorticoid receptors": "protein"}, {"blood lymphocytes": "cell_type"}]', 'prediction': {'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}}
{'idx': 507, 'sentence': 'Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .', 'label': {'TCF-2 alpha': 'protein', 'TCR alpha enhancer': 'DNA', 'CREB': 'protein', 'transcription factors': 'protein', 'T alpha 1': 'protein', 'TCR': 'protein', 'TCF-1 alpha': 'protein'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "This sentence does not contain any entities relevant to the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "This sentence does not contain any entities relevant to the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "This sentence does not contain any entities relevant to the target sentence."}\n]', 'response3': '[\n    {"TCF-1 alpha": "protein"},\n    {"TCF-2 alpha": "protein"},\n    {"T alpha 1": "protein"},\n    {"CREB": "protein"},\n    {"TCR alpha enhancer": "DNA"}\n]', 'prediction': {'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1': 'protein', 'CREB': 'protein', 'TCR alpha enhancer': 'DNA'}}
{'idx': 460, 'sentence': "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.", 'label': {'HIV LTRs': 'DNA', 'regulatory elements': 'DNA'}, 'response1': "['DNA']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 131, 'sentence': 'Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .', 'label': {'TRs': 'protein', 'carboxyl-terminus': 'protein', 'TR alpha 1': 'protein', 'nuclear proteins': 'protein', 'amino acid 210': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[]\n[]', 'response3': '[{"TR alpha 1": "protein"}, {"DNA": "DNA"}, {"TRs": "protein"}]', 'prediction': {'TR alpha 1': 'protein', 'DNA': 'DNA', 'TRs': 'protein'}}
{'idx': 692, 'sentence': 'The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .', 'label': {'virally encoded transactivator protein': 'protein', 'Tax -response element': 'DNA', 'TRE': 'DNA', 'human T-cell leukemia virus type I ( HTLV-I ) promoter': 'DNA', 'Tax': 'protein'}, 'response1': "['DNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[\n{"TRE": "DNA"},\n{"Tax": "protein"}\n]', 'prediction': {'TRE': 'DNA', 'Tax': 'protein'}}
{'idx': 43, 'sentence': 'T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .', 'label': {'cysteine-rich antigen segments': 'protein', 'T-helper-cell determinants': 'protein', 'protein antigens': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[]', 'response3': '[{"T-helper-cell": "cell_type"}, {"protein": "protein"}, {"cysteine-rich antigen segments": "protein"}, {"cathepsin B": "protein"}, {"cathepsin L": "protein"}, {"cathepsin D": "protein"}]', 'prediction': {'T-helper-cell': 'cell_type', 'protein': 'protein', 'cysteine-rich antigen segments': 'protein', 'cathepsin B': 'protein', 'cathepsin L': 'protein', 'cathepsin D': 'protein'}}
{'idx': 1204, 'sentence': 'Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.', 'label': {}, 'response1': "['cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any named entities related to the entity types in the target sentence."},\n{"Example 2": 3},\n{"Reason 2": "The sentence mentions tumors, ovary, and clinical course, which could potentially be related to cell_type entities."},\n{"Example 3": 2},\n{"Reason 3": "The sentence talks about genes and isoforms, which are related to DNA and RNA entities, but the context is not directly related to the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1134, 'sentence': 'Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .', 'label': {'LCLs': 'cell_line'}, 'response1': "['protein', 'cell_line']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 471, 'sentence': 'The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).', 'label': {'lymphocyte nuclear T3 receptor': 'protein'}, 'response1': "['protein', 'DNA']", 'response2': '[]\n[]', 'response3': '[{"T3 receptor": "protein"}, {"DNA": "DNA"}]', 'prediction': {'T3 receptor': 'protein', 'DNA': 'DNA'}}
{'idx': 1205, 'sentence': 'Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .', 'label': {}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 14, 'sentence': 'Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .', 'label': {'c-fos': 'DNA', 'nuclear proto-oncogenes': 'DNA', 'c-jun': 'DNA', 'platelet-activating factor': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"c-fos": "protein"}, {"c-jun": "protein"}]', 'prediction': {'c-fos': 'protein', 'c-jun': 'protein'}}
{'idx': 145, 'sentence': 'Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .', 'label': {'nuclear proteins': 'protein', 'major histocompatibility complex (MHC) class II promoters': 'DNA', 'B cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"X boxes": "protein"},\n{"Y boxes": "protein"},\n{"B cells": "cell_type"},\n{"major histocompatibility complex (MHC) class II": "protein"}\n]', 'prediction': {'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II': 'protein'}}
{'idx': 1449, 'sentence': 'DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.', 'label': {'upstream stimulatory factor': 'protein'}, 'response1': "['DNA']", 'response2': '[]\n[]', 'response3': '[{"DNA binding specificity": "DNA"}, {"complex 3": "protein"}, {"upstream stimulatory factor": "protein"}]', 'prediction': {'DNA binding specificity': 'DNA', 'complex 3': 'protein', 'upstream stimulatory factor': 'protein'}}
{'idx': 1292, 'sentence': "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .", 'label': {'thromboxane receptor': 'protein', 'thromboxane receptor gene': 'DNA', 'CAT': 'protein', 'chloramphenicol acetyltransferase': 'protein', "5' flanking region": 'DNA', 'thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids': 'DNA', 'K562 cells': 'cell_line'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[]\n[]', 'response3': '[{"thromboxane receptor gene": "DNA"}, {"thromboxane receptor gene": "protein"}, {"K562 cells": "cell_line"}]', 'prediction': {'thromboxane receptor gene': 'protein', 'K562 cells': 'cell_line'}}
{'idx': 120, 'sentence': 'Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.', 'label': {'RPMI 8402': 'cell_line', 'T cell lines': 'cell_line', 'CEM': 'cell_line'}, 'response1': "['cell_line']", 'response2': '[]\n[]', 'response3': '[{"CEM": "cell_line"}, {"RPMI 8402": "cell_line"}]', 'prediction': {'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}}
{'idx': 468, 'sentence': 'A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 138, 'sentence': 'The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .', 'label': {'beta interferon promoter': 'DNA', 'regulatory elements': 'DNA', 'HIV long terminal repeat': 'DNA', 'TNF-alpha': 'protein', 'LTR': 'DNA', 'reporter chloramphenicol acetyltransferase plasmids': 'DNA'}, 'response1': "['protein', 'DNA']", 'response2': '[\n{"Example 1": 1, "Example 2": 1, "Example 3": 1},\n{"Reason 1": "These examples do not contain any of the entity types present in the target sentence."},\n{"Reason 2": "The examples do not provide relevant information related to DNA, RNA, cell_type, protein, or cell_line entities."}\n]', 'response3': '[{"TNF-alpha": "protein"}, {"HIV long terminal repeat (LTR)": "DNA"}, {"beta interferon promoter": "DNA"}]', 'prediction': {'TNF-alpha': 'protein', 'HIV long terminal repeat (LTR)': 'DNA', 'beta interferon promoter': 'DNA'}}
{'idx': 64, 'sentence': 'Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .', 'label': {'IFN beta promoter deletions': 'DNA'}, 'response1': "['cell_line', 'protein']", 'response2': '[]', 'response3': '[{"HeLa": "cell_line"}, {"IFN beta": "protein"}]', 'prediction': {'HeLa': 'cell_line', 'IFN beta': 'protein'}}
{'idx': 1760, 'sentence': 'This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .', 'label': {}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 676, 'sentence': 'The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .', 'label': {'IL-2': 'protein', 'interleukin 2': 'protein', 'interleukin 2 ( IL-2 ) gene promoter': 'DNA', 'T-cell': 'cell_type'}, 'response1': "['DNA', 'cell_type', 'protein']", 'response2': '[]\n[]', 'response3': '[{"interleukin 2": "protein"}, {"IL-2": "protein"}, {"cell-type-specific": "cell_type"}, {"ubiquitous": "cell_type"}, {"transcriptional regulators": "protein"}, {"signaling systems": "cell_type"}, {"T-cell": "cell_type"}]', 'prediction': {'interleukin 2': 'protein', 'IL-2': 'protein', 'cell-type-specific': 'cell_type', 'ubiquitous': 'cell_type', 'transcriptional regulators': 'protein', 'signaling systems': 'cell_type', 'T-cell': 'cell_type'}}
{'idx': 1052, 'sentence': 'Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.', 'label': {'IL-2R alpha': 'protein', 'SEA': 'protein', 'IL-2R gamma': 'protein', 'SEB': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"IL-2R beta": "protein"}, {"IL-2R gamma": "protein"}, {"IL-2R alpha": "protein"}]', 'prediction': {'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}}
{'idx': 487, 'sentence': 'Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.', 'label': {'human monocytes': 'cell_type', 'normal human monocytes': 'cell_type', 'M-CSF': 'protein', 'immediate early response genes': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 570, 'sentence': 'Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1370, 'sentence': 'Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .', 'label': {'CD28': 'protein', 'anti- CD28 MoAb': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 994, 'sentence': 'The role of BSAP ( Pax-5 ) in B-cell development .', 'label': {'BSAP': 'protein', 'Pax-5': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[]', 'prediction': {}}
{'idx': 438, 'sentence': 'This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).', 'label': {'OTF factors': 'protein', 'nuclear proteins': 'protein', 'sequence motif': 'DNA', 'octamer transcription factors': 'protein', 'Oct': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"octamer transcription factors": "protein"}]', 'prediction': {'octamer transcription factors': 'protein'}}
{'idx': 270, 'sentence': 'There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .', 'label': {}, 'response1': "['DNA']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1481, 'sentence': 'We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 1807, 'sentence': 'We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .', 'label': {'cell genes': 'DNA', 'cyclin E': 'DNA', 'cyclin D2': 'DNA', 'CD23': 'DNA', 'cdc-2': 'DNA'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"cdc-2": "protein"}, {"cyclin E": "protein"}, {"CD23": "protein"}, {"cyclin D2": "protein"}]', 'prediction': {'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein'}}
{'idx': 1169, 'sentence': 'However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .', 'label': {'SPXX motifs': 'protein', 'nuclear targeting sequence': 'protein', 'gene regulatory proteins': 'protein', 'B4-2': 'DNA'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"B4-2": "protein"}, {"proline": "protein"}, {"nuclear targeting sequence": "protein"}, {"SPXX motifs": "protein"}, {"gene regulatory proteins": "protein"}]', 'prediction': {'B4-2': 'protein', 'proline': 'protein', 'nuclear targeting sequence': 'protein', 'SPXX motifs': 'protein', 'gene regulatory proteins': 'protein'}}
{'idx': 1180, 'sentence': 'We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .', 'label': {'IL-2R': 'protein', 'IL-2': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'IL-2 receptor': 'protein', 'JAK1': 'protein', 'IL-2R beta': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 968, 'sentence': 'These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.', 'label': {'NF-kappa B': 'protein'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"NF-kappa B": "protein"}]', 'prediction': {'NF-kappa B': 'protein'}}
{'idx': 497, 'sentence': 'The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .', 'label': {'T cells': 'cell_type'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"T cells": "cell_type"}, {"proteins": "protein"}]', 'prediction': {'T cells': 'cell_type', 'proteins': 'protein'}}
{'idx': 1606, 'sentence': 'Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .', 'label': {'CD11b/CD18': 'protein', 'CD35': 'protein', 'p50/p65': 'protein', 'CR1': 'protein', 'HIV-infected monocytic cells': 'cell_type', 'complement receptors': 'protein', 'human monocytes': 'cell_type', 'NF-kappa B': 'protein', 'CR3': 'protein'}, 'response1': "['protein', 'cell_type']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "This sentence does not contain any of the entity types present in the target sentence, so it is not helpful for predicting named entities."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1653, 'sentence': 'Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .', 'label': {'nonmyeloid cells': 'cell_type', 'GM-CSF': 'protein', 'PU.1': 'protein', 'GM-CSF receptor alpha promoter': 'DNA'}, 'response1': "['protein']", 'response2': '[\n    {"Example 1": 1},\n    {"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 2": 1},\n    {"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n    {"Example 3": 1},\n    {"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 833, 'sentence': 'Mapping of B-cell epitopes of the human hepatitis B virus X protein .', 'label': {'human hepatitis B virus X protein': 'protein', 'B-cell epitopes': 'protein'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"hepatitis B virus X protein": "protein"}]', 'prediction': {'hepatitis B virus X protein': 'protein'}}
{'idx': 389, 'sentence': 'The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .', 'label': {'periplasmic domain': 'protein', 'PhoQ protein': 'protein', 'cationic proteins': 'protein', 'defensin': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"PhoQ protein": "protein"}, {"defensin": "protein"}]', 'prediction': {'PhoQ protein': 'protein', 'defensin': 'protein'}}
{'idx': 193, 'sentence': 'The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .', 'label': {'c-myc': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 1349, 'sentence': 'Its expression was always restricted to the nucleus .', 'label': {}, 'response1': "['cell_type']", 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 882, 'sentence': 'This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .', 'label': {'c-Jun': 'protein', 'heterodimeric activator protein-1 transcription complex': 'protein', 'c-Fos': 'protein', 'cDNA': 'DNA', 'human c-Jun protein': 'protein', 'cDNA clone': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]', 'response3': '[{"cDNA clone": "DNA"}, {"human c-Jun protein": "protein"}, {"c-Fos": "protein"}, {"activator protein-1": "protein"}]', 'prediction': {'cDNA clone': 'DNA', 'human c-Jun protein': 'protein', 'c-Fos': 'protein', 'activator protein-1': 'protein'}}
{'idx': 725, 'sentence': 'Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .', 'label': {'Rex': 'protein', 'HTLV-infected cells': 'cell_type', 'gag/pol': 'protein', 'env mRNA': 'RNA'}, 'response1': "['RNA', 'protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[\n{"Rex": "protein"},\n{"gag/pol": "protein"},\n{"env mRNA": "RNA"},\n{"HTLV-infected cells": "cell_line"}\n]', 'prediction': {'Rex': 'protein', 'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_line'}}
{'idx': 867, 'sentence': 'In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).', 'label': {'conserved binding sites': 'DNA', 'nuclear factor kappa B': 'protein', 'long terminal repeat': 'DNA', 'LTR': 'DNA', 'NF kappa B': 'protein', 'transcriptional enhancer': 'DNA'}, 'response1': "['DNA', 'protein']", 'response2': '[]\n[]', 'response3': '[{"long terminal repeat": "DNA"}, {"transcriptional enhancer": "DNA"}, {"nuclear factor kappa B": "protein"}]', 'prediction': {'long terminal repeat': 'DNA', 'transcriptional enhancer': 'DNA', 'nuclear factor kappa B': 'protein'}}
{'idx': 841, 'sentence': 'Such tests may become useful diagnostic tools .', 'label': {}, 'response1': 'None.', 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any specific entities related to the given entity labels."}\n]', 'response3': '[]', 'prediction': {}}
{'idx': 956, 'sentence': 'BSAP : a key regulator of B-cell development and differentiation .', 'label': {'BSAP': 'protein', 'B-cell': 'cell_type'}, 'response1': "['protein']", 'response2': '[]', 'response3': '[{"BSAP": "protein"}, {"B-cell": "cell_type"}]', 'prediction': {'BSAP': 'protein', 'B-cell': 'cell_type'}}
{'idx': 1769, 'sentence': 'We have tried to find out whether these receptors could show any difference in sex or age distribution.', 'label': {}, 'response1': 'None.', 'response2': '[]\n[]', 'response3': '[]', 'prediction': {}}
{'idx': 110, 'sentence': 'Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .', 'label': {'long terminal repeat': 'DNA', 'NF-KB': 'protein', 'double repeat-KB enhancer sequence': 'DNA', 'cellular transactivation factor': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"NF-KB": "protein"}]', 'prediction': {'NF-KB': 'protein'}}
{'idx': 1379, 'sentence': 'Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .', 'label': {'TCL1': 'DNA'}, 'response1': "['protein']", 'response2': '[\n{"Example 1": 1},\n{"Reason 1": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 2": 1},\n{"Reason 2": "The sentence does not contain any of the entity types present in the target sentence."},\n{"Example 3": 1},\n{"Reason 3": "The sentence does not contain any of the entity types present in the target sentence."}\n]', 'response3': '[{"TCL1": "protein"}]', 'prediction': {'TCL1': 'protein'}}
{'idx': 1338, 'sentence': 'The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .', 'label': {'Bcl-2 family': 'protein', 'cellular proteins': 'protein'}, 'response1': "['protein']", 'response2': '[]\n[]', 'response3': '[{"Bcl-2": "protein"}]', 'prediction': {'Bcl-2': 'protein'}}
{'idx': 1323, 'sentence': 'PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .', 'label': {'PRE-I': 'DNA', 'Jurkat cells': 'cell_line', 'multiple DNA-protein complexes': 'protein'}, 'response1': "['DNA', 'protein', 'cell_line']", 'response2': '[]', 'response3': '[{"PRE-I": "DNA"}, {"Jurkat cells": "cell_line"}]', 'prediction': {'PRE-I': 'DNA', 'Jurkat cells': 'cell_line'}}
